memoria de investigación hospital clínico san carlos

2009
MEMORIA DE INVESTIGACIÓN
HOSPITAL CLÍNICO SAN CARLOS
Elaborado por:
Fundación para la Investigación Biomédica del HCSC
Muchas gracias a Náyade del Prado, Manuel Espantaleón y Emilio
Vargas por su colaboración en la elaboración de este documento
1
Índice
Publicaciones científicas
1. Estrategia de búsqueda bibliográfica……………………………………………………………
4
2. Número de publicaciones según tipo……………………………………………………………
4
3. Idioma de las publicaciones………………………………………………………………………….
5
4. Factor de impacto y distribución en cuartiles por tipo de publicación ............ 5
5. Evolución del factor de impacto de los artículos originales desde el año 2000 6
6. Número de publicaciones por área temática de la WOK………………………………. 7
7. Listado de los investigadores con mayor número de publicaciones (mínimo
7) y mayor factor de impacto total (mínimo 25)…………………………………………… 8
Proyectos de investigación
8. Solicitudes en concurrencia competitiva………………………………………………………
11
9. Proyectos obtenidos en concurrencia competitiva y activos en 2009…………...
12
10. Ensayos clínicos……………………………………………………………………………………………
13
Anexos
11. Listado de publicaciones del HCSC correspondientes al año 2009………………… 14
12. Listado de proyectos competitivos del HCSC activos durante el año 2009…. 52
2
Publicaciones científicas
3
1. Estrategia de búsqueda bibliográfica
Se realizó una búsqueda bibliográfica en Web of Knowledge (WOK) de ISI. La búsqueda se
realizó en la sección ‘All Databases’ con las variantes:
Clin OR Clin OR Clinico OR Univ OR Universitario OR Universitary en Address AND S Carlos OR
San Carlos en Address AND Hosp* en Address AND Year Published = 2009. El resultado se
exporta mediante Output Records seleccionando Step 1 Todos los Records, Step 2 plus
Abstract y Step 3 Save to Plain Text y posteriormente desde este archivo a Excel.
2. Número de publicaciones según tipo
Correction
3 (0,6%)
Proceedings Paper
19 (3,9%)
Review
33 (6,7%)
Letter
38 (7,7%)
Editorial Material
32 (6,5%)
Meeting Abstract
100 (20,3%)
Article
268 (54,4%)
0
50
100
150
200
250
300
Figura 1. Número de publicaciones según tipo.
El 75% de las publicaciones científicas del Hospital Clínico San Carlos durante el año 2009 se
correspondieron con artículos originales y abstracts.
4
3. Idioma de las publicaciones
2. Número de publicaciones según tipo
Figura 2. Idioma de publicación.
4. Factor de impacto y distribución en cuartiles por tipo de publicación (JCR 2009)
Tabla 1. Factor de impacto y distribución en
cuartiles según el tipo de publicación
Tipo de publicación
Article
Proceedings paper
Review
Total general
Tipo de publicación
Article
Proceedings paper
Review
Total general
Q1
81
2
15
98 (31,1%)
Factor de impacto
Total
Medio
827,24
3,09
40,98
2,16
100,15
3,03
968,36
3,03
Nº de publicaciones
Q3
Q2
50
71
5
5
5
7
60 (26,3%)
83 (26,3%)
Q4
62
7
5
74 (23,5%)
5
5. Evolución del factor de impacto de los artículos originales desde el año 2000
En la Figura 2 se presenta la evolución del factor de impacto total de los artículos
originales publicados desde el año 2000. El factor de impacto del periodo 2000-2007 se
ha extraído de las memorias de investigación realizadas por la Unidad de Apoyo
Metodológico del Hospital Clínico San Carlos.
La metodología empleada en la elaboración de las memorias del periodo 2000-2007
frente a la empleada en las memorias 2008-2009 es diferente, circunstancia que debe
tenerse en cuenta al interpretar el ascenso en el impacto de los dos últimos año; las
memorias del periodo 2000-2007 tomaban como unidad de análisis las publicaciones
notificadas por los servicios del hospital, mientras que las memorias de los años 2008 y
2009 obtienen la información de búsquedas bibliográficas en bases de datos
electrónicas.
900
827,24
751,70
Factor de impacto total
800
700
630,11
600
562,76
2005
2006
457,53
500
400
556,05
329,45
358,96
310,41
292,44
2002
2003
300
200
100
0
2000
2001
2004
2007
2008
2009
Año
Figura 3. Evolución del factor de impacto total desde el año 2000.
6
6. Número de publicaciones por área temática de la WOK
Tabla 2. Número de publicaciones por área temática de la WOK.
Área temática
Allergy; Immunology
Tipo de publicación
Article
Review
Automation & Control Systems; Computer Science, Artificial Intelligence Article
Behavioral Sciences; Clinical Neurology; Psychiatry
Article
Biochemical Research Methods; Biochemistry & Molecular Biology
Review
Biochemistry & Molecular Biology
Article
Biophysics; Engineering, Biomedical; Physiology
Article
Biotechnology & Applied Microbiology; Genetics & Heredity
Article
Cardiac & Cardiovascular Systems
Article
Proceedings paper
Cell Biology; Immunology; Pathology
Article
Chemistry, Medicinal
Article
Clinical Neurology
Article
Proceedings Paper
Review
Computer Science, Interdisciplinary Applications
Article
Dentistry, Oral Surgery & Medicine
Review
Dermatology
Article
Endocrinology & Metabolism
Article
Engineering, Multidisciplinary
Article
Environmental Sciences
Article
Gastroenterology & Hepatology
Article
Review
Genetics & Heredity
Article
Geriatrics & Gerontology
Article
Health Care Sciences & Services
Article
Hematology
Article
Immunology
Article
Proceedings paper
Infectious Diseases
Article
Proceedings Paper
Review
Medicine, General & Internal
Article
Medicine, Research & Experimental; Pathology
Article
Multidisciplinary Sciences
Article
Mycology; Veterinary Sciences
Article
Neurosciences
Article
Proceedings paper
Review
Nursing
Article
Obstetrics & Gynecology
Article
Oncology
Article
Proceedings Paper
Review
Ophthalmology
Article
Proceedings paper
Nº
7
1
1
2
1
8
1
2
38
3
3
1
25
1
4
1
1
1
8
1
2
13
2
4
1
1
9
10
9
6
2
1
13
1
1
1
5
1
3
1
1
29
1
8
12
1
7
Tabla 2. Número de publicaciones por área temática de la WOK.
Área temática
Otorhinolaryngology
Pediatrics
Peripheral Vascular Disease
Pharmacology & Pharmacy
Psychiatry
Psychology, Clinical
Public, Environmental & Occupational Health
Radiology, Nuclear Medicine & Medical Imaging
Respiratory System
Rheumatology
Tipo de publicación
Article
Article
Article
Article
Article
Article
Article
Article
Article
Article
Proceedings Paper
Review
Article
Review
Article
Review
Article
Surgery
Urology & Nephrology
Virology
Total general
Nº
1
2
3
3
6
8
5
4
3
12
1
4
6
1
11
1
1
320
7. Listado de los investigadores con mayor número de publicaciones (mínimo 7) y
mayor factor de impacto total (mínimo 25)
Investigador
Gómez de la Concha, Emilio
Urcelay, Elena
Fernández-Arquero, Miguel
Martínez, Alfonso
Macaya, Carlos
Martín, Miguel
Díaz-Rubio, Manuel
Pérez de Isla, Leopoldo
Zamorano, José Luis
Sastre, Javier
Pérez-Flores, Isabel
Núñez, Concepción
López-Ibor, Juan José
Díaz-Rubio, Eduardo
Taxonera, Carlos
Calvo, Natividad
Mendoza, Juan Luis
Fernández-Gutiérrez, Benjamín
Barquero, María Sagrario
Servicio
Inmunología
Inmunología
Inmunología
Inmunología
Cardiología
Oncología
Ap. Digestivo
Cardiología
Cardiología
Oncología
Nefrología
Inmunología
Psiquiatría
Oncología
Ap. Digestivo
Nefrología
Ap. Digestivo
Reumatología
Neurología
Nº de
publicaciones
18
16
15
13
12
10
10
10
9
9
9
9
8
8
7
7
7
7
7
8
Investigador
Gómez de la Concha, Emilio
González-Larriba, José Luis
Urcelay, Elena
Macaya, Carlos
Fernández-Arquero, Miguel
Martínez, Alfonso
Lopez-Ibor, Juan José
Martín, Miguel
Bañuelos, Camino
Díaz-Rubio, Manuel
Alfonso, Fernando
Núñez, Concepción
Hernández, Rosa Ana
Escaned, Javier
Jiménez-Quevedo, Pilar
Fernández-Gutiérrez, Benjamín
Aragoncillo, Paloma
Taxonera, Carlos
Mendoza, Juan Luis
Díaz-Rubio, Eduardo
Fernández-Rivas, Montserrat
Servicio Suma de FI
Inmunología
62,55
Oncología
59,90
Inmunología
58,72
Cardiología
51,87
Inmunología
50,39
Inmunología
45,98
Psiquiatría
38,27
Oncología
36,18
Cardiología
35,59
Ap. Digestivo
34,89
Cardiología
32,46
Inmunología
31,15
Cardiología
30,10
Cardiología
30,10
Cardiología
30,10
Reumatología
29,44
Anat. Patológica
27,85
Ap. Digestivo
27,38
Ap. Digestivo
26,10
Oncología
25,91
Alergia
25,35
9
Proyectos de investigación
10
8. Solicitudes concedidas en concurrencia competitiva
Durante el año 2009 fueron concedidos, en concurrencia competitiva, un total de 29
proyectos en el Hospital Clínico San Carlos (HCSC), ascendiendo a 2.346.101€
concedidos por las entidades financiadoras para todas las anualidades de los
proyectos. El 76% de las solicitudes se presentaron a agencias públicas de financiación
y el 24% a entidades privadas. La Figura 4 resume el número de solicitudes por tipo de
convocatoria.
MICINN-Investigación Fundamental
1
MICINN-Estrategias y ERANETS
1
MICINN-Infraestructuras
1
MSPS-Traslación Apl. Terapéutica
1
ISCIII-AES-RETICS
2
CE/PROGRAMA MARCO
2
ISCIII-AES-Evaluación Tec. Sanitarias
4
ISCIII-AES-Proyectos de investigación
5
MSPS-Estrategias de Salud
5
FMM
7
0
1
2
3
4
5
6
7
8
Figura 4. Número de proyectos concedidos en 2009 en convocatorias competitivas.
11
9. Proyectos obtenidos en concurrencia competitiva y activos en 2009
Durante el año 2009 la Fundación para la Investigación Biomédica del Hospital Clínico
San Carlos (FIBHCSC) tenía registrados como activos un total de 148 proyectos
obtenidos en concurrencia competitiva; el 56,1% tenían financiación pública, un 37,8%
financiación privada y el 6,1% estaban cofinanciados.
El 94% de los proyectos eran nacionales y había 9 proyectos internacionales, 8 de ellos
con financiación exclusiva procedente de la Comisión Europea, tanto del Sexto como
del Séptimo Programa Marco.
La Figura 5 muestra la distribución de los proyectos activos según el origen de la
financiación.
Otros privados
1
Otros públicos
2
Fundación Maphre
2
MICINN
7
Comisión Europea/Programa Marco/NIH
9
MSPS
13
Fundación Mutua Madrileña
53
ISCIII
64
0
10
20
30
40
50
60
70
Figura 5. Número de proyectos activos en 2009 según origen de la financiación.
12
El siguiente listado muestra la distribución del número de proyectos en función del
servicio asistencial de procedencia del investigador principal:
Alergia
4
Microbiología
1
Anatomía Patológica
4
Nefrología
2
Angiología y Cirugía Vascular
1
Neonatología
1
Aparato Digestivo
6
Neumología
2
Cardiología
11
Neurocirugía
2
Cardiología Intervencionista
5
Neurología
12
Cirugía General I
3
Obstetricia y Ginecología
2
Cirugía General II
2
Oftalmología
7
Cirugía Mayor Ambulatoria (CMA)
2
Oncología Médica
13
Cirugía Torácica
1
Psicología Clínica
1
Dirección Enfermería
1
Psiquiatria
13
Endocrinología
5
Radiodiagnóstico
2
Farmacología Clínica
1
Reumatología
4
Física Médica
4
Sala Blanca
1
Geriatria
1
Subdirección Enfermería
2
Inmunología
7
Traumatología y C. Ortopédica
4
Medicina Interna
2
UCM
2
Medicina Interna III
4
Unidad de Arritmias
1
Medicina Nuclear
1
Unidad de Ecocardiografía
5
Medicina Preventiva
4
Urgencias
1
10. Ensayos clínicos
La FIBHCSC tenía registrados en el año 2009 un total de 550 ensayos clínicos activos,
de los cuales el 47% habían comenzado en el año 2008 y el 10,5% en el mismo año
2009.
13
11. Listado de publicaciones del HCSC correspondientes al año 2009
1.
Fernandez-Rivas, M. The place of lipid transfer proteins (LTP) in the cross -reactivity of plant foods.
Rev. Fr. Allergol., 2009; 49(5):433-436.
2.
Kummeling, I; Mills, ENC; Clausen, M; Dubakiene, R; Perez, CF; Fernandez-Rivas, M; Knulst, AC;
Kowalski, ML; Lidholm, J; Le, TM; Metzler, C; Mustakov, T; Popov, T; Potts, J; van Ree, R; Sakellariou,
A; Tondury, B; Tzannis, K; Burney, P. The EuroPrevall sur veys on the prevalence of food allergies in
children and adults: background and study methodology. Allergy, 2009; 64(10):1493-1497.
3.
del Rio, PR; Gonzalez-Gutierrez, ML; Sanchez-Lopez, J; Nunez-Acevedo, B; Alvarez, JMB; MartinezCocera, C. Urticaria Caused by Antihistamines: Report of 5 Cases. J. Invest. Allergol. Clin. Immunol.,
2009; 19(4):317-320.
4.
Schulten, V; Radakovics, A; Hartz, C; Mari, A; Vazquez-Cortes, S; Fernandez-Rivas, M; Lauer, I; JahnSchmid, B; Eiwegger, T; Scheurer, S; Bohle, B. Characteriza tion of the allergic T-cell response to Pru
p 3, the nonspecific lipid transfer protein in peach. J. Allergy Clin. Immunol., 2009; 124(1):100-107.
5.
Fernandez-Rivas, M; Fernandez, SG; Nadal, JA; de Durana, MDAD; Garcia, BE; Gonzalez-Mancebo, E;
Martin, S; Barber, D; Rico, P; Tabar, AI. Randomized double-blind, placebo-controlled trial of
sublingual immunotherapy with a Pru p 3 quantified peach extract. Allergy, 2009; 64(6):876 -883.
6.
Rivas, MF. Food Allergy in Alergologica -2005. J. Invest. Allergol. Clin. Immunol., 2009; 19(Suppl.
2):37-44.
7.
Serrano, P; Justicia, JL; Sanchez, C; Cimarra, M; Fernandez-Tavora, L; Orovitg, A; Moreno, C; Guerra,
F; Alva, V. Systemic tolerability of specific subcutaneous immunotherapy with index -of-reactivitystandardized allergen extracts administered using clustered regimens: a retrospective,
observational, multicenter study. Ann. Allergy Asthma Immunol., 2009; 102(3):247 -252.
8.
de Arellano, IRR; Vazquez-Cortes, S; Sinaniotis, AC; Fernandez-Rivas, M. False Positive Placebo
Reaction in a Double-Blind Placebo-Controlled Food Challenge [Editorial] J. Invest. Allergol. Clin.
Immunol., 2009; 19(3):241-242.
9.
Rodriguez-del Rio, P; Sanchez-Lopez, J; Robledo Echarren, T; Martinez-Cocera, C; Fernandez-Rivas,
M. Selective allergy to Venus antiqua clam [Editorial] Allergy, 2009; 64(5):815-815.
10. Schulten, V; Radakovics, A; Hartz, C; Mari, A; Vazquez-Cortes, S; Fernandez-Rivas, M; Lauer, I; JahnSchmid, B; Eiwegger, T; Scheurer, S; Bohle, B. Characterisation of the allergic T cell response to Pru p
3, the nonspecific lipid transfer protein in peach. Allergy, 2009; 64(Suppl. 90):99-.
11. de Lema, BMG; Perez, MR; del Rio, PR; Echarren, TR; Gutierrez, MG; Cocera, CM. Feno and ECP as
markers of bronchial inflammation in a population of grass pollen allergic patients. Allergy, 2009;
64(Suppl. 90):421-.
12. Fernandez-Rivas, M; Tolosa, LB; Vazquez-Cortes, S; Zayas, L; Rodriguez-Jimenez, B; Fernandez, C;
Cocera, CM. Grass pollen allergy: factors associated with an asthma phenotype in patients from
Spain. Allergy, 2009; 64(Suppl. 90):834-.
13. Hoffmann-Sommergruber, K; Sancho, A; Holzhauser, T; Lidholm, J; Marknell, DA; Skov, P; Alessandri,
S; Lovegrove, A; Marsh, J; Neubauer, A; Lauer, I; Hofstetter, G; Radauer, C; Reese, G; FernandezRivas, M; Vieths, S; Shewry, P; Mills, C. Update on the Europrevall food allergen library:
requirements for high quality allergens to improve in vitro diagnosis. Allergy, 2009; 64(Suppl.
90):931-.
14
14. Sifuentes, LG; Pastor, C; Acevedo, BN; Cortes, SV; Cocera, CM; Fernandez-Rivas, M. Life-threatening
anaphylaxis in an adult patient monosensi tised to almond: a case report. Allergy, 2009; 64(Suppl.
90):943-.
15. del Rio, PR; Vazquez-Cortes, S; Tolosa, LB; de Arellano, IRR; Martinez-Cocera, C; Fernandez-Rivas, M.
Factors related to positive outcome of double-blind placebo-controlled food challenges in egg
allergic children. Allergy, 2009; 64(Suppl. 90):948-.
16. Perez, MR; Fernandez, CG; Marin, PR; de Arcaya, CVD. First description of contact dermatitis to
eupatorium aromatizans, a compositae plant of the Dominican Republic. Allergy, 2009; 64(Suppl.
90):1036-.
17. Acevedo, BN; Tolosa, LB; Vazquez-Cortes, S; Martin, FC; Martin, MC; Sifuentes, LG; Cocera, CM;
Fernandez-Rivas, M. Component resolved diagnosis of grass pollen allergic patients from Spain.
Allergy, 2009; 64(Suppl. 90):1108-.
18. Rodriguez-Alvarez, M; Rivas, MF; Vazquez-Cortes, S; del Rio, PR; Zayas, L; Echarren, TR; Cocera, CM.
Follow up of desensitised patients and immunological changes after specific oral tolerance
induction to milk. Allergy, 2009; 64(Suppl. 90):1258 -.
19. Vazquez-Cortes, S; Escudero, SC; Acevedo, BN; Radauer, C; Zayas, L; Griesmeier, U; Breiteneder, H;
Fernandez-Rivas, M. Diagnostic performance of an rGad c 1 and rCyp c 1 specific immunoassay.
Allergy, 2009; 64(Suppl. 90):1322-.
20. Ruiz-Gimenez, L; Moreira, A; Rodriguez, R; Rubira, JG; Ferna ndez-Rivas, M. Kounis syndrome due to
amoxicillin. Allergy, 2009; 64(Suppl. 90):1392-.
21. Fernandez-Rivas, M; Barreales, L; Fernandez, C; Rodriguez-Jimenez, B; Zayas, L; Cimarra, M;
Martinez-Cocera, C. Factors Associated With The Presence Of Asthma In Grass P ollen Allergic
Patients From Spain. J. Allergy Clin. Immunol., 2009; 123(2. Suppl. S):54 -.
22. Rodriguez-Alvarez, M; Rivas, MF; Echarren, TR; Cortes, SV; Martinez-Cocera, C. Prognostic Markers
For Specific Oral Tolerance Induction (soti) To Milk. J. Allergy Cl in. Immunol., 2009; 123(2. Suppl.
S):83-.
23. Asero, R; Fernandez-Rivas, M; Knulst, AC; Bruijnzeel -Koomen, CAFM. Double-blind, placebocontrolled food challenge in adults in everyday clinical practice: a reappraisal of their limitations and
real indications. Curr. Opin. Allergy Clin. Immunol., 2009; 9(4):379-385.
24. Abasolo, D; Hornero, R; Espino, P. APPROXIMATE ENTROPY OF EEG BACKGROUND ACTIVITY IN
ALZHEIMER'S DISEASE PATIENTS. Intell. Autom. Soft Comput., 2009; 15(4):591 -603.
25. Maestu, F; Campo, P; Garcia-Morales, I; del Barrio, A; Paul, N; del Pozo, F; Ortiz, T; Gil -Nagel, A.
Biomagnetic profiles of verbal memory success in patients with mesial temporal lobe epilepsy.
Epilepsy Behav., 2009; 16(3):527-533.
26. Garcia-Morales, I; Maestu, F; Perez-Jimenez, MA; Elices, E; Ortiz, T; Alvarez-Linera, J; Gil-Nagel, A. A
clinical and magnetoencephalography study of MRI -negative startle epilepsy. Epilepsy Behav., 2009;
16(1):166-171.
27. Camafeita, E; Lamas, JR; Calvo, E; Lopez, JA; Fernandez-Gutierrez, B. Proteomics: New insights i nto
rheumatic diseases. Proteom. Clin. Appl., 2009; 3(2):226 -241.
28. Bernal-Lopez, MR; Ripodas, A; Aragoncillo, P; Carbonell, A; Rufilanchas, JJ; Fernandez-Durango, R;
Tinahones, FJ; Gomez-Huelgas, R; Fernandez-Cruz, A. Characterization and localization of the
endothelin receptors in human end-stage heart failure ETA/ETB receptor system-Role in the failing
human heart. Process Biochem., 2009; 44(6):661-667.
15
29. Varade, J; Lamas, JR; Fernandez-Arquero, M; Jover, JA; de la Concha, EG; Martinez, A; FernandezGutierrez, B; Urcelay, E. NO role of NOS2A susceptibility polymorphisms in rheumatoid arthritis.
Nitric Oxide-Biol. Chem., 2009; 21(40271):171-174.
30. Ruiz, E; Redondo, S; Gordillo-Moscoso, A; Rodriguez, E; Reguillo, F; Martinez-Gonzalez, J; Tejerina, T.
EPC adhesion to arteries from diabetic and non-diabetic patients: effect of pioglitazone. Front.
Biosci., 2009; 14():3608-3618.
31. Antoniou, AC; Sinilnikova, OM; McGuffog, L; Healey, S; Nevanlinna, H; Heikkinen, T; Simard, J;
Spurdle, AB; Beesley, J; Chen, XQ; Neuhausen, SL; Ding, YC; Couch, FJ; Wang, XS; Fredericksen, Z;
Peterlongo, P; Peissel, B; Bonanni, B; Viel, A; Bernard, L; Radice, P; Szabo, CI; Foretova, L; Zikan, M;
Claes, K; Greene, MH; Mai, PL; Rennert, G; Lejbkowicz, F; Andrulis, IL; Ozcelik, H; Glendon, G;
Gerdes, AM; Thomassen, M; Sunde, L; Caligo, MA; Laitman, Y; Kontorovich, T; Cohen, S; Kaufman, B;
Dagan, E; Baruch, RG; Friedman, E; Harbst, K; Barbany-Bustinza, G; Rantala, J; Ehrencrona, H;
Karlsson, P; Domchek, SM; Nathanson, KL; Osorio, A; Blanco, I; Las a, A; Benitez, J; Hamann, U;
Hogervorst, FBL; Rookus, MA; Collee, JM; Devilee, P; Ligtenberg, MJ; van der Luijt, RB; Aalfs, CM;
Waisfisz, Q; Wijnen, J; van Roozendaal, CEP; Peock, S; Cook, M; Frost, D; Oliver, C; Platte, R; Evans,
DG; Lalloo, F; Eeles, R; Izatt, L; Davidson, R; Chu, C; Eccles, D; Cole, T; Hodgson, S; Godwin, AK;
Stoppa-Lyonnet, D; Buecher, B; Leone, M; Bressac-de Paillerets, B; Remenieras, A; Caron, O; Lenoir,
GM; Sevenet, N; Longy, M; Ferrer, SF; Prieur, F; Goldgar, D; Miron, A; John, EM; Buys, SS; Daly, MB;
Hopper, JL; Terry, MB; Yassin, Y; Singer, C; Gschwantler-Kaulich, D; Staudigl, C; Hansen, TVO;
Barkardottir, RB; Kirchhoff, T; Pal, P; Kosarin, K; Offit, K; Piedmonte, M; Rodriguez, GC; Wakeley, K;
Boggess, JF; Basil, J; Schwartz, PE; Blank, SV; Toland, AE; Montagna, M; Casella, C; Imyanitov, EN;
Allavena, A; Schmutzler, RK; Versmold, B; Engel, C; Meindl, A; Ditsch, N; Arnold, N; Niederacher, D;
Deissler, H; Fiebig, B; Suttner, C; Schonbuchner, I; Gadzicki, D; Caldes, T; de la Hoya, M; P ooley, KA;
Easton, DF; Chenevix-Trench, G. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for
BRCA1 and BRCA2 mutation carriers. Hum. Mol. Genet., 2009; 18(22):4442 -4456.
32. Marquez, A; Varade, J; Robledo, G; Martinez, A; Mendoza, JL; Taxonera, C; Fernandez-Arquero, M;
Diaz-Rubio, M; Gomez-Garcia, M; Lopez-Nevot, MA; de la Concha, EG; Martin, J; Urcelay, E. Specific
association of a CLEC16A/KIAA0350 polymorphism with NOD2/CARD15(-) Crohn's disease patients.
Eur. J. Hum. Genet., 2009; 17(10):1304-1308.
33. Martin-Aragon, S; Bermejo-Bescos, P; Benedi, J; Felici, E; Gil, P; Ribera, JM; Villar, AM.
Metalloproteinase's Activity and Oxidative Stress in Mild Cognitive Impairment and Alzheimer's
Disease. Neurochem. Res., 2009; 34(2):373-378.
34. Hernando, E; Sarmentero-Estrada, J; Koppie, T; Belda-Iniesta, C; de Molina, VR; Cejas, P; Ozu, C; Le,
C; Sanchez, JJ; Gonzalez-Baron, M; Koutcher, J; Cordon-Cardo, C; Bochner, BH; Lacal, JC; de Molina,
AR. A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas. Oncogene,
2009; 28(26):2425-2435.
35. Campos-Mollo, E; Lopez-Garrido, MP; Blanco-Marchite, C; Garcia-Feijoo, J; Peralta, J; BelmonteMartinez, J; Ayuso, C; Escribano, J. CYP1B1 mutations in Spanish patients with primary congenital
glaucoma: phenotypic and functional variability. Mol. Vis., 2009; 15(42):417 -431.
36. Cervigon, R; Moreno, J; Reilly, RB; Perez-Villacastin, J; Castells, F. Ventricular rhythm in atrial
fibrillation under anaesthetic infusion with propofol. Physiol. Meas., 2009; 30(8):833-845.
37. Rosinol, L; Cibeira, MT; Martinez, J; Mateos, MV; Terol, MJ; de la Rubia, J; Palomera, L; de Arriba, F;
Oriol, A; Alegre, A; Besalduch, J; de Paz, R; Garcia -Larana, J; Diaz-Mediavilla, J; Sureda, A; Lahuerta,
JJ; Miguel, JS; Blade, J. High-dose therapy/autologous stem cell transplantation increases complete
remission rate in multiple myeloma irrespective of the induction regimen used: TD
16
(Thalidomide/dexamethasone), VTD (bortezomib/thalidomide/dexamethasone) or VBMCP/VBAD
plus bortezom. Bone Marrow Transpla nt., 2009; 43(Suppl. 1):S18-S19.
38. Santiago, JL; Li, WT; Lee, A; Martinez, A; Chandrasekaran, A; Fernandez-Arquero, M; Khalili, H; de la
Concha, EG; Urcelay, E; Gregersen, PK. Localization of Type 1 Diabetes susceptibility in the ancestral
haplotype 18.2 by high density SNP mapping. Genomics, 2009; 94(4):228-232.
39. Martinez-Laso, J; Roman, A; Rodriguez, M; Cervera, I; Head, J; Rodriguez-Avial, I; Picazo, JJ. Diversity
of the G3 genes of human rotaviruses in isolates from Spain from 2004 to 2006: cross -species
transmission and inter-genotype recombination generates alleles. J. Gen. Virol., 2009; 90(Part
4):935-943.
40. Revilla, A; Lopez, J; Sevilla, T; Villacorta, E; Sarria, C; Manzano, MD; Fulquet, E; Pozo, E; Mota, P;
Gomez, I; Vilacosta, I; Roman, JAS. In-Hospital Prognosis of Prosthetic Valve Endocarditis After
Urgent Surgery. Rev. Esp. Cardiol., 2009; 62(12):1388-1394.
41. Escaned, J; Colmenarez, H; Ferrer, MC; Gutierrez, M; Jimenez-Quevedo, P; Hernandez, R; Alfonso, F;
Banuelos, C; de Isla, LP; Zamorano, JL; Macaya, C. Diastolic Dysfunction in Diabetic Patients
Assessed With Doppler Echocardiography: Relationship With Coronary Atherosclerotic Burden and
Microcirculatory Impairment. Rev. Esp. Cardiol., 2009; 62(12):1395 -1403.
42. Gil, IJN; de Isla, LP; Garcia-Rubira, JC; Fernandez-Ortiz, A; Ferrer, JJG; Vivas, D; Loeches, JAD;
Macaya, C; Zamorano, J. Ischemic Mitral Regurgitation and Non-ST-Segment Elevation Acute
Myocardial Infarction: Long-Term Prognosis. Rev. Esp. Cardiol., 2009; 62(11):1267-1275.
43. Popescu, BA; Andrade, MJ; Badano, LP; Fox, KF; Flachskampf, FA; Lancellotti, P; Varga, A; Sicari, R;
Evangelista, A; Nihoyannopoulos, P; Zamorano, JL; Derumeaux, G; Kasprzak, JD; Roelandt, JRTC.
European Association of Echocardiography recommendations for training, competence, and quality
improvement in echocardiography. Eur. J. Echocardiogr., 2009; 10(8):893 -905.
44. Becerra, JM; Almeria, C; de Isla, LP; Zamorano, J. Usefulness of 3D transoesophageal
echocardiography for guiding wires and closure devices in mitral perivalvular leak s. Eur. J.
Echocardiogr., 2009; 10(8):979-981.
45. Garcia-Rubira, JC; Nunez-Gil, I; Garcia-Borbolla, R; Lennie, V; Manzano, MC; Cobos, MA; de Isla, LP;
Fernandez-Ortiz, A; Macaya, C. Distortion of the QRS in elderly patients with myocardial infarction.
Cardiol. J., 2009; 16(5):418-425.
46. Fernandez-Golfin, C; Pachon, M; Corros, C; Bustos, A; Cabeza, B; Ferreiros, J; de Isla, LP; Macaya, C;
Zamorano, J. Left ventricular trabeculae: quantification in different cardiac diseases and impact on
left ventricular morphological and functional parameters assessed with cardiac magnetic resonance.
J. Cardiovasc. Med., 2009; 10(11):827-833.
47. Bover, R; Perez-Gomez, F; Maluenda, MP; Asenjo, S; Perez-Saldana, R; Igea, A; Suarez, M; Coleto, D;
Fernandez, C. Long-Term Follow-Up of Atrial Fibrillation Patients in the NASPEAF Study. Prospective
Evaluation of Different Antiplatelet Treatments. Rev. Esp. Cardiol., 2009; 62(9):992 -1000.
48. Moreno, J; Archondo, T; Barrios, R; Perez-Castellano, N; Porro, R; Quintanilla, JG; Godoy, VC;
Cervigon, R; Lobo, L; Fayad, Y; Macaya, C; Perez-Villacastin, J. Ablation of Atrioventricular Nodal
Reentrant Tachycardia Using Remote Magnetic Guidance (Stereotaxis (R)) Requires Lower
Temperature and Power Settings Because of Improved Local Contact. Rev. Esp. Car diol., 2009;
62(9):1001-1011.
49. Coca, A; Cea-Calvo, L; Lozano, JV; Inaraja, V; Fernandez-Perez, C; Navarro, J; Bonet, A; Redon, J.
High-Density Lipoprotein Cholesterol and Cardiovascular Disease in Spanish Hypertensive Women.
The RIMHA Study. Rev. Esp. Cardi ol., 2009; 62(9):1022-1031.
17
50. Rodriguez, E; Maroto, L; Cobiella, J; Silva, J; Banuelos, C; Hernandez-Antolin, R; Zamorano, JL;
Ginestal, F. Transapical Aortic Valve Implantation. Initial Experience. Rev. Esp. Cardiol., 2009;
62(8):933-936.
51. Martin-Ventura, JL; Madrigal-Matute, J; Munoz-Garcia, B; Blanco-Colio, LM; Van Oostrom, M; Zalba,
G; Fortuno, A; Gomez-Guerrero, C; Ortega, L; Ortiz, A; Diez, J; Egido, J. Increased CD74 expression in
human atherosclerotic plaques: contribution to inflammatory responses in vascular cells.
Cardiovasc. Res., 2009; 83(3):586-594.
52. Miro, O; Llorens, P; Martin-Sanchez, FJ; Herrero, P; Pavon, J; Perez-Dura, MJ; Alvarez, AB; Jacob, J;
Gonzalez, C; Gonzalez-Armengol, JJ; Gil, V; Alonso, H. Short-Term Prognostic Factors in Elderly
Patients Seen in Emergency Departments for Acute Heart Failure. Rev. Esp. Cardiol., 2009;
62(7):757-764.
53. Azar, F; de Isla, LP; Moreno, M; Landaeta, A; Refoyo, E; Fernandez, TL; Macaya, C; Zamorano, J.
Three-Dimensional Echocardiographic Assessment of Left Atrial Size and Function and the Normal
Range of Asynchrony in Healthy Individuals. Rev. Esp. Cardiol., 2009; 62(7):816 -819.
54. de Isla, LP; de Agustin, A; Rodrigo, JL; Almeria, C; Manzano, MD; Rodriguez, E; Garcia, A; Macaya, C;
Zamorano, J. Chronic Mitral Regurgitation: A Pilot Study to Assess Preoperative Left Ventricular
Contractile Function Using Speckle-Tracking Echocardiography. J. Am. Soc. Echocardiogr., 2009;
22(7):831-838.
55. Kukreja, N; Serruys, PW; De Bruyne, B; Colombo, A; Macaya, C; Richardt, G; Fajadet, J; Hamm, C;
Goedhart, D; Macours, N; Stoll, HP. Sirolimus -eluting stents, bare metal stents or coronary artery
bypass grafting for patients with multivessel disease including involvement of the proximal left
anterior descending artery: analysis of the Arterial Revascularization Therapies study part 2 (ARTSII). Heart, 2009; 95(13):1061-1066.
56. Alfonso, F; Perez-Vizcayno, MJ; Ruiz, M; Suarez, A; Cazares, M; Hernandez, R; Escaned, J; Banuelos,
C; Jimenez-Quevedo, P; Macaya, C. Coronary Aneurysms After Drug-Eluting Stent Implantation
Clinical, Angiographic, and Intravascular Ultrasound Findings. J. Am. Coll. Cardiol., 2009;
53(22):2053-2060.
57. Alcazar, MC; Alswies, A; Guisasola, JAS; Lacruz, LFR; Castellanos, LCM; Medinilla, EV; Vallejo, LFO;
Carnicer, JC; Rocafort, AG; Landa, VDA; Cristobal, JLC; Aguado, MG; Hernandez, JER. Clinical
Outcomes With Off-Pump Coronary Surgery After Angioplasty With Stent. Rev. Esp. Cardiol., 2009;
62(5):520-527.
58. de Agustin, JA; Nunez-Gil, IJ; Ruiz-Mateos, B; Manzano, MD; Vivas , D; de Isla, LP; Zamorano, J;
Macaya, C. Calcified right ventricular thrombus and antiphospholipid syndrome. Eur. J.
Echocardiogr., 2009; 10(3):471-472.
59. de Isla, LP; Balcones, DV; Fernandez-Golfin, C; Marcos-Alberca, P; Almeria, C; Rodrigo, JL; Macaya, C;
Zamorano, J. Three-Dimensional-Wall Motion Tracking: A New and Faster Tool for Myocardial Strain
Assessment: Comparison With Two-Dimensional-Wall Motion Tracking. J. Am. Soc. Echocardiogr.,
2009; 22(4):325-330.
60. Manzano Nieto, CM; Vilacosta, I; Corros, C; Almeria, C; Rodriguez, E. Huge tricuspid valve abscess.
Eur. J. Echocardiogr., 2009; 10(2):372-373.
61. Aleong, G; Jimenez-Ouevedo, P; Alfonso, F. Collagen Embolization for the Successful Treatment of a
Distal Coronary Artery Perforation. Catheter. Cardiovasc. Interv., 2009; 73(3):332-335.
62. Alfonso, F; Canales, E; Aleong, G. Spontaneous coronary artery dissection: diagnosis by optical
coherence tomography. Eur. Heart J., 2009; 30(3):385-385.
18
63. Matias, C; de Isla, LP; Vasconcelos, M; Almeria, C; Rodrigo, JL; Serra, V; Zamorano, J. Speckletracking-derived strain and strain-rate analysis: a technique for the evaluation of early alterations in
right ventricle systolic function in patients with systemic sclerosis and normal pulmonary artery
pressure. J. Cardiovasc. Med., 2009; 10(2):129-134.
64. Toro, R; Perez-Isla, L; Doxastaquis, G; Barba, MA; Gallego, AR; Pintos, G; Barbados, FJ; Mangas, A;
Zamorano, JL. Clinical usefulness of tissue Doppler imaging in predicting preclinical Fabry
cardiomyopathy. Int. J. Cardiol., 2009; 132(1):38-44.
65. Martinez-Selles, M; Lopez-Palop, R; Datino, T; Banuelos, C. Update on Geriatric Cardiology. Rev. Esp.
Cardiol., 2009; 62(Sp. Iss. 1):53-66.
66. Perez-Castellano, N; Villacastin, J; Salinas, J; Moreno, J; Doblado, M; Ruiz, E; Isa, R; Macaya, C.
Cooled ablation reduces pulmonary vein isolation time: results of a prospective randomised trial.
Heart, 2009; 95(3):203-209.
67. Senior, R; Monaghan, M; Main, ML; Zamorano, JL; Tiemann, K; Agati, L; Weissman, NJ; Klein, AL;
Marwick, TH; Ahmad, M; DeMaria, AN; Zabalgoitia, M; Becher, H; Kaul, S; Udelson, JE; Wackers, FJ;
Walovitch, RC; Picard, MH. Detection of coronary artery disease with perfusion stress
echocardiography using a novel ultrasound imaging agent: two Phase 3 international trials in
comparison with radionuclide perfusion imaging. Eur. J. Echocardiogr., 2009; 10(1):26 -35.
68. Venneri, L; Rossi, F; Botto, N; Andreassi, MG; Salcone, N; Emad, A; Lazzeri, M; Gori, C; Vano, E;
Picano, E. Cancer risk from professional exposure in staff working in cardiac catheterozation
laboratory: Insights from the National Research Council's Biological Effects of Ionizing Radiation VII
Report. Am. Heart J., 2009; 157(1):118-124.
69. Alfonso, F. Blood Transfusion After Myocardial Infarction Friend, Foe, or Double-Edged Sword?
[Editorial] JACC-Cardiovasc. Interv., 2009; 2(7):633-635.
70. de Isla, LP; Rodriguez, E; Alswies, A; Bucce, R; Carnero, M; Macaya, C; Zamorano, J. Medium-Term
Echocardiographic Follow-Up of Systolic and Diastolic Left Ventricular Abnormalities After Surgical
Treatment of Subacute Rupture [Editorial] Rev. Esp. Cardiol., 2009; 62(12):1478 -1481.
71. Goncalves, A; Marcos-Alberca, P; Zamorano, JL. Left atrium wall diverticulum: an additional
anatomical consideration in atrial fibrillation catheter ablation [Editorial] Eur. H eart J., 2009;
30(17):2164-2164.
72. Gonzalez-Ferrer, JJ; Balbacid, E; Vilacosta, I. Middle aortic syndrome, severe hypertension, and
endovascular repair [Editorial] Eur. Heart J., 2009; 30(13):1553 -1553.
73. Alfonso, F. Left Main Coronary Artery Stenting Crossing the Rubicon [Editorial] J. Am. Coll. Cardiol.,
2009; 53(19):1769-1772.
74. de Agustin, JA; Nunez-Gil, IJ; Manzano, MD; Vivas, D; Mateos, BR; Carda, R; Vilacosta, I; Zamorano,
JL; Macaya, C. Occlusion of the left main coronary artery and collateral circulation via the conus
branch [Editorial] J. Cardiovasc. Med., 2009; 10(5):431 -432.
75. Babiker, A; de Agustin, JA; Jimenez-Quevedo, P. Giant calcified cardiomegaly [Editorial] Eur. Heart J.,
2009; 30(2):130-130.
76. Alfonso, F; Dutary, J; Zakhem, B. Letter by Alfonso et al Regarding Article, "Impact of Intravascular
Ultrasound Guidance on Long-Term Mortality in Stenting for Unprotected Left Main Coronary
Artery Stenosis" [Letter] Circ.-Cardiovasc. Interv., 2009; 2(5):E3-E3.
77. Miro, O; Llorens, P; Martin-Sanchez, FJ; Herrero, P. Importance of Determining the Left Ventricular
Ejection Fraction in Elderly Patients With Acute Heart Failure Seen in Emergency Departments
Response [Letter] Rev. Esp. Cardiol., 2009; 62(12):1506-1507.
19
78. Alfonso, F; Garcia, J; Perez-Vizcayno, MJ; Hernando, L; Hernandez, R; Escaned, J; Jimenez-Quevedo,
P; Banuelos, C; Macaya, C. New Stent Implantation for Recurrences After Stenting for In -Stent
Restenosis Implications of a Third Metal Layer in Human Coronary Arteries [Letter] J. Am. Coll.
Cardiol., 2009; 54(11):1036-1038.
79. Luaces, M; Vilacosta, I; Fernandez, C; Sarria, C; Roman, JAS; Graupner, C; Nunez-Gil, IJ. Vegetation
size at diagnosis in infective endocarditis: Influencing factors and prognostic implications [Letter]
Int. J. Cardiol., 2009; 137(1):76-78.
80. Canales, EI; Cordova, J; Escaned, J; Hernandez-Antolin, R. Stereotaxis: A New Approach to Treating
Highly Tortuous and Angulated Coronary Lesions After Conventional Techniques Have Failed [Letter]
Rev. Esp. Cardiol., 2009; 62(8):942-944.
81. Loban, CFG; Lopez-Guarch, CJ; Centeno, J. Caseous Calcification of the Mitral Annulus: Role of
Cardiac Magnetic Resonance [Letter] Rev. Esp. Cardiol., 2009; 62(7):827 -830.
82. Nunez-Gil, IJ; Garcia-Rubira, JC; Luaces, M. Outflow tract obstruction and Takotsubo syndrome
[Letter] Am. Heart J., 2009; 158(1):-.
83. Luaces, M; Rodriguez-Benavente, AM; Vilacosta, I; Martin, JJA. Thrombosis of an Apparently Normal
Thoracic Aorta: Another Case, Another Conundrum [Letter] Rev. Esp. Cardiol., 2009; 62(5):576 -577.
84. de Isla, LP; Canadas, V; Contreras, L; Almeria, C; Rodrigo, JL; Aubele, AL; Mataix, L; Herrera, D; Serra,
V; Zamorano, J. Diastolic heart failure in the elderly: In-hospital and long-term outcome after the
first episode [Letter] Int. J. Cardiol., 2009; 134(2):265-270.
85. Guinea, GV; Atienza, JM; Fantidis, P; Rojo, FJ; Ortega, A; Torres, M; Gonzalez, P; Elices, ML; Hayashi,
K; Elices, M. Effect of atherosclerosis on thermo-mechanical properties of arterial wall and its
repercussion on plaque instability [Letter] Int. J. Cardiol., 200 9; 132(3):444-446.
86. Martin, FJ; Herrero, P; Soriano, PL; Gil, V. Epidemiology of Heart Failure in Spain: Towards a More
Global Perspective [Letter] Rev. Esp. Cardiol., 2009; 62(3):334 -335.
87. Serruys, PW; Onuma, Y; Garg, S; De Bruyne, B; Colombo, A; Macaya, C; Richardt, G; Fajadet, J;
Hamm, C; Schuijer, M; Wittebols, K; Stoll, HP. Five-year Clinical Outcomes of the Arterial
Revascularization Therapies Study Part 2 Of the Sirolimus -eluting Stent In the Treatment Of Patients
with Multivessel de novo Coronary Artery Lesions. Am. J. Cardiol., 2009; 104(6A. Suppl. S):8D-8D.
88. Jimenez-Quevedo, P; Hernando, L; Gomez-Hospital, JA; Iniguez, A; SanRoman, A; Antolin, RH;
Alfonso, F; Banuelos, C; Escaned, J; Macaya, C; Sabate, M. Four years follow-up of DIABETES trial. J.
Am. Coll. Cardiol., 2009; 53(10. Suppl. 1):A33-A33.
89. Angiolillo, D; Bernardo, E; Capranzano, P; Sabate, M; Jimenez-Quevedo, P; Ferreiro, JL; Alfonso, F;
Hernandez, R; Macaya, C; Fernandez-Ortiz, A; Bass, TA. Prognostic Implications of High Platelet
Reactivity as Defined by Multiple Agonists in Diabetes Mellitus Patients on Dual Antiplatelet
Therapy. J. Am. Coll. Cardiol., 2009; 53(10. Suppl. 1):A68-A68.
90. Angiolillo, DJ; Bernardo, E; Capranzano, P; Sabate, M; Ferreiro, JL; Alfonso, F; Jimenez-Quevedo, P;
Hernandez, R; Guzman, LA; Macaya, C; Fernandez-Ortiz, A; Bass, TA. Platelet Disaggregation: a
Novel Parameter of Clopidogrel Responsiveness?. J. Am. Coll. Cardiol., 2009; 53(10. Suppl. 1):A72 A73.
91. Zamorano, J; de Agustin, JA. Three-dimensional echocardiography for assessment of mitral valve
stenosis. Curr. Opin. Cardiol., 2009; 24(5):415-419.
92. Vilacosta, I; Aragoncillo, P; Canadas, V; Roman, JAS; Ferreiros, J; Rodriguez, E. Acute aortic
syndrome: a new look at an old conundrum. Heart, 2009; 95(14):1130-1139.
20
93. Badano, LP; Agricola, E; de Isla, LP; Gianfagna, P; Zamorano, JL. Evaluation of the tricuspid valve
morphology and function by transthoracic real -time three-dimensional echocardiography. Eur. J.
Echocardiogr., 2009; 10(4):477-484.
94. Martinez-Selles, M; Vidan, MT; Lopez-Palop, R; Rexach, L; Sanchez, E; Datino, T; Cornide, M; Carrillo,
P; Ribera, JM; Diaz-Castro, O; Banuelos, C. End-Stage Heart Disease in the Elderly. Rev. Esp. Cardiol.,
2009; 62(4):409-421.
95. Senior, R; Becher, H; Monaghan, M; Agati, L; Zamorano, J; Vanoverschelde, JL; Nihoyannopoulos, P.
Contrast echocardiography: evidence-based recommendations by European Association of
Echocardiography. Eur. J. Echocardiogr., 2009; 10(2):194 -212.
96. Sicari, R; Nihoyannopoulos, P; Evangelista, A; Kasprzak, J; Lancellotti, P; Poldermans, D; Voigt, JU;
Zamorano, JL. Stress Echocardiography Expert Consensus Statement - Executive Summary. Eur.
Heart J., 2009; 30(3):278-289.
97. Escaned, J; Flores, A; Garcia-Pavia, P; Segovia, J; Jimenez, J; Aragoncillo, P; Salas, C; Alfonso, F;
Hernandez, R; Angiolillo, DJ; Jimenez-Quevedo, P; Banuelos, C; Alonso-Pulpon, L; Macaya, C.
Assessment of Microcirculatory Remodeling With Intracoronary Flow Velocity and Pressure
Measurements Validation With Endomyocardial Sampling in Cardiac Allografts. Circulation, 2009;
120(16):1561-1568.
98. Vivas, D; Garcia-Guereta, L; Bret, M; Rubio, D; Burgueros, M; Gil, M; Gutierrez-Larraya, F. Hypoplasia
of the Abdominal Aorta and Hypomelanosis of Ito "Pseudo-Cauda Equina" Imaging [Editorial]
Circulation, 2009; 120(20):2025-2026.
99. Jimenez-Quevedo, P; de Agustin, JA; Fernandez-Jimenez, R; Aragoncillo, P; Macaya, C. Aortic
Pseudoaneurysm Complicated by Aortopulmonary Fistula [Editorial] Circulation, 2009;
119(23):3036-3039.
100.Luaces, M; Nunez-Gil, IJ; Jimenez-Hernandez, RM; Awamleh, P; Talavera-Calle, P; Medina, M;
Rodriguez-Robles, A; Alonso-Martin, JJ. Midwall Fractional Shortening and Circumferential EndSystolic Wall Stress in Morbidly Obese Patients Before and After Bariatric Surger y. Circulation, 2009;
120(18. Suppl. 2):S746-S746.
101.Luaces, M; Jimenez-Hernandez, RM; Nunez-Gil, IJ; Awamleh, P; Serrano-Antolin, JM; AntequeraVarela, A; de Villar, NP; Alonso-Martin, JJ. Left Ventricular Geometric Pattern in Morbidly Obese
Patients Before and After Bariatric Surgery. Circulation, 2009; 120(18. Suppl. 2):S908 -S908.
102.Vano, E; Ubeda, C; Leyton, F; Miranda, P; Gonzalez, L. Staff Radiation Doses in Interventional
Cardiology: Correlation With Patient Exposure. Pediatr. Cardiol., 2009; 30(4):409 -413.
103.Vano, E; Sanchez, R; Fernandez, JM; Gallego, JJ; Verdu, JF; de Garay, MG; Azpiazu, A; Segarra, A;
Hernandez, MT; Canis, M; Diaz, F; Moreno, F; Palmero, J. Patient Dose Reference Levels for
Interventional Radiology: A National Approach. Cardiovasc. Interv. Radiol., 2009; 32(1):19-24.
104.Vano, E; Sanchez, R; Fernandez, JM; Rosales, F; Garcia, MA; Sotil, J; Hernandez, J; Carrera, F; Ciudad,
J; Soler, MM; Ballester, T. Importance of Dose Settings in the X-Ray Systems Used for Interventional
Radiology: A National Survey. Cardiovasc. Interv. Radiol., 2009; 32(1):121 -126.
105.Maroto, LC; Rodriguez, JE; Cobiella, J; Siva, J. Delayed dislocation of a transapically implanted aortic
bioprosthesis. Eur. J. Cardio-Thorac. Surg., 2009; 36(5):935-937.
106.Rocafort, AG; Castellanos, LCM; Hernandez, JER. Right coronary artery giant aneurysm [Editorial]
Eur. J. Cardio-Thorac. Surg., 2009; 35(3):534-534.
21
107.Fernandez, E; Calatayud, J; Jarabo, JR; Hernando, F; Rodriguez, O; Gomez, AM; Soria, A; Del Rio, F.
Profitability of our l ung retrieval program from non heart beating donors. Eur. J. Cardio-Thorac.
Surg., 2009; 35(2):287-292.
108.Roman, A; Cervera, I; Herraiz, MA; Vidart, J; Martinez-Laso, J. A new allele, HLA-G*01010106, with
changes in intron 2. Tissue Antigens, 2009; 74(3):271-271.
109.Lopez-Mejias, R; del Pozo, N; Fernandez-Arquero, M; Ferreira, A; Garcia-Rodriguez, MC; de la
Concha, EG; Fontan, G; Urcelay, E; Martinez, A; Nunez, C. Role of polymorphisms in the TNFRSF13B
(TACI) gene in Spanish patients with immunoglobulin A defici ency. Tissue Antigens, 2009; 74(1):4245.
110.Dema, B; Martinez, A; Fernandez-Arquero, M; Maluenda, C; Polanco, I; Figueredo, MA; de la
Concha, EG; Urcelay, E; Nunez, C. Autoimmune disease association signals in CIITA and KIAA0350
are not involved in celiac di sease susceptibility. Tissue Antigens, 2009; 73(4):326-329.
111.Cervera, I; Herraiz, MA; Roman, A; Vidart, J; Martinez-Laso, J. The novel HLA-G*01010302 allele
differs from G*01010301 by a single nucleotide change in intron 5 [Editorial] Tissue Antigens, 2009;
74(5):463-464.
112.Portoles, A; Prieto, E; Calvo, A; Laredo, L; Fernandez, N; Vargas, E. Truncated Area under the Urinary
Excretion Rate Curve in the Evaluation of Alendronate Bioequivalence after a Single Dose in Healthy
Volunteers. Arzneimittelforschung, 2009; 59(8):397-402.
113.Garcia-Ramos, R; Morales, IG; Vela, A; Galan, L; Serna, C; Porta, J; Matias -Guiu, J. Analysis of
hospital consultations to Neurology in a tertiary hospital. Neurologia, 2009; 24(10):835 -840.
114.Morales, IG. Neuroethics. Neurologia, 2009; (Suppl. 1):12-15.
115.Garcia, RGR. Neurophilosophy. From Cartesian dualism to biological naturalism. Neurologia, 2009;
(Suppl. 1):16-22.
116.Davila, LG. Social Neurosciences. Neurologia, 2009; (Suppl. 1):32 -35.
117.Porta-Etessam, J. Taste: new cuisine from a neuroscientific approach. Neurologia, 2009; (Suppl.
1):56-59.
118.Porta-Etessam, J. Neuromagic: the brain playing to deceive itself. Neurologia, 2009; (Suppl. 1):6062.
119.Simal, P; Garcia, AM; Masjuan, J; de Lecinana, MA; Fuentes, B; Diaz-Otero, F; Gil-Nunez, A; DiezTejedor, E; Egido, JA. Thrombolysis in Madrid: is there improvement in the 4 years temporal
analysis?. Neurologia, 2009; 24(9):804-807.
120.Porta-Etessam, J; Casanova, I; Garcia-Cobos, R; Lapena, T; Fernandez, MJ; Garcia -Ramos, R; Serna, C.
Osmophobia analysis in primary headache. Neurologia, 2009; 24(5):315 -317.
121.Alvarez-Lafuente, R; Garcia-Montojo, M; De Las Heras, V; Dominguez-Mozo, MI; Bartolome, M;
Arroyo, R. CD46 expression and HHV-6 infection in patients with multiple sclerosis. Acta Neurol.
Scand., 2009; 120(4):246-250.
122.Cenit, MDC; Blanco-Kelly, F; Heras, VDL; Bartolome, M; de la Concha, EG; Urcelay, E; Arroyo, R;
Martinez, A. Glypican 5 is an interferon-beta response gene: a replication study. Mult. Scler., 2009;
15(8):913-917.
123.Garcia-Losarcos, N; Gonzalez-Hidalgo, M; Franco-Carcedo, C; Poch-Broto, J. ELECTRICAL
STIMULATION OF THE FACIAL NERVE WITH A PROGNOSTIC FUNCTION IN PAROTID SURGERY. Rev.
Neurologia, 2009; 49(3):119-122.
22
124.Ristol, EGA; Martin, JGA. THE BEGINNINGS OF NEUROSCIENCE IN SPAIN. 'NEURAL CIRCULATION' IN
THE WORK OF THE ILLUSTRIOUS NOVATOR MARTIN MARTINEZ (1684-1734). Rev. Neurologia, 2009;
49(2):95-99.
125.Linazasoro, G; Sesar, A; Valldeoriola, F; Compta, Y; Herrero, MT; Castrillo, JCM; Lozano, JJL;
Bergaretxe, A; Vela, L; Fernandez, JM; Castro, A; Kulisevski, J; Lezcano, E; Vaamonde, J; del Val, JL;
Chacon, J; Vivancos, F; Luquin, R; Aguilar, M; Burguera, JA; Salvador, C; Guisasola, LM; Catalan, MJ;
Mir, P; Campos, V; Grandas, F; Minguez, A; Balaguer, E; Yanez, R; Leiva, C; Ruiz, PG; Cubo, E.
Neuroprotection in Parkinson's disease: analysis though group of expert's methodology. Neurologia,
2009; 24(2):113-124.
126.Gonzalez-Hidalgo, M; Saldana, CJ; Alonso-Lera, P; Gomez-Bustamante, G. THE USEFULNESS OF
ELECTROMYOGRAPHICAL MONITORING WITH INTRAOPERATIVE BRAIN MAPPING DURING MOTOR
LESIONECTOMY. Rev. Neurologia, 2009; 48(12):620-624.
127.de Bobadilla, JF; Moreno, R; Fernandez, C; Martinez, A; Sanchez-Maestre, C; Ezpeleta-Echevarri, D.
EFFECT OF INTENSIVE TREATMENT WITH ATORVASTATIN VERSUS STANDARD DOSES OF STATINS ON
THE RISK OF STROKE. A META-ANALYSIS FROM FIVE RANDOMIZED TRIALS INCLUDING 25,709
PATIENTS. Rev. Neurologia, 2009; 48(11):561-565.
128.Garcia-Perez, A; Martinez-Granero, MA; Verdu-Perez, A; Castro, PDCD; Garzo-Fernandez, C;
Vazquez-Lopez, M; Martinez-Bermejo, A; Simon-De las Heras, R; Martinez-Menendez, B; AntonioArce, VS; de Santos-Moreno, MT; Carrasco-Marina, ML; Cazorla-Calleja, MR. CODING IN
NEUROPEDIATRICS BASED ON THE INTERNATIONAL CLASSIFICATION DISEASES, 9TH REVISION (ICD9), 5TH EDITION (2006). Rev. Neurologia, 2009; 48(2):58 -60.
129.Martinez-Salio, A; Porta-Etessam, J. Neuroeconomics. New fields of Neurology Introduction
[Editorial] Neurologia, 2009; ():1-3.
130.Matias-Guiu, J; Ramos, RG. Improvement and decision-making process of an article [Editorial]
Neurologia, 2009; 24(6):353-358.
131.Manzano, S; Gonzalez, JL; Marcos, A; Matias -Guiu, J. Genetics and Alzheimer's Disease [Editorial]
Neurologia, 2009; 24(2):83-89.
132.Matias-Guiu, J; Garcia-Ramos, R. Author and authorship in medical journals [Editorial] Neurologia,
2009; 24(1):1-6.
133.Alfonso, F. Spanish biomedical journals: academic relevance, scientific impact or impact factor.
What really matters? [Editorial] Rev. Neurologia, 2009; 48(3):113 -116.
134.Campos-Castello, J. Coding in paediatric neurology: a good indicator of the quality of health care
[Editorial] Rev. Neurologia, 2009; 48(2):57-57.
135.Rivero-Garvia, M; Boto, GR; Gutierrez-Gonzalez, R; Perez-Zamarron, A; Saldana, CJ. Chronic
expanding intracerebral hematoma [Letter] Rev. Neurologia, 2009; 49(4):223 -224.
136.Porta-Etessam, J; Parejo-Carbonell, B; Gomez-Vicente, L; Vega, MAMD. Gabapentin in the treatment
of ocular neuromyotonia [Letter] Rev. Neurologia, 2009; 48(6):332-333.
137.Alvarez-Lafuente, R; Garcia-Montojo, M; Dominguez-Mozo, MI; Villar, LM; Garcia-Martinez, A;
Gonzalez-Valcarcel, J; De Las Heras, V; Bartolome, M; Alvarez-Cermeno, JC; Arroyo, R. Seasonal
distribution of the first relapses in multiple sclerosis: intriguing associations. Mult. Scler., 2009;
15(9. Suppl. S):S44-S44.
138.Alvarez-Lafuente, R; Garcia-Montojo, M; Heras, VD; Dominguez-Mozo, MI; Bartolome, M; GarciaMartinez, A; Arroyo, R. A two-year follow-up study: multiple sclerosis functional composite versus
expanded disability status scale. Mult. Scler., 2009; 15(9. Suppl. S):S55-S56.
23
139.Lopez-Cavanillas, M; de las Heras, V; De La Concha, EG; Bartolome, M; Urcelay, E; Gonzalez, RA.
IL7RA functional polymorphism and multipl e sclerosis susceptibility: replication and meta -analysis.
Mult. Scler., 2009; 15(9. Suppl. S):S66-S66.
140.Lopez-Cavanillas, M; De Las Heras, V; De La Concha, EG; Bartolome, M; Urcelay, E; Arroyo, R.
Association of the osteopontin gene with the clinical cours e in mutiple sclerosis. Mult. Scler., 2009;
15(9. Suppl. S):S66-S67.
141.Dominguez-Mozo, MI; Alvarez-Lafuente, R; Garcia-Montojo, M; Heras, VD; Bartolome, M; Garcia Martinez, A; Arroyo, R. Study of cerebrospinal fluid total protein levels and clinical prognosi s in
multiple sclerosis. Mult. Scler., 2009; 15(9. Suppl. S):S80-S81.
142.Dominguez-Mozo, MI; Alvarez-Lafuente, R; Garcia-Montojo, M; De Las Heras, V; Bartolome, M;
Garcia-Martinez, A; Arroyo, R. JC virus in multiple sclerosis patients treated with natalizumab . Mult.
Scler., 2009; 15(9. Suppl. S):S86-S86.
143.Garcia-Montojo, M; Blanco-Kelly, F; Dominguez-Mozo, MI; Martinez, A; De Las Heras, V; LopezCavanillas, M; Garcia-Martinez, A; de la Concha, EG; Bartolome, M; Urcelay, E; Arroyo, R; AlvarezLafuente, R. CD46 expression and HHV-6 infection in multiple sclerosis patients treated with
interferon-beta. A one-year follow-up study. Mult. Scler., 2009; 15(9. Suppl. S):S86-S86.
144.Cenit, MC; Blanco, F; Bartolome, M; Martinez, A; Alvarez-Lafuente, R; de Las Heras, V; Arroyo, R.
Glypican 5 is an interferon-beta response gene in multiple sclerosis patients. Mult. Scler., 2009;
15(9. Suppl. S):S184-S184.
145.Cenit, MC; De Las Heras, V; Urcelay, E; Bartolome, M; De La Concha, EG; Arroyo, R. Effect of BSNMST1 locus on multiple sclerosis susceptibility. Mult. Scler., 2009; 15(9. Suppl. S):S184 -S185.
146.Alvarez-Lafuente, R; Lopez-Cavanillas, M; Garcia-Montojo, M; Cenit, MC; Dominguez-Mozo, MI;
Martinez, A; De Las Heras, V; Garcia-Martinez, A; De La Concha, EG; Bartolome, M; Urcelay, E;
Arroyo, R. TLR9 and HHV-6: innate immunity in multiple sclerosis. Mult. Scler., 2009; 15(9. Suppl.
S):S194-S194.
147.Diaz-Guzman, J; Egido-Herrero, JA; Fuentes, B; Fernandez-Perez, C; Gabriel-Sanchez, R; Barbera, G;
Abilleira, S. INCIDENCE OF STROKES IN SPAIN: THE IBERICTUS STUDY. DATA FROM THE PILOT STUDY.
Rev. Neurologia, 2009; 48(2):61-65.
148.Serna-Candel, C; Portilla, J; Matias -Guiu, J. Carotid artery disease and human immunodeficiency
virus (HIV) infection. Neurologia, 2009; 24(5):318-330.
149.Manzano, S; Gonzalez, JL; Marcos, A; Payno, M; Villanueva, C; Matias -Guiu, J. Experimental models
in Alzheimer's disease. Neurologia, 2009; 24(4):255-262.
150.Fernandez-de-las-Penas, C; Penacoba-Puente, C; Lopez-Lopez, A; Valle, B; Cuadrado, M; Barriga, F;
Pareja, JA. Depression and anxiety are not related to nummular headache. J. Headache Pain, 2009;
10(6):441-445.
151.Gallego, JM; Ortiz, L; Gutierrez, R; Barcia, JA. Continuous bilateral infusion of GABA in the
dorsomedian nucleus of the thalamus elevates the generalized seizure threshold in amygdalakindled rats. Seizure, 2009; 18(7):537-540.
152.Fernandez-de-las-Penas, C; de la Llave-Rincon, AI; Fernandez-Carnero, J; Cuadrado, ML; ArendtNielsen, L; Pareja, JA. Bilateral widespread mechanical pain sensitivity in carpal tunnel syndro me:
evidence of central processing in unilateral neuropathy. Brain, 2009; 132():1472-1479.
153.Cuadrado, ML; Valle, B; Fernaandez-de-las-Penas, C; Barriga, FJ; Pareja, JA. Bifocal nummular
headache: the first three cases. Cephalalgia, 2009; 29(5):583 -586.
24
154.Porta-Etessam, J; Garcia-Morales, I; Di Capua, D; Garcia-Cobos, R. A patient with primary sexual
headache associated with hypnic headaches [Letter] J. Headache Pain, 2009; 10(2):135 -135.
155.Cobos, RG; de Vega, AM; Montero, TL; Vela, A; Martinez, A; Galan, L. Sporadic late onset nemaline
myopathy. Eur. J. Neurol., 2009; 16(Suppl. 3):219-219.
156.Oreja-Guevara, C; De Andres, C; Martin-Barriga, ML; Sanchez, MD; Garcia-Dominguez, JM;
Rodriguez, E; Blasco, MR; Ayuso, L; De las Heras, V; Gomez, M; Caminero, AB. Frequency of use of
complementary and alternative medicine by multiple sclerosis patients in Spain. Eur. J. Neurol.,
2009; 16(Suppl. 3):264-264.
157.Perez-Cejuela, CG; Sampedro, A; Di Capua, D; Porta, J. Cryptococcal meningoencephalitis in a third
level hospital between 1998-2008. Eur. J. Neurol., 2009; 16(Suppl. 3):510-510.
158.Miralles, A; Izquierdo, N. Restless legs syndrome and high risk pregnancy. Eur. J. Neurol., 2009;
16(Suppl. 3):621-621.
159.Campo, P; Maestu, F; Garcia-Morales, I; Gil-Nagel, A; Strange, B; Morales, M; Ortiz, T. Modulation of
medial temporal lobe activity in epilepsy patients with hippocampal sclerosis during verbal working
memory. J. Int. Neuropsychol. Soc., 2009; 15(4):536-546.
160.Porta-Etessam, J; Casanova, I; Pajuelo, B; Di Capua, D; del Val, J; Garcia , MEG; Marcos, A. See-Saw
Nystagmus in a Patient with Wallenberg Syndrome [Letter] J. Neuro-Ophthal., 2009; 29(1):73-74.
161.van Walraven, C; Hart, RG; Connolly, S; Austin, PC; Mant, J; Hobbs, R; Koudstaal, PJ; Petersen, P;
Perez-Gomez, F; Knottnerus, JA; Boode, B; Ezekowitz, MD; Singer, DE. Effect of Age on Stroke
Prevention Therapy in Patients With Atrial Fibrillation The Atrial Fibrillation Investigators. Stroke,
2009; 40(4):1410-1416.
162.Fuentes, B; Castillo, J; Jose, BS; Leira, R; Serena, J; Vivancos, J; Dava los, A; Nunez, AG; Egido, J; DiezTejedor, E. The Prognostic Value of Capillary Glucose Levels in Acute Stroke The GLycemia in Acute
Stroke (GLIAS) Study. Stroke, 2009; 40(2):562-568.
163.Fuentes, B; Ortega-Casarrubios, MA; SanJose, B; Castillo, J; Serena, J; Vivancos, J; Davalos, A; Gil Nunez, A; Egido, J; Diez-Tejedor, E. Sustained Hyperglycaemia In Acute Ischemic Stroke Patients.
How Well Are We Correcting It? Implications On Outcome. Stroke, 2009; 40(4):E164 -E165.
164.Gutierrez-Gonzalez, R; Boto, GR; Rivero-Garvia, M; Perez-Zamarron, A. Intraventricular
haemorrhage caused by the rupture of a dural arteriovenous malformation of the middle cranial
fossa. Acta Neurochir., 2009; 151(8):1009-1012.
165.Boto, GR; Gomez, PA; De la Cruz, J; Lobato, RD. A historical analysis of severe head injury.
Neurosurg. Rev., 2009; 32(3):343-353.
166.Diaz, JL; Barreto, P; Gallego, JM; Barbero, J; Bayes, R; Barcia, JA. Proper information during the
surgical decision-making process lowers the anxiety of patients with high-grade gliomas. Acta
Neurochir., 2009; 151(4):357-362.
167.Prieto, R; Pascual, JM; Gutierrez, R; Santos, E. Recovery from paraplegia after the treatment of
spinal dural arteriovenous fistula: case report and review of the literature. Acta Neurochir., 2009;
151(11):1385-1397.
168.Cervigon, R; Moreno, J; Sanchez, C; Reilly, RB; Villacastin, J; Millet, J; Castells, F. Atrial fibrillation
organization: quantification of propofol effects. Med. Biol. Eng. Comput., 2009; 47(3):333-341.
169.Sanchez, M; Francois, B; Squires, RA; Boulain, T; De La Fuente, E; Coimbra, R; Hardalo, CJ.
EPIDEMIOLOGY OF CENTRAL VENOUS (CVC) AND ARTERIAL (AC) INTRAVASCULAR CATHETERS (IVC)
25
IN INTENSIVE CARE UNITS (ICU). AGGREGATE DATA FROM TWO INTERNATIONAL MULTICENTRE
TRIALS. Intensive Care Med., 2009; 35(Suppl. 1):1182-.
170.Lafaurie, G; Fedele, S; Lopez, RMG; Wolff, A; Strietzel, F; Porter, SR; Konttinen, YT. Biotechnological
advances in neuro-electro-stimulation for the treatment of hyposalivation and xerostomia. Med.
Oral Patol. Oral Cir. Bucal, 2009; 14(2):E76-E80.
171.Requena, C; Requena, L; Kutzner, H; Yus, ES. Spitz Nevus: A Clinicopathological Study of 349 Cases.
Am. J. Dermatopathol., 2009; 31(2):107-116.
172.Vano-Galvan, S; Jimenez-Garcia, D; Vano-Galvan, E; Jaen, P. Accidental subcutaneous implant of
mercury after thermometer trauma [Letter] J. Am. Acad. Dermatol., 2009; 61(3):535-537.
173.Campos-Munoz, L; Pedraz-Munoz, J; Conde-Taboada, A; Lopez-Bran, E. Dermoscopy of PeutzJeghers syndrome [Letter] J. Eur. Acad. Dermatol. Venereol., 2009; 23(6):730 -731.
174.Conde-Taboada, A; Munoz, JP; Munoz, LC; Lopez-Bran, E. Infliximab treatment for severe psoriasis
in a patient with active hepatitis B virus infection [Letter] J. Am. Acad. Dermatol., 2009; 60(6):10771080.
175.Calderero, V; Garcia-Muro, X; Puente, J; Trigo, JM; Castro, AJ; Martin-Escudero, V; Yebenes, M;
Casado, MA. COST OF MANAGING ADVERSE EVENTS IN THE TREATMENT OF FIRST LINE METASTASIC
RENAL CELL CARCINOMA: BEVACIZUMAB plus INTERFERON ALPHA-2A COMPARED WITH SUNITINIB
IN SPAIN. Value Health, 2009; 12(7):A263-A263.
176.Carrasco, JL; Olivares, JM; Alvarez, E; de Salas, M; Rejas, J. COST-EFFECTIVENESS OF PREGABALIN
VERSUS USUAL CARE IN DULOXETINE-REFRACTORY OUT-PATIENTS WITH GENERALIZED ANXIETY
DISORDER: AN ECONOMIC EVALUATION UNDER MEDICAL USUAL PRACTICE IN MENTAL HEALTH
CENTERS. Value Health, 2009; 12(7):A357-A357.
177.Olivares, JM; Alvarez, E; Carrasco, JL; Barrueta, A; Lopez-Gomez, V; Rejas, J. COST-EFFECTIVENESS
OF PREGABALIN VERSUS ISRS/ISRN IN BENZODIAZEPINE-REFRACTORY OUT-PATIENTS WITH
GENERALIZED ANXIETY DISORDER: AN ECONOMIC EVALUATION UNDER MEDICAL USUAL PRACTICE
IN MENTAL HEALTH CENTERS. Value Health, 2009; 12(7):A357-A357.
178.Alvarez, E; Carrasco, JL; Olivares, JM; Ferro, MB; Perez, M; Rejas, J. COST-EFFECTIVENESS OF
PREGABALIN VERSUS USUAL CARE IN REFRACTORY OUT-PATIENTS WITH GENERALIZED ANXIETY
DISORDER: A NESTED-CASE-CONTROL ECONOMIC EVALUATION UNDER USUAL MEDICAL PRACTICE
IN MENTAL HEALTH CENTERS. Value Health, 2009; 12(7):A358-A358.
179.Matias-Guiu, J; Guerrero, M; Lopez-Trigo, J; Montero, J; Ortega, A; Rejas, J. A COST CONSEQUENCE
EVALUATION OF TWO MODELS OF CARE OF OUTPATIENTS WITH CHRONIC NEUROPATHIC PAIN IN
NEUROLOGY SETTINGS IN SPAIN: GENERAL CLINICS VERSUS SPECIALIZED PAIN CLINICS. Value
Health, 2009; 12(7):A379-A379.
180.Marazuela, M; Lucas, T; Alvarez-Escola, C; Puig-Domingo, M; de la Torre, NG; de Miguel -Novoa, P;
Duran-Hervada, A; Manzanares, R; Luque-Ramirez, M; Halperin, I; Casanueva, FF; Bernabeu, I. Longterm treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor
antagonist pegvisomant: its efficacy in relation to gender and previous radiotherapy. Eur. J.
Endocrinol., 2009; 160(4):535-542.
181.Fernandez-Rebollo, E; Perez, O; Martinez-Bouzas, C; Cotarelo-Perez, MC; Garin, I; Ruibal, JL; PerezNanclares, G; Castano, L; de Nanclares, GP. Two cases of deletion 2q37 associated with segregation
of an unbalanced translocation 2;21: choanal atresia leading to misdiagnosis of CHARGE syndrome.
Eur. J. Endocrinol., 2009; 160(4):711-717.
26
182.Cabezas-Cerrato, J; Gonzalez-Quintela, A; Perez-Rodriguez, M; Calle, A; Faure-Noguera, E; VazquezGarcia, JA. Combination of cardiorespiratory reflex parameters and heart rate variability power
spectrum analysis for early diagnosis of diabetic cardiac autonomic neuropathy. Diabetes Metab.,
2009; 35(4):305-311.
183.Cascon, A; Lopez-Jimenez, E; Landa, I; Leskela, S; Leandro-Garcia, LJ; Maliszewska, A; Leton, R; de la
Vega, L; Garcia-Barcina, MJ; Sanabria, C; Alvarez-Escola, C; Rodriguez-Antona, C; Robledo, M.
Rationalization
of
Genetic
Testing
in
Patients
with
Apparently
Sporadic
Pheochromocytoma/Paraganglioma. Horm. Metab. Res., 2009; 41(9):672-675.
184.Cecilia, D; Jodar, E; Fernandez, C; Resines, C; Hawkins, F. Effect of alendronate in elderly patients
after low trauma hip fracture repair. Osteoporosis Int., 2009; 20(6):903-910.
185.Cascon, A; Pita, G; Burnichon, N; Landa, I; Lopez-Jimenez, E; Montero-Conde, C; Leskela, S; LeandroGarcia, LJ; Leton, R; Rodriguez-Antona, C; Diaz, JA; Lopez-Vidriero, E; Gonzalez-Neira, A; Velasco, A;
Matias-Guiu, X; Gimenez-Roqueplo, AP; Robledo, M. Genetics of Pheochromocytoma and
Paraganglioma in Spanish Patients. J. Clin. Endocrinol. Metab., 2009; 94(5):1701-1705.
186.Gonzalez-Sanchez, JL; Zabena, C; Martinez-Larrad, MT; Martinez-Calatrava, MJ; Perez-Barba, M;
Serrano-Rios, M. Variant rs9939609 in the FTO gene is associated with obesity in an adult
population from Spain. Clin. Endocrinol., 2009; 70(3):390 -393.
187.Jimenez-Quevedo, P; Suzuki, N; Corros, C; Ferrer, C; Angiolillo, DJ; Alfonso, F; Hernandez-Antolin, R;
Banuelos, C; Escaned, J; Fernandez, C; Costa, M; Macaya, C; Bass, T; Sabate, M. Vessel Shrinkage as
a Sign of Atherosclerosis Progression in Type 2 Diabetes A Serial Intravascular Ultrasound Analysis.
Diabetes, 2009; 58(1):209-214.
188.Larrad, MTM; Fernandez-Perez, C; Zabena, C; Corbaton, A; Serrano-Rios, M. Glucose tolerance:
association with high blood pressure and metabolic syndrome in Spanish population. Diabetologia,
2009; 52(Suppl. 1):1311-.
189.Capdevila-Castillon, J; Crespo, G; Garcia-Carbonero, R; Vilar, E; Jimenez-Lacave, A; del Prado, MPM;
Orduna, VA; Sevilla-Garcia, I; Teule, A; Diaz-Perez, JA; Llanos-Munoz, M; Beguiristain-Gomez, A;
Villabona-Artero, C; Sastre-Valera, J; Marazuela-Azpiroz, M; Alvarez-Escola, C; Castellano, D; Soler,
RS. Results of the Gastroenteropancreatic NETs Spanish Registry in the 2001-2009 Period.
Neuroendocrinology, 2009; 90(1):19-.
190.Sicilia, JJ; Sicilia, MA; Sanchez-Alonso, S; Garcia-Barriocanal, E; Pontikaki, M. Knowledge
representation issues in ontology-based clinical Knowledge Management systems. Int. J. Technol.
Manage., 2009; 47(40238):191-206.
191.Jimenez, E; Linares, C; Rodriguez, LF; Bleda, MJ; Diaz, J. Short-term impact of particulate matter
(PM2.5) on daily mortality among the over-75 age group in Madrid (Spain). Sci. Total Environ., 2009;
407(21):5486-5492.
192.Vano, E; Ubeda, C; Fernandez, JM; Sanchez, RM; Prieto, C. Dose assessment during the
commissioning of flat detector imaging systems for cardiology. Radiat. Prot. Dosim., 2009;
136(1):30-37.
193.Taxonera, C; Rodrigo, L; Casellas, F; Calvet, X; Gomez-Camacho, F; Ginard, D; Cas tro, M; Castro, L;
Ponce, M; Martinez-Montiel, P; Ricart, E; Gisbert, JP; Lopez-San Roman, A; Morales, JM; Casado,
MA. Infliximab Maintenance Therapy Is Associated With Decreases in Direct Resource Use in
Patients With Luminal or Fistulizing Crohn's Diseas e. J. Clin. Gastroenterol., 2009; 43(10):950-956.
194.Marquez, A; Nunez, C; Martinez, A; Mendoza, JL; Taxonera, C; Fernandez-Arquero, M; Diaz-Rubio,
M; de la Concha, EG; Urcelay, E. Role of ATG16L1 Thr300Ala Polymorphism in Inflammatory Bowel
27
Disease: A Study in the Spanish Population and a Meta -analysis. Inflamm. Bowel Dis., 2009;
15(11):1697-1704.
195.Palacios, NL; Agundez, JAG; Mendoza, JL; Garcia -Martin, E; Martinez, C; Ferrer, MEF; Ladero, JM;
Taxonera, C; Diaz-Rubio, M. Analysis of a non-synonymous single nucleotide polymorphism of the
human diamine oxidase gene (ref. SNP ID: rs1049793) in patients with Crohn's disease. Scand. J.
Gastroenterol., 2009; 44(10):1207-1212.
196.Rey, E; Alvarez-Sanchez, A; Rodriguez-Artalejo, F; Elola-Olaso, CM; Almansa, C; Diaz-Rubio, M. Onset
and disappearance rates of gastroesophageal reflux symptoms in the Spanish population, and their
impact on quality of life. Rev. Esp. Enferm. Dig., 2009; 101(7):477-482.
197.Mendoza, JL; Lana, R; Martin, MC; de la Concha, EG; Urcelay, E; Diaz-Rubio, M; Abreu, MT; Mitchell,
AA. FcRL3 Gene Promoter Variant Is Associated with Peripheral Arthritis in Crohn's Disease.
Inflamm. Bowel Dis., 2009; 15(9):1351-1357.
198.Marquez, A; Orozco, G; Martinez, A; Palomino-Morales, R; Fernandez-Arquero, M; Mendoza, JL;
Taxonera, C; Diaz-Rubio, M; Gomez-Garcia, M; Nieto, A; Lopez-Nevot, MA; de la Concha, EG; Martin,
J; Urcelay, E. Novel Association of the Interleukin 2-Interleukin 21 Region With Inflammatory Bowel
Disease. Am. J. Gastroenterol., 2009; 104(8):1968-1975.
199.Gisbert, JP; Bermejo, F; Perez-Calle, JL; Taxonera, C; Vera, I; McNicholl, AG; Algaba, A; Lopez, P;
Lopez-Palacios, N; Calvo, M; Gonzalez-Lama, Y; Carneros, JA; Velasco, M; Mate, J. Fecal Calprotectin
and Lactoferrin for the Prediction of Inflammatory Bowel Disease Relapse. Inflamm. Bowel Dis.,
2009; 15(8):1190-1198.
200.Arraez-Aybar, LA; Gonzalez-Gomez, CC; Torres-Garcia, AJ. Morgagni-Larrey
diaphragmatic hernia in the adult. Rev. Esp. Enferm. Dig., 2009; 101(5):357 -362.
parasternal
201.Rey, E; Ortega, MM; Alonso, MOG; Diaz-Rubio, M. Constructive thinking, rational intelligence and
irritable bowel syndrome. World J. Gastroenterol., 2009; 15(25):3106 -3113.
202.Almansa, C; Rey, E; Sanchez, RG; Sanchez, AA; Diaz-Rubio, M. Prevalence of Functional
Gastrointestinal Disorders in Patients With Fibromyalgia and the Role of Psychologic Distress. Clin.
Gastroenterol. Hepatol., 2009; 7(4):438-445.
203.Ladero, JM; Lopez-Alonso, G; Devesa, MJ; Cuenca, F; Ortega, L; Agreda, M; Suarez, A; Ropero, P;
Diaz-Rubio, M. Oscillations in serum ferritin associated with antiviral therapy in chronic hepatitis C.
Rev. Esp. Enferm. Dig., 2009; 101(1):31-40.
204.Rey, E; Garcia-Alonso, M; Moreno-Ortega, M; Almansa, C; Alvarez-Sanchez, A; Diaz-Rubio, M.
Influence of Psychological Distress on Characteristics of Symptoms in Patients with GERD: The Role
of IBS Comorbidity. Dig. Dis. Sci., 2009; 54(2):321-327.
205.Mendoza, JL; Lana, R; Diaz-Rubio, M. Mycobacterium avium subspecies paratuberculosis and its
relationship with Crohn's disease. World J. Gastroenterol., 2009; 15(4):417-422.
206.Vigo, AG; Martinez, A; de la Concha, EG; Urcelay, E; de Leon, AR. Suggested Association of NOS2A
Polymorphism in Idiopathic Achalasia: No Evidence in a Large Case-Control Study [Letter] Am. J.
Gastroenterol., 2009; 104(5):1326-1327.
207.Ladero, JM; Lopez-Alonso, G; Devesa, MJ; Cuenca, F; Ladero, J; Suarez, A; Ropero, P; Diaz-Rubio, M.
OSCILLATIONS IN SERUM FERRITIN ASSOCIATED TO ANTIVIRAL THERAPY IN CHRONIC HEPATITIS C. J.
Hepatol., 2009; 50(Suppl. 1):626-.
208.Rey, E; Talley, NJ. Irritable bowel syndrome: Novel views on the epidemiology and potential risk
factors. Dig. Liver Dis., 2009; 41(11):772-780.
28
209.Mendoza, JL; Abreu, MT. Biological markers in inflammatory bowel disease: Practical consideration
for clinicians. Gastroenterol. Clin. Biol., 2009; 33(Suppl. 3):S158-S173.
210.Dema, B; Martinez, A; Fernandez-Arquero, M; Maluenda, C; Polanco, I; de la Concha, EG; Urcelay, E;
Nunez, C. Association of IL18RAP and CCR3 with coeliac disease in the Spanish population. J. Med.
Genet., 2009; 46(9):617-619.
211.Marquez, A; Cenit, MC; Nunez, C; Mendoza, JL; Taxonera, C; Diaz-Rubio, M; Bartolome, M; Arroyo,
R; Fernandez-Arquero, M; de la Concha, EG; Urcelay, E. Effect of BSN-MST1 locus on inflammatory
bowel disease and multiple sclerosis susceptibility. Genes Immun., 20 09; 10(7):631-635.
212.Dema, B; Martinez, A; Fernandez-Arquero, M; Maluenda, C; Polanco, I; de la Concha, EG; Urcelay, E;
Nunez, C. Lack of replication of celiac disease risk variants reported in a Spanish population using an
independent Spanish sample. Genes Immun., 2009; 10(7):659-661.
213.Trujillo-Tiebas, MJ; Fenollar-Cortes, M; Lorda-Sanchez, I; Diaz-Recasens, J; Redondo, AC; Ramos Corrales, C; Ayuso, C. Prenatal diagnosis of skeletal dysplasia due to FGFR3 gene mutations: a 9 -year
experience. J. Assist. Reprod. Genet., 2009; 26(8):455-460.
214.Barabash, A; Marcos, A; Ancin, I; Vazquez-Alvarez, B; de Ugarte, C; Gil, P; Fernandez, C; Encinas, A;
Lopez-Ibor, JJ; Cabranes, JA. APOE, ACT and CHRNA7 genes in the conversion from amnestic mild
cognitive impairment to Alzheimer's disease. Neurobiol. Aging, 2009; 30(8):1254-1264.
215.Martinez-Ramos, C; Cerdan, MT; Lopez, RS. Mobile Phone-Based Telemedicine System for the Home
Follow-Up of Patients Undergoing Ambulatory Surgery. Telemed. J. e-Health, 2009; 15(6):531-537.
216.Trinidad, EM; Ballesteros, M; Zuloaga, J; Zapata, A; Alonso-Colmenar, LM. An impaired
transendothelial migration potential of chronic lymphocytic leukemia (CLL) cells can be linked to
ephrin-A4 expression. Blood, 2009; 114(24):5081-5090.
217.Paiva, B; Vidriales, MB; Mateo, G; Perez, JJ; Montalban, MA; Sureda, A; Montejano, L; Gutierrez, NC;
de Coca, AG; de las Heras, N; Mateos, MV; Lopez-Berges, MC; Garcia-Boyero, R; Galende, J;
Hernandez, J; Palomera, L; Carrera, D; Martinez, R; de la Rubia, J; Martin, A; Gonzalez, Y; Blade, J;
Lahuerta, JJ; Orfao, A; San-Miguel, JF. The persistence of immunophenotypically normal residual
bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic
multiple myeloma patients. Blood, 2009; 114(20):4369 -4372.
218.Montesinos, P; Diaz-Mediavilla, J; Deben, G; Prates, V; Tormo, M; Rubio, V; Perez, I; Fernandez, I;
Viguria, M; Rayon, C; Gonzalez, J; de la Serna, J; Esteve, J; Bergua, JM; Rivas, C; Gonzalez, M;
Gonzalez, JD; Negri, S; Brunet, S; Lowenberg, B; Sanz, MA. Central nervous system involvement at
first relapse in patients with acute promyelocytic leukemia treated with all -trans retinoic acid and
anthracycline monochemotherapy without intrathecal prophylaxis. Haematol-Hematol. J., 2009;
94(9):1242-1249.
219.Santamaria, CM; Chillon, MC; Garcia-Sanz, R; Perez, C; Caballero, MD; Ramos, F; de Coca, AG;
Alonso, JM; Giraldo, P; Bernal, T; Queizan, JA; Rodriguez, JN; Fernandez-Abellan, P; Barez, A;
Penarrubia, MJ; Balanzategui, A; Vidriales, MB; Sarasquete, ME; Alcoceba, M; Diaz-Mediavilla, J;
Miguel, JFS; Gonzalez, M. Molecular stratification model for prognosis in cytogenetically normal
acute myeloid leukemia. Blood, 2009; 114(1):148-152.
220.Perez-Chacon, G; Rosado, S; Rebolleda, N; Losada -Fernandez, I; Vargas, JA; Morado, M; Jorda, J;
Perez-Aciego, P. Prognostic irrelevance of HLA-G in B-cell chronic lymphocytic leukemia. Int. J. Lab.
Hematol., 2009; 31(3):327-337.
29
221.Gonzalez Fernandez, FA; Villegas, A; Ropero, P; Carreno, MD; Anguita, E; Polo, M; Pascual, A;
Henandez, A. Haemoglobinopathies with high oxygen affinity. Experience of Erythropathology
Cooperative Spanish Group. Ann. Hematol., 2009; 88(3):235 -238.
222.Montesinos, P; Bergua, JM; Vellenga, E; Rayon, C; Parody, R; de la Serna, J; Leon, A; Esteve, J;
Milone, G; Deben, G; Rivas, C; Gonzalez, M; Tormo, M; Diaz-Mediavilla, J; Gonzalez, JD; Negri, S;
Amutio, E; Brunet, S; Lowenberg, B; Sanz, MA. Differentiation syndrome in patients with acute
promyelocytic leukemia treated with all -trans retinoic acid and anthracycline chemotherapy:
characteristics, outcome, and prognostic factors. Blood, 2009; 113(4):775-783.
223.Mateos, MV; Oriol, A; Martinez, J; Cibeira, MT; Gutierrez, NC; Terol, MJ; de Paz, R; Garcia -Larana, J;
Bengoechea, E; Garcia-Sancho, AM; Martinez, R; Palomera, L; de Arriba, F; Gonzalez, Y; Hernandez,
J; Sureda, A; Bello, JL; Lahuerta, JJ; Blade, J; San-Miguel, JF. A Prospective, Multicenter, Randomized,
Trial of Bortezomib/Melphalan/Prednisone (VMP) Versus Bortezomib/Thalidomide/Prednisone
(VTP) as Induction Therapy Followed by Maintenance Treatment with Bortezomib/Thalidomide (VT)
Versus Bortezomib/Prednisone (VP) in Elderly Untreated Patients with Multiple Myeloma Older
Than 65 Years. Blood, 2009; 114(22):3-4.
224.Rosinol, L; Cibeira, MT; Martinez, J; Mateos, MV; Oriol, A; Terol, MJ; Garcia-Larana, J; Hernandez, D;
de la Rubia, J; Sureda, A; Besalduch, J; Palomera, L; Gonzalez, Y; Echebeste, MA; Diaz-Mediavilla, J;
de Arriba, F; Alegre, A; Hernandez, MT; Lahuerta, JJ; San Miguel, JFF; Blade, J. Thalidomide
Dexamethasone (TD) Vs. Bortezomib (Velcade)(a)over-cap Thalidomide Dexamethasone (VTD) Vs.
VBMCP/VBAD/Velecade(a)over-cap as Induction Regimens Prior Autologous Stem Cell
Transplantation (ASCT) in Multiple Myeloma (MM): Results of a Phase III PETHEMA/GEM Trial.
Blood, 2009; 114(22):59-59.
225.Cervantes, F; Lopez-Garrido, P; Montero, MI; Jonte, F; Martinez, J; Hernan-Dez-Boluda, JC;
Calbacho, M; Sureda, A; Perez-Rus, G; Nieto, J; Perez-Lopez, C; Roman, J; Gonzalez, M; Pereira, A;
Colomer, D. Early Optimization of Imatinib Thera py in Patients Newly Diagnosed with Chronic-Phase
Chronic Myeloid Leukemia (CP-CML). A Study of the Spanish PETHEMA Group.. Blood, 2009;
114(22):456-457.
226.Chillon, C; Santamaria, C; Garcia -Sanz, R; Hernandez, M; Gutierrez, NC; Caballero, D; Vidriales, MB;
Perez, C; Balanzategui, A; Alcoceba, M; Sarasquete, ME; Puig, N; Ramos, F; de Coca, AG; DiazMediavilla, J; Miguel, JFS; Gonzalez, M. Value of Gene Expression Profiling by Taqman (R) Low
Density Arrays in the Diagnosis and Prognosis of Acute Myeloid Leukemia.. Blood, 2009;
114(22):648-648.
227.Martinez-Lopez, J; Blade, J; del Castillo, MCG; Mateos, MV; Alegre, A; Garcia -Larana, J; Sureda, A; de
la Rubia, J; Conde, E; Martinez, R; de Arriba, F; Zamudio, JLG; Besalduch, J; Cabrera, R; Biguria, MC;
Moraleda, JM; San Miguel, JF; Lahuerta, JJ. Long Term Significance of Response in Multiple
Myeloma After Stem Cell Transplantation. Blood, 2009; 114(22):719-720.
228.Roig, M; Ibanez, A; Garcia, I; Vera, JA; Aguilar, C; del Campo, R; Gonzalez, N; Martinez, R; Palomera,
L; Picon, I; Rodriguez, JN; Sanz, MA; de la Rubia, J. Activity and Safety of Lenalidomide and
Dexamethasone in Multiple Myeloma Patients with Advanced Renal Failure: a Spanish Multicenter
Retrospective Study.. Blood, 2009; 114(22):749-749.
229.Sanchez-Espiridion, B; Montalban, C; Garcia-Cosio, M; Garcia-Larana, J; Menarguez, J; Sabin, P;
Ramos, R; Rodriguez, J; Mestre, F; Canales, M; Alves, FJ; Canovas, A; Camarero, C; Salar, A; Serrano,
S; Castano, A; Sanchez-Godoy, P; Bas, A; Arranz, R; Acevedo, A; Rayon, C; Fresno, MF; Santonja, C;
Lopez, JL; Mollejo, M; Cruz, MA; Alvarez-Arguelles, H; LLanos, M; Martin, C; Martinez, R; GonzalezCarrero, J; Poderos, C; Mazorra, F; Conde, E; Flores, T; Garcia -Sanz, R; Forteza, J; Fraga, M; Bello, JL;
Mestre, MJ; Mendez, M; Quiben, R; Borbolla, L; Marin-Niebla, A; Rios, E; Morente, MM; Piris, MA;
30
Garcia, JF. Identification of Molecular Risk Score in Advanced Hodgkin Lymphoma: Integrating
Tumor and Microenvironment Signatures.. Blood, 2009; 114(22):1411-1411.
230.Paiva, B; Vidriales, M; Cervero, J; Mateo, G; Perez, J; Montalban, MA; Sureda, A; Montejano, L;
Gutierrez, N; de Coca, AG; De las Heras, N; Mateos, M; Lopez-Berges, M; Garcia-Boyero, R; Galende,
J; Hernandez, J; Palomera, L; Carrera, D; Martinez, R; De la Rubia, J; Martin, A; Blade, J; Lahuerta, J;
Orfao, A; San Miguel, JF. THE PRESENCE OF RESIDUAL NORMAL PLASMA CELLS BY
MULTIPARAMETER FLOW CYTOMETRY IN THE BONE MARROW OF SYMPTOMATIC MULTIPLE
MYELOMA PATIENTS AT DIAGNOSIS IDENTIFIES A GOOD PROGNOSTIC SUBGROUP. HaematolHematol. J., 2009; 94(Suppl. 2):386-.
231.Paiva, B; Vidriales, M; Cervero, J; Mateo, G; Perez, J; Montalban, MA; Sureda, A; Montejano, L;
Gutierrez, N; de Coca, AG; De las Heras, N; Mateos, M; Lopez-Berges, M; Garcia-Boyero, R; Galende,
J; Hernandez, J; Palomera, L; Carrera, D; Martinez, R; De la Rubia, J; Martin, A; Blade, J; Lahuerta, J;
Orfao, A; San Miguel, JF. MULTIPARAMTER FLOW CYTOMETRY QUANTIFICATION OF BONE
MARROW PLASMA CELLS AT DIAGNOSIS IS A VALID METHOD FOR PREDICTION OF MULTIPLE
MYELOMA PATIENTS OUTCOME. Haematol-Hematol. J., 2009; 94(Suppl. 2):545-.
232.Grande, C; Sanchez, PJG; de la Rubia, J; Serrano, D; Duarte, ML; Boyero, RG; Rosique, P; Heras, I;
Martinez, R; Lahuerta, JJ. INTRAVENOUS BUSULFAN IN AUTOLOGOUS STEM CELL
TRANSPLANTATION CONDITIONING REGIMEN FOR ADULT PATIENTS WITH ACUTE MYELOID
LEUKEMIA. MULTICENTRE RETROSPECTIVE ANALYSIS. Haematol -Hematol. J., 2009; 94(Suppl. 2):719.
233.Ortiz-Munoz, G; Martin-Ventura, JL; Hernandez-Vargas, P; Mallavia, B; Lopez-Parra, V; LopezFranco, O; Munoz-Garcia, B; Fernandez-Vizarra, P; Ortega, L; Egido, J; Gomez-Guerrero, C.
Suppressors of Cytokine Signaling Modulate JAK/STAT-Mediated Cell Responses During
Atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2009; 29(4):525-531.
234.Verde, Z; Santiago, C; Valle, B; Fernandez-Santander, A; Bandres, F; Calvo, E; Ruiz, JR; Lucia, A;
Gallego, FG. Pharmacogenetics of acenocoumarol: CYP2C9*2 and VKORCI c.-1639G > A, 497C > G,
1173C > T and 3730G > A variants influence drug dose in anticoagulated patients [Letter] Thromb.
Haemost., 2009; 101(3):591-593.
235.Rioboo, JP; Sanchez-Iriso, E; Ruano-Ravina, A; Lema, MLV; Sanchez-Guisande, D; GonzalezRodriguez, L; Herrero, JA; Barril, G; Maduell, F; Hernandez, J; Otero, A; Bajo, MA; Sanchez, R. Short
Daily versus Conventional Hemodialysis Quality of Life: A Cross -Sectional Multicentric Study in
Spain. Blood Purif., 2009; 28(3):159-164.
236.Dema, B; Fernandez-Arquero, M; Maluenda, C; Polanco, I; Figueredo, MA; de la Conc ha, EG;
Urcelay, E; Nunez, C. Lack of association of NKX2-3, IRGM, and ATG16L1 inflammatory bowel
disease susceptibility variants with celiac disease. Hum. Immunol., 2009; 70(11):946 -949.
237.del Pozo, N; Lopez-Mejias, R; Fernandez-Arquero, M; Ferreira, A; Garcia-Rodriguez, MC; de la
Concha, EG; Fontan, G; Urcelay, E; Nunez, C. Lack of evidence of a role of XBP1 and PRDM1
polymorphisms in Spanish patients with immunoglobulin A deficiency. Hum. Immunol., 2009;
70(11):950-952.
238.Dema, B; Martinez, A; Fernandez-Arquero, M; Maluenda, C; Polanco, I; Figueredo, MA; de la
Concha, EG; Urcelay, E; Nunez, C. The IL6-174G/C polymorphism is associated with celiac disease
susceptibility in girls. Hum. Immunol., 2009; 70(3):191 -194.
239.Roman, A; Rodriguez, M; Herraiz, MA; Jorda, J; Cervera, I; Penaloza, J; Vidart, JA; Martinez-Laso, J.
Heterogeneous expression of HLA-G1,-G2,-G5,-G6, and-G7 in myeloid and plasmacytoid dendritic
cells isolated from umbilical cord blood. Hum. Immunol., 2009; 70(2):104-109.
31
240.Mallolas, J; Podzamczer, D; Milinkovic, A; Domingo, P; Clotet, B; Ribera, E; Gutierrez, F; Knobel, H;
Cosin, J; Ferrer, E; Arranz, JA; Roca, V; Vidal, F; Murillas, J; Pich, J; Pedrol, E; Llibre, JM; Dalmau, D;
Garcia, I; Aranda, M; Cruceta, A; Martinez, E; Blanco, JL; de Lazzari, E; Gatell, JM. Efficacy and Safety
of Switching From Boosted Lopinavir to Boosted Atazanavir in Patients With Virological Suppression
Receiving a LPV/r-Containing HAART: The ATAZIP Study. JAIDS, 2009; 51(1):29-36.
241.Martinez, E; Arranz, JA; Podzamczer, D; Lonca , M; Sanz, J; Barragan, P; Ribera, E; Knobel, H; Roca, V;
Gutierrez, F; Blanco, JL; Mallolas, J; Llibre, JM; Clotet, B; Dalmau, D; Segura, F; Arribas, JR; Cosin, J;
Barrufet, P; Casas, E; Ferrer, E; Curran, A; Gonzalez, A; Pich, J; Cruceta, A; Arnaiz, JA; Miro, JM;
Gatell, JM. A Simplification Trial Switching From Nucleoside Reverse Transcriptase Inhibitors to
Once-Daily Fixed-Dose Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1-Infected Patients
With Virological Suppression. JAIDS, 2009; 51(3):290-297.
242.Knuf, M; Szenborn, L; Moro, M; Petit, C; Bermal, N; Bernard, L; Dieussaert, I; Schuerman, L.
Immunogenicity of Routinely Used Childhood Vaccines When Coadministered With the 10 -Valent
Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV).
Pediatr. Infect. Dis. J., 2009; 28(4):S97-S108.
243.Nunez-Fernandez, C; Martin-Carbonero, L; Valencia, ME; Aguilera, J; Garcia -Samaniego, J; GonzalezLahoz, J; Soriano, V. Liver Complications Have Reached a Plateau as Cause of Hospital Admission
and Death in HIV Patients in Madrid. Aids Res. Hum. Retrovir., 2009; 25(4):383-385.
244.de Andres, C; Aristimuno, C; Bartolome, M; de las Heras, V; Martinez-Gines, ML; Arroyo, R;
Fernandez-Cruz, E; Sanchez-Ramon, S. Clinical response to interferon-beta-1a may be linked to low
baseline circulating BDCA1 myeloid dendritic cells Differential role of circulating dendritic cells and
CD4(+) regulatory T-cells in relapsing-remitting multiple sclerosis: A 1-year longitudinal study. J.
Neuroimmunol., 2009; 212(40210):112-120.
245.Comabella, M; Fernandez-Arquero, M; Rio, J; Guinea, A; Fernandez, M; Cenit, MC; de la Concha, EG;
Montalban, X. HLA class I and II alleles and response to treatment with interferon -beta in relapsingremitting multiple sclerosis. J. Neuroimmunol., 2009; 210(40210):116-119.
246.Comabella, M; Fernandez-Arquero, M; Rio, J; Guinea, A; Fernandez, M; Cenit, MC; de la Concha, EG;
Montalban, X. HLA class I and II alleles and response to treatment with interferon -beta in relapsingremitting multiple sclerosis (vol 210, pg 116, 2009). J. Neuroimmunol., 2009; 214(40210):132-132.
247.Santillan, I; Verdu, V; Prados, F; Badajoz, V; Lamas, JR; Fernandez, F. Soluble MHC Class I chain related molecule serum and follicular levels as predictive markers for IVF outcomes. J. Reprod.
Immunol., 2009; 81(2):145-145.
248.Hernandez, D; Sanchez-Fructuoso, A; Gonzalez-Posada, JM; Arias, M; Campistol, JM; Rufino, M;
Morales, JM; Moreso, F; Perez, G; Torres, A; Seron, D. A Novel Risk Score for Mortality in Renal
Transplant Recipients Beyond the First Posttransplant Year. Transplantation, 2009; 88(6):803-809.
249.Fructuoso, AIS; de la Higuera, MAM; Garcia -Ledesma, P; Giorgi, M; Ramos, F; Calvo, N; Perez-Flores,
I; Barrientos, A. Graft Outcome and Mycophenolic Acid Trough Level Monitoring in Ki dney
Transplantation. Transplant. Proc., 2009; 41(6):2102 -2103.
250.Sanchez-Fructuoso, AI; de la Higuera, MAM; Giorgi, M; Ramos, F; Ledesma, PG; Calvo, N; PerezFlores, I; Barrientos, A. Inadequate Mycophenolic Acid Exposure and Acute Rejection in Kidney
Transplantation. Transplant. Proc., 2009; 41(6):2104-2105.
251.Perez-Flores, I; Sanchez-Fructuoso, A; Santiago, JL; Fernandez-Arquero, M; Calvo, N; de la Concha,
EG; Barrientos, A. Intracellular ATP Levels in CD4+Lymphocytes Are a Risk Marker of Rejection and
Infection in Renal Graft Recipients. Transplant. Proc., 2009; 41(6):2106-2108.
32
252.Rodriguez-Moreno, A; Ridao, N; Garcia-Ledesma, P; Calvo, N; Perez-Flores, I; Marques, M;
Barrientos, A; Sanchez-Fructuoso, AI. Sirolimus and Everolimus Induced Pneumonitis in Adult Renal
Allograft Recipients: Experience in a Center. Transplant. Proc., 2009; 41(6):2163 -2165.
253.Sanchez-Fructuoso, A; Ruiz, JC; Rengel, M; Andres, A; Morales, JM; Beneyto, I; Guirado, LI; Cantarell,
C. Use of Mycophenolate Sodium in Stable Renal Transplant Recipients in Spain: Preliminary Results
of the MIDATA Study. Transplant. Proc., 2009; 41(6):2309 -2312.
254.Sanchez-Fructuoso, AI; Maestro, ML; Calvo, N; Viudarreta, M; Perez-Flores, I; Veganzone, S; De la
Orden, V; Ortega, D; Arroyo, M; Barrientos, A. The Prevalence of Uridine DiphosphateGlucuronosyltransferase 1A9 (UGT1A9) Gene Promoter Region Single-Nucleotide Polymorphisms T275A and C-2152T and Its Influence on Mycophenolic Acid Pharmacokinetics in Stable Renal
Transplant Patients. Transplant. Proc., 2009; 41(6):2313-2316.
255.Carrasco, FR; Perez-Flores, I; Calvo, N; Ridao, N; Sanchez, A; Barrientos. Treatment of Persistent
Hyperparathyroidism in Renal Transplant Patients With Cinacalcet Improves Control of Blood
Pressure. Transplant. Proc., 2009; 41(6):2385-2387.
256.Carrasco, FR; Moreno, A; Ridao, N; Calvo, N; Perez-Flores, I; Rodriguez, A; Sanchez, A; Marques, M;
Barrientos. Kidney Transplantation Complications Related to Psychiatric or Neurological Disorders.
Transplant. Proc., 2009; 41(6):2430-2432.
257.Fuster, M; Estrada, V; Fernandez-Pinilla, MC; Fuentes-Ferrer, ME; Tellez, MJ; Vergas, J; SerranoVillar, S; Fernandez-Cruz, A. Smoking cessation in HIV patients: rate of success and associated
factors. HIV Med., 2009; 10(10):614-619.
258.Picazo, JJ; Betriu, C; Culebras, E; Rodriguez-Avial, I; Gomez, M; Lopez, F. Activity of daptomycin
against staphylococci collected from bloodstream infections in Spanish medical centers. Diagn.
Microbiol. Infect. Dis., 2009; 64(4):448-451.
259.Cano, S; Fuentes, M; Ballesteros, J; Clavo, P; Menendez, B; Del Romero, J. Gonorrhea diagnoses in a
center for sexually transmitted disease (STD) and their relationship with HIV and other STD (Madrid,
2005). Enferm. Infec. Microbiol. Clin., 2009; 27(6):338-341.
260.Rodriguez, NA; Chaves, F; Inigo, J; Bouza, E; de Viedma, DG; Andres, S; Cias, R; Daza, R; Domingo, D;
Esteban, J; Garcia, J; Mampaso, EG; Herranz, M; Palenque, E; Serrano, MJR. Transmission
permeability of tuberculosis involving immigrants, revealed by a multicentre analysis of clusters.
Clin. Microbiol. Infect., 2009; 15(5):435-442.
261.Betriu, C; Rodriguez-Avial, I; Lopez, F; Picazo, JJ. Comparative study of the in vitro activity of
tigecycline against multiresistant Enterococcus faecium isolates [Letter] Enferm. Infec. Microbiol.
Clin., 2009; 27(5):302-303.
262.Picazo, JJ. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of
pneumococcal conjugate vaccines. Clin. Microbiol. Infect., 2009; 15(Suppl. 3):4 -6.
263.Olaechea, PM; Alvarez-Lerma, F; Sanchez, M; Torres, A; Palomar, M; Fernandez, P; Miro, JM;
Cisneros, JM; Torres, M. Evaluation of the status of patients with severe infection, criteria for
intensive care unit admittance. Enferm. Infec. Microbiol. Clin., 2009; 27(6):342 -352.
264.Osinalde, EP; Vilacosta, I; Manzano, M; San Roman, A; Sarria, C; Fernandez, C; Lopez, J; Rodriguez, E;
Silva, J. INFECTIVE ENDOCARDITIS ON APPARENTLY NORMAL LEFT-SIDED NATIVE VALVES. Int. J.
Antimicrob. Agents, 2009; 33(Suppl. 2):20-.
265.Osinalde, EP; Vilacosta, I; San Roman, A; Manzano, M; Sarria, C; Fer nandez, C; Lopez, J; Silva, J;
Rodriguez, E. INFECTIVE ENDOCARDITIS IN YOUNG PATIENTS NON INTRAVENOUS DRUGS USERS.
Int. J. Antimicrob. Agents, 2009; 33(Suppl. 2):21-.
33
266.Osinalde, EP; Vilacosta, I; San Roman, AS; Fernandez, C; Sarria, C; Lopez, J; Silva, J; Rodriguez, E;
Balbacid, E. INFECTIVE ENDOCARDITIS TREATMENT: EXPERIENCE IN THE LAST TEN YEARS. Int. J.
Antimicrob. Agents, 2009; 33(Suppl. 2):22-.
267.Osinalde, EP; Vilacosta, I; Roman, AS; Sarria, C; Lopez, J; Rodriguez, E; Silva, J; Fernandez, C;
Balbacid, E. MORTALITY PREDICTORS IN STAPHYLOCOCCUS AUREUS INFECTIVE ENDOCARDITIS. Int.
J. Antimicrob. Agents, 2009; 33(Suppl. 2):38-.
268.Osinalde, EP; Vilacosta, I; Manzano, M; Sarria, C; Roman, AS; Fernandez, C; Silva, J; Lopez, J;
Rodriguez, E. INFECTIVE ENDOCARDITIS IN OCTOGENARIAN PATIENTS. Int. J. Antimicrob. Agents,
2009; 33(Suppl. 2):55-.
269.Osinalde, EP; Vilacosta, I; Manzano, M; Roman, AS; Sarria, C; Fernandez, C; Rodriguez, E; Lopez, J;
Silva, J. INFECTIVE ENDOCARDITIS IN LEFT-SIDED VALVES AFTER DENTAL PROCEDURES. Int. J.
Antimicrob. Agents, 2009; 33(Suppl. 2):109-.
270.Garcia, MS. Early antibiotic treatment failure. Int. J. Antimicrob. Agents, 2009; 34(Suppl. 3).
271.Pulido, F; Estrada, V; Baril, JG; Logue, K; Schewe, K; Plettenberg, A; Duiculescu, D; Yau, L; Vavro, C;
Lim, ML; Pharo, C. Long-Term Efficacy and Safety of Fosamprenavir plus Ritonavir Versus
Lopinavir/Ritonavir in Combination with Abacavir/Lamivudine over 144 Weeks. HIV Clin. Trials,
2009; 10(2):76-87.
272.Pulido, F; Perez-Valero, I; Delgado, R; Arranz, A; Pasqua u, J; Portilla, J; Rubio, R; Gonzalez-Garcia, J;
Miralles, P; Perez-Elias, MJ; Ocampo, A; Hernando, A; Estrada, V; Clotet, B; Podzamczer, D; Arribas,
JR. Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir
monotherapy for maintenance of HIV suppression. Antivir. Ther., 2009; 14(2):195 -201.
273.Martin, RB; Martinez, JM; Losa, JE; Lebrato, JC; Canteli, SP; Gaviria, AZ. Two-year analysis of Internal
Medicine activity in the National Health Care System hospitals. Rev. Clin. Es p., 2009; 209(10):459466.
274.Rodriguez-Cerrillo, M; Alvarez-Arcaya, A; Fernandez-Diaz, E; Fernandez-Cruz, A. A prospective study
of the management of non-massive pulmonary embolism in the home. Eur. J. Intern. Med., 2009;
20(6):598-600.
275.Monzon, T; Castillo, J; Yague, MR; Jimenez, R. Patient with bilateral lung nodes like metastasis. Late
silicosis. Rev. Clin. Esp., 2009; 209(8):388-390.
276.Contreras, EM; Claros, NM; Guillen, VG; De Pablos, JLM; Von Wichman, MD; Martinez, JJC; Garcia,
JE; Vilas, JCP. Non-pharmacological intervention as a strategy to improve antihypertensive
treatment compliance. Aten. Prim., 2009; 41(9):501-510.
277.Rosell, R; Moran, T; Queralt, C; Porta, R; Cardenal, F; Camps, C; Majem, M; Lopez-Vivanco, G; Isla, D;
Provencio, M; Insa, A; Massuti, B; Gonzalez-Larriba, JL; Paz-Ares, L; Bover, I; Garcia-Campelo, R;
Moreno, MA; Catot, S; Rolfo, C; Reguart, N; Palmero, R; Sanchez, JM; Bastus, R; Mayo, C; Bertran Alamillo, J; Molina, MA; Sanchez, JJ; Taron, M. Screening for Epidermal Growth Fac tor Receptor
Mutations in Lung Cancer.. N. Engl. J. Med., 2009; 361(10):958-U38.
278.Contreras, EM; Claros, NM; Guillen, VG; De Pablos, JLM; Wichman, MDV; Martinez, JJC; Garcia, JE.
Control of therapeutic inertia in the treatment of arterial hypertension by us ing different strategies.
Aten. Prim., 2009; 41(6):315-323.
279.Conthe, P; Gomez-Fernandez, P; de Alvaro, F; Fernandez-Perez, C; Gonzalez-Esteban, J; Cea-Calvo, L.
HDL cholesterol and cardiovascular disease in a population with hypertension and type 2 diabetes
mellitus. RICARHD Study. Rev. Clin. Esp., 2009; 209(5):227-233.
34
280.Cortada, EB; Munoz, JLDM; Pinilla, CF; Garcia -Aranda, VL; Torrell, JMR; de Burgoa, VS; Vazquez, ER.
Profile of the patient who wants to quick smoking seen in the Primary Care and Specialized
consultations in Spain. Rev. Clin. Esp., 2009; 209(4):160 -167.
281.Gil-Mosquera, M; Vano-Galvan, S; Gomez-Guerra, R; Jaen, P. A cutaneous horn on the ear. Aust.
Fam. Physician, 2009; 38(3):118-118.
282.Campos-Castello, J. Role of generic antiepileptic drugs in the treatment of childhood epilepsy. Med.Buenos Aires, 2009; 69(1):109-113.
283.Ropero, P; Gonzalez, FA; Hernandez, A; Sanchez, H; Cela, E; Villegas, A. Prenatal diagnosis of
hemoglobinopathies and thalassemias. Med. Clin., 2009; 132(2):53 -56.
284.Ruiz, MA; Pardo, A; de la Casa, JMM; Polo, V; Esquirol, J; Soto, J. Cultural adaptation and validation
into Spanish of the Glaucoma Symptom Scale (GSS). Med. Clin., 2009; 132(3):89 -97.
285.Vallejo-Garcia, JL; Vano-Galvan, S; Rayward, O; Moreno-Martin, P. Painful eye with a faci al rash
[Editorial] Clevel. Clin. J. Med., 2009; 76(7):410-412.
286.del Nogal, ML. Falls among older persons [Editorial] Med. Clin., 2009; 133(4):147-153.
287.De Velasco, JA; Del Campo, A; Heras, M; Macaya, C. Cardiologists opinion on the situation of the
secondary prevention of ischemic heart disease in Spain [Editorial] Med. Clin., 2009; 132(15):599602.
288.Martin, M. Unravelling the mystery of the TACT trial [Editorial] Lancet, 2009; 373(9676):1662 -1663.
289.Villar, SS; Perez-Somarriba, J; Costa, TS; Winstanley, S; Lopez, TS; Mora, LE; Gonzalez, BO. A 38 year
old woman with hypotensive shock at the onset of menstruation: case outcome [Editorial] Br. Med.
J., 2009; 338():-.
290.Barroso; Villar, SS. Commentary: Patient's view [Editorial] Br. Med. J., 2009; 338():-.
291.Villar, SS. Commentary: Managing clinician's assessment [Editorial] Br. Med. J., 2009; 338():-.
292.Villar, SS; Perez-Somarriba, J; Costa, TS; Winstanley, S; Lopez, TS; Mora, LE; Gonzalez, BO. A 38 year
old woman with hypotensive shock at the onset of menstruation: case progression [Editorial] Br.
Med. J., 2009; 338():-.
293.Villar, SS; Perez-Somarriba, J; Costa, TS; Winstanley, S; Lopez, TS; Mora, LE; Gonzalez, BO. A 38 year
old woman with hypotensive shock at the onset of menstruation: case presentation [Editorial] Br.
Med. J., 2009; 338():-.
294.Forner, A; Ayuso, C; Real, MI; Sastre, J; Robles, R; Sangro, B; Varela, M; de la Mata, M; Buti, M;
Marti-Bonmati, L; Bru, C; Tabernero, J; Llovet, JM; Bruix, J. Diagnosis and treatment of
hepatocellular carcinoma [Editorial] Med. Clin., 2009; 132(7):272-287.
295.Segura, PP. Genetic studies and the Law of Biomedical Research [Editorial] Med. Clin., 2009;
132(4):154-156.
296.Llorens, P; Perello, R; Martin, FJ; Herrero, P. Functional status as risk factor for mortality in patients
with acute heart failure at the emergency department [Letter] Med. Clin., 2009; 133(14):566-567.
297.Casado, JMR. Cardiac surgery in octogenarians [Letter] Med. Clin., 2009; 133(2):77-77.
298.Llorens, P; Miro, O; Martin-Sanchez, FJ; Herrero, P. Prevalence of anemia in heart failure: a practical
approach [Letter] Rev. Clin. Esp., 2009; 209(3):154-155.
35
299.Rivero-Garvia, M; Boto, GR; Perez-Zamarron, A; Gutierrez-Gonzalez, R. Distal aneurysm of the left
middle cerebral artery located with neuronavigation during surgery [Letter] Rev. Clin. Esp., 2009;
209(1):54-55.
300.Hernandez, MAS; Manchado, TD; Gonzalez, P; Ruiz-Yague, M. External jugular vein thrombosis
[Letter] Rev. Clin. Esp., 2009; 209(1):55-56.
301.Diaz, PG; Hernandez, MAS; Manzano, A; Jimenez, R. Hemolytic anemia and alcohol abuse: should
we consider Zieve's syndrome? [Letter] Rev. Clin. Esp., 2009; 209(1):56-57.
302.Llorens, P; Gonzalez-Armengol, JJ; Burillo-Putze, G; Miro, O. On the possibilities of earl y antibiotic
administration in the emergency department [Letter] Med. Clin., 2009; 132(6):240-240.
303.Cea-Calvo, L; Lozano, JV; Fernandez-Perez, C; Llisterri, JL; Marti-Canales, JC; Aznar, J; Gil -Guillen, V;
Redon, J. Prevalence of low HDL cholesterol, and relationship between serum HDL and
cardiovascular disease in elderly Spanish population: the PREV-ICTUS study. Int. J. Clin. Pract., 2009;
63(1):71-81.
304.Arias-Diaz, J; Ildefonso, JA; Munoz, JJ; Zapata, A; Jimenez, E. Both tacrolimus and sirolimus decrease
Th1/Th2 ratio, and increase regulatory T lymphocytes in the liver after ischemia/reperfusion. Lab.
Invest., 2009; 89(4):433-445.
305.Flamand, L; Gravel, A; Boutolleau, D; Alvarez-Lafuente, R; Jacobson, S; Malnati, MS; Kohn, D; Tang,
YW; Yoshikawa, T; Ablashi, D. Multicenter Comparison of PCR Assays for Detection of Human
Herpesvirus 6 DNA in Serum (vol 46, pg 2700, 2008). J. Clin. Microbiol., 2009; 47(2):519-519.
306.Cela-Conde, CJ; Ayala, FJ; Munar, E; Maestu, F; Nadal, M; Capo, MA; del Rio, D; Lopez-Ibor, JJ; Ortiz,
T; Mirasso, C; Marty, G. Sex-related similarities and differences in the neural correlates of beauty.
Proc. Natl. Acad. Sci. U. S. A., 2009; 106(10):3847-3852.
307.Buitrago, MJ; Merino, P; Puente, S; Gomez-Lopez, A; Arribi, A; Zancope-Oliveira, RM; Gutierrez, MC;
Rodriguez-Tudela, JL; Cuenca-Estrella, M. Utility of Real -time PCR for the detection of
Paracoccidioides brasiliensis DNA in the diagnosis of imported paracoccidioidomycosis. Med.
Mycol., 2009; 47(8):879-882.
308.Solomon, A; Leoni, V; Kivipelto, M; Besga, A; Oksengard, AR; Julin, P; Svensson, L; Wahlund, LO;
Andreasen, N; Winblad, B; Soininen, H; Bjorkhem, I. Plasma levels of 24S-hydroxycholesterol reflect
brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's
disease. Neurosci. Lett., 2009; 462(1):89-93.
309.Bartolome, MV; Zuluaga, P; Carricondo, F; Gil -Loyzaga, P. Immunocytochemical detection of
synaptophysin in C57BL/6 mice cochlea during aging process. Brain Res. Rev., 2009; 60(2):341-348.
310.Barcia, JA; Gallego, JM. Intraventricular and Intracerebral Delivery of Anti -epileptic Drugs in the
Kindling Model. Neurotherapeutics, 2009; 6(2):337-343.
311.Tajima, K; Diaz-Marsa, M; Montes, A; Garcia-Andrade, RF; Casado, A; Carrasco, JL. Neuroimaging
studies in the borderline pers onality disorder. Actas Esp. Psiquiatri., 2009; 37(3):123 -127.
312.Arza, R; Diaz-Marsa, M; Lopez-Mico, C; de Pablo, NF; Lopez-Ibor, JJ; Carrasco, JL. Neuropsychological
dysfunctions in personality borderline disorder: detection strategies. Actas Esp. Psiquiatr i., 2009;
37(4):185-190.
313.Osorio, R; de Lozar, BG; Ramos, I; Aguera, L. Executive function in patients with late onset
depression. Actas Esp. Psiquiatri., 2009; 37(4):196-199.
36
314.Arza, R; Diaz-Marsa, M; Lopez-Mico, C; de Pablo, NF; Lopez-Ibor, JJ; Carrasco, JL. Neuropsychological
rehabilitation in patients with borderline personality disorder: a case series. Actas Esp. Psiquiatri.,
2009; 37(4):236-239.
315.Barcia, JA; Gonzalez-Hidalgo, M; Lopez-Ibor, MI; Ortiz, T; Reyes, L; Lopez-Ibor, JJ. Deep brain
stimulation in mood disorders: is it as esasy as it seems? [Letter] Actas Esp. Psiquiatri., 2009;
37(5):297-298.
316.Tajima, K; Fernandez, H; Lopez-Ibor, JJ; Carrasco, JL; Diaz-Marsa, M. Schizophrenia treatment.
Critical review on the drugs and mechanisms of action of antipsychotics. Actas Esp. Psiquiatri., 2009;
37(6):330-342.
317.Gutierrez-Gonzalez, R; Boto, GR; Perez-Zamarron, A; Rivero-Garvia, M. Intracraneal tumoral link:
coexistance of low-grade glioma, multiform glioblastoma and meningioma in the same patient
[Letter] Neurocirugia, 2009; 20(2):176-178.
318.Prieto, R; Gutierrez-Gonzalez, R; Pascual, JM; Roda, JM; Cerdan, S; Matias -Guiu, J; Barcia, JA.
Experimental models of traumatic brain injury. Neurocirugia, 2009; 20(3):225-244.
319.Baker, J; Ajani, J; Scotte, F; Winther, D; Martin, M; Aapro, MS; von Minckwitz, G. Docetaxel -related
side effects and their management. Eur. J. Oncol. Nurs., 2009; 13(1):49-59.
320.Moro, M; Perez-Rodriguez, J; Figueras-Aloy, J; Fernandez, C; Domenech, E; Jimenez, R; Perez-Sheriff,
V; Quero, J; Roques, V. Predischarge Morbidities in Extremely and Very Low-Birth-Weight Infants in
Spanish Neonatal Units. Am. J. Perinatol., 2009; 26(5):335-343.
321.Maestro, LM; Sastre, J; Rafael, SB; Veganzones, SB; Vidaurreta, M; Martin, M; Olivier, C; De La
Orden, VB; Garcia-Saenz, JA; Alfonso, R; Arroyo, M; Diaz-Rubio, E. Circulating Tumor Cells in Solid
Tumor in Metastatic and Localized Stages. Anticancer Res., 2009; 29(11):4839 -4843.
322.Osorio, A; Milne, RL; Pita, G; Peterlongo, P; Heikkinen, T; Simard, J; Chenevix-Trench, G; Spurdle, AB;
Beesley, J; Chen, X; Healey, S; Neuhausen, SL; Ding, YC; Couch, FJ; Wang, X; Lindor, N; Manoukian, S;
Barile, M; Viel, A; Tizzoni, L; Szabo, CI; Foretova, L; Zikan, M; Claes, K; Greene, MH; Mai, P; Rennert,
G; Lejbkowicz, F; Barnett-Griness, O; Andrulis, IL; Ozcelik, H; Weerasooriya, N; Gerdes, AM;
Thomassen, M; Cruger, DG; Caligo, MA; Friedman, E; Kaufman, B; Laitman, Y; Cohen, S; Kontorovich,
T; Gershoni-Baruch, R; Dagan, E; Jernstrom, H; Askmalm, MS; Arver, B; Malmer, B; Domchek, SM;
Nathanson, KL; Brunet, J; Cajal, TRY; Yannoukakos, D; Hamann, U; Hogervorst, FBL; Verhoef, S;
Garcia, EBG; Wijnen, JT; van den Ouweland, A; Easton, DF; Peock, S; Cook, M; Oliver, CT; Frost, D;
Luccarini, C; Evans, DG; Lalloo, F; Eeles, R; Pichert, G; Cook, J; Hodgson, S; Morrison, PJ; Douglas, F;
Godwin, AK; Sinilnikova, OM; Barjhoux, L; Stoppa -Lyonnet, D; Moncoutier, V; Giraud, S; Cassini, C;
Olivier-Faivre, L; Revillion, F; Peyrat, JP; Muller, D; Fricker, JP; Lynch, HT; John, EM; Buys, S; Daly, M;
Hopper, JL; Terry, MB; Miron, A; Yassin, Y; Goldgar, D; Singer, CF; Gschwantler -Kaulich, D; Pfeiler, G;
Spiess, AC; Hansen, TV; Johannsson, OT; Kirchhoff, T; Offit, K; Kosarin, K; Piedmonte, M; Rodriguez,
GC; Wakeley, K; Boggess, JF; Basil, J; Schwartz, PE; Blank, SV; Toland, AE; Montagna, M; Casella, C;
Imyanitov, EN; Allavena, A; Schmutzler, RK; Versmold, B; Engel, C; Meindl, A; Ditsch, N; Arnold, N;
Niederacher, D; Deissler, H; Fiebig, B; Varon-Mateeva, R; Schaefer, D; Froster, UG; Caldes, T; de la
Hoya, M; McGuffog, L; Antoniou, AC; Nevanlinna, H; Radice, P; Benitez, J. Evaluation of a candidate
breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers.
Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). Br. J. Cancer,
2009; 101(12):2048-2054.
323.Candel, VA; Mena, AC; Garcia, EDR; Vilaplana, PG; Baron, MG; Jimenez, MM; Conejo, EA; Espinosa,
JC; Colomer, R; Hernandez, JJC; Molins, ABI; Herrero, CC; de Tejerina, AMCF; Torrent, JC; Figueiras,
MC; Gregori, JG; Casado, MDI; Sureda, BM; Pulla, MP; Sanchez, CAR; Ortiz, JS. Spanish Society of
37
Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer
patients. Clin. Transl. Oncol., 2009; 11(11):727-736.
324.Mackey, J; Gelmon, K; Martin, M; McCarthy, N; Pinter, T; Rupin, M; Youssoufian, H. TRIO -012: A
Multicenter, Multinational, Randomized, Double-Blind Phase III Study of IMC-1121B Plus Docetaxel
Versus Placebo Plus Docetaxel in Previously Untreated Patients With HER2-Negative, Unresectable,
Locally Recurrent or Metastatic Breast Cancer. Clin. Breast Cancer, 2009; 9(4):258-261.
325.Manas, A; Palacios, A; Contreras, J; Sanchez-Magro, I; Blanco, P; Fernandez-Perez, C. Incidence of
oral mucositis, its treatment and pain management in patients receiving cancer treatment at
Radiation Oncology Departments in Spanish hospitals (MUCODOL Study). Clin. Transl. Oncol., 2009;
11(10):669-676.
326.Martin, M; Garcia-Saenz, JA; De Las Casas, MLM; Vidaurreta, M; Puente, J; Veganzones, S;
Rodriguez-Lajusticia, L; De La Orden, V; Oliva, B; De La Torre, JC; Lopez-Tarruella, S; Casado, A;
Sastre, J; Diaz-Rubio, E. Circulating Tumor Cells in Metastatic Breast Cancer: Timing of Blood
Extraction for Analysis. Anticancer Res., 2009; 29(10):4185-4187.
327.Castellano, D; del Muro, XG; Perez-Gracia, JL; Gonzalez-Larriba, JL; Abrio, MV; Ruiz, MA; Pardo, A;
Guzman, C; Cerezo, SD; Grande, E. Patient-reported outcomes in a phase III, randomized study of
sunitinib versus interferon-alpha as first-line systemic therapy for patients with metastatic renal cell
carcinoma in a European population. Ann. Oncol., 2009; 20(11):1803-1812.
328.Fernandez-Ramires, R; Sole, X; De Cecco, L; Llort, G; Cazorla, A; Bonifaci, N; Garcia, MJ; Caldes, T;
Blanco, I; Gariboldi, M; Pierotti, MA; Pujana, MA; Benitez, J; Osorio, A. Gene expression profiling
integrated into network modelling reveals heterogeneity in the mechanisms of BRCA1
tumorigenesis. Br. J. Cancer, 2009; 101(8):1469-1480.
329.Rivera, F; Carrato, A; Gravalos, C; Pericay, C; Sastre, J; Aranda, E. Recommendations on current
approach to gastric cancer. Clin. Transl. Oncol., 2009; 11(8):518-525.
330.Garcia-Saenz, JA; Martin, M; Maestro, ML; Vidaurreta, M; Veganzones, S; Rafael, S; Casado, A;
Bobokova, J; Sastre, J; De la Orden, V; Arroyo, M; Diaz-Rubio, E. Circulating tumour cells in locally
advanced breast cancer. Clin. Transl. Oncol., 2009; 11(8):544 -547.
331.Martin, M; Blasinska-Morawiec, M; Salas, JF; Falcon, S; Rolski, J; Ferrari, BL; Gulyas, S; Liu, YS;
Benhadji, KA. A Multicenter, Single-Arm Phase II Study of Pemetrexed Plus Doxorubicin
Administered Every 21 Days in Patients With Advanced Breast Cancer. Clin. Breast Cancer, 2009;
9(3):155-160.
332.Carrato, A; Rodriguez, LPA; Lescure, AR; de Tejerina, AMCF; Garcia, EDR; Segura, PP; Figueiras, MC;
Carbonero, RG; Codina, JG; Hernandez, AL; Rey, JPM; Jimenez, MM; Camara, JIM; Nogueira, JAM;
Dominguez, AR. Spanish Society of Medical Oncology consensus for the use of haematopoietic
colony-stimulating factors in cancer patients. Clin. Transl. Oncol., 2009; 11(7):446-454.
333.Albanell, J; Andreu, X; Calasanz, MJ; Concha, A; Corominas, JM; Garcia -Caballero, T; Lopez, JA;
Lopez-Rios, F; Cajal, SRY; Vera-Sempere, FJ; Colomer, R; Martin, M; Alba, E; Gonzalez-Martin, A;
Llombart, A; Lluch, A; Palacios, J. Guidelines for HER2 testing in breast cancer: a national consensus
of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).
Clin. Transl. Oncol., 2009; 11(6):363-375.
334.Hidalgo, M; Abad, A; Aranda, E; Diez, L; Feliu, J; Gomez, C; Irigoyen, A; Lopez, R; Rivera, F; Rubio, C;
Sastre, J; Tabernero, J; Diaz-Rubio, E. Consensus on the treatment of pancreatic cancer in Spain.
Clin. Transl. Oncol., 2009; 11(5):290-301.
38
335.Hugh, J; Hanson, J; Cheang, MCU; Nielsen, TO; Perou, CM; Dumontet, C; Reed, J; Krajewska, M;
Treilleux, I; Rupin, M; Magherini, E; Mackey, J; Martin, M; Vogel, C. Breast Cancer Subtypes and
Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition
in the BCIRG 001 Trial. J. Clin. Oncol., 2009; 27(8):1168-1176.
336.Rebbeck, TR; Antoniou, AC; Llopis, TC; Nevanlinna, H; Aittomaki, K; Simard, J; Spurdle, AB; Couch, FJ;
Pereira, LHM; Greene, MH; Andrulis, IL; Pasche, B; Kaklamani, V; Hamann, U; Szabo, C; Peock, S;
Cook, M; Harrington, PA; Donaldson, A; Male, AM; Gardiner, CA; Gregory, H; Side, LE; Robinson, AC;
Emmerson, L; Ellis, I; Peyrat, JP; Fournier, J; Vennin, P; Adenis, C; Muller, D; Fricker, JP; Longy, M;
Sinilnikova, OM; Stoppa-Lyonnet, D; Schmutzler, RK; Versmold, B; Engel, C; Meindl, A; Kast, K;
Schaefer, D; Froster, UG; Chenevix-Trench, G; Easton, DF. No association of TGFB1 L10P genotypes
and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi -center cohort study. Breast
Cancer Res. Treat., 2009; 115(1):185-192.
337.Sanchez-Espiridion, B; Sanchez-Aguilera, A; Montalban, C; Martin, C; Martinez, R; Gonzalez-Carrero,
J; Poderos, C; Bellas, C; Fresno, MF; Morante, C; Mestre, MJ; Mendez, M; Mazorra, F; Conde, E;
Castano, A; Sanchez-Godoy, P; Tomas, JF; Morente, MM; Piris, MA; Garcia, JF. A TaqMan LowDensity Array to Predict Outcome in Advanced Hodgkin's Lymphoma Using Paraffin -Embedded
Samples. Clin. Cancer Res., 2009; 15(4):1367-1375.
338.Martin-Jimenez, M; Rodriguez-Lescure, A; Ruiz-Borrego, M; Segui-Palmer, MA; Brosa-Riestra, M.
Cost-effectiveness analysis of docetaxel (TaxotereA (R)) vs. 5-fluorouracil in combined therapy in
the initial phases of breast cancer. Clin. Transl. Oncol., 2009; 11(1):41-47.
339.Garcia, MJ; Fernandez, V; Osorio, A; Barroso, A; Llort, G; Lazaro, C; Blanco, I; Caldes, T; de la Hoya,
M; Cajal, TRY; Alonso, C; Tejada, MI; Roman, CS; Robles -Diaz, L; Urioste, M; Benitez, J. Analysis of
FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2 -negative Spanish breast cancer
families. Breast Cancer Res. Treat., 2009; 113(3):545-551.
340.Hugh, J; Hanson, J; Cheang, M; Nielsen, T; Perou, C; Dumontet, C; Reed, J; Krajewska, M; Treilleux, I;
Rupin, M; Magherini, E; Mackey, J; Martin, M; Vogel, C. Breast Cancer Subtypes and Response to
Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG
001 Trial Reply [Letter] J. Clin. Oncol., 2009; 27(26):E112-E113.
341.Hugh, J; Hanson, J; Cheang, M; Nielsen, T; Perou, C; Dumontet, C; Reed, J; Krajewska, M; Treilleux, I;
Rupin, M; Magherini, E; Mackey, J; Martin, M; Vogel, C. Metronomic Schedule of Paclitaxel Is
Effective in Hormone Receptor-Positive and Hormone Receptor-Negative Breast Cancer Reply
[Letter] J. Clin. Oncol., 2009; 27(18):3068-3069.
342.Barrios, C; Liu, MC; Lee, SC; Vanlemmens, L; Ferrero, JM; Tabei, T; Pivot, X; Iwata, H; Aogi, K;
Brickman, M; Zhang, K; Kern, K; Martin, M. Phase III Randomized Trial of Sunitinib (SU) vs.
Capecitabine (C) in Patients (Pts) with Previously Treated HER2 -Negative Advanced Breast Cancer
(ABC). Cancer Res., 2009; 69(24. Suppl. 3):497S-497S.
343.Mackey, J; Hurvitz, S; Crown, J; Forbes, J; Roche, H; Pinter, T; Eiermann, W; Kennedy, MJ; Priou, F;
Provencher, L; Adrover, E; Pienkowski, T; Houe, V; Rupin, M; Martin, M. CIRG/TORI 010: 10-Month
Analysis of a Randomized Phase II Trial of Motesanib Plus Weekly Paclitaxel as First Line Therapy in
HER2-Negative Metastatic Breast Cancer (MBC). Cancer Res., 2009; 69(24. Suppl. 3):497S-498S.
344.Blay, JY; Lluch, A; Gutierrez, M; Martin, M; Kozloff, MF; Prady, C; Huang, X; Verkh, L; Chen, C;
Tassell, V; Kern, K; Verma, S. Sunitinib (SU) in Combination with Trastuzumab (T) for the Treatment
of Advanced Breast Cancer (ABC): Activity and Safety Results from a Phase II Study.. Cancer Res.,
2009; 69(24. Suppl. 3):510S-510S.
39
345.Laporte, S; Jones, S; Chapelle, C; Jacquin, JP; Martin, M. Consistency of Effect of Docetaxel Containing Adjuvant Chemotherapy in Patients with Early Stage Breast Cancer Independent of
Nodal Status: Meta-Analysis of 12 Randomized Clinical Trials.. Cancer Res., 2009; 69(24. Suppl.
3):523S-523S.
346.Lopez-Tarruella, S; Puente, J; Lluch, A; Climent, MA; Pastor, M; Alba, E; Mayordomo, JI; Diaz-Rubio,
E; Casado, A; Cano, S; Martin, M. Impact on Survival of Primary Tumor Resection in Wo men with
Metastatic Breast Cancer at Initial Diagnosis. The Alamo Project. Cancer Res., 2009; 69(24. Suppl.
3):681S-681S.
347.Saura, C; Martin, M; Moroose, R; Harb, W; Liem, K; Arena, F; Gressler, V; Cortes, J; Wade, M; Powell,
C; Shapiro, M. Safety of Neratinib (HKI-272) in Combination with Capecitabine in Patients with Solid
Tumors: A Phase 1/2 Study. Cancer Res., 2009; 69(24. Suppl. 3):801S-802S.
348.Campone, M; Dittrich, C; Cufer, T; Dudov, A; Phan, PD; Schmelter, T; Giurescu, M; Martin, M. Phase
II Study of the Novel Epothilone Sagopilone (ZK-EPO) in Patients with Progressive Metastatic Breast
Cancer.. Cancer Res., 2009; 69(24. Suppl. 3):858S-859S.
349.de Paredes, MG; Bejar, E; Montesinos, F; Garcia -Saenz, JA; de Antunano, BG; Ares, LP. Evaluating
the satisfaction of the Spanish online breast cancer consulting service. EJC Suppl., 2009; 7(2):180180.
350.Camps, C; Anton, A; Carrato, A; De las Heras, M; Manas, A; Valentin, V; Casas, A. Cognitive function
association with anaemia in patients with methastasic or advanced s olid tumour undergoing
oncologic treatment - EVOLUTION study. EJC Suppl., 2009; 7(2):193-193.
351.Rivera, F; Gravalos, C; Massuti, B; Puente, J; Marcuello, E; Valladares, M; Gutierrez, V; Layos, L; DiazRubio, E; Aranda, E. Cetuximab plus capecitabine as first-line treatment for elderly patients (pts)
with advanced colorectal cancer (mCRC). Final analysis of activity and survival according to KRAS
status - the TTD-06-01 Spanish Cooperative Group trial. EJC Suppl., 2009; 7(2):216-216.
352.Martin, M; Hurvitz, S; Kennedy, J; Forbes, J; Roche, H; Pinter, T; Eiermann, W; Buyse, M; Rupin, M;
Mackey, J. CIRG/TORI 010: first analysis of a randomized phase II trial of motesanib plus weekly
paclitaxel (P) as first line therapy in HER2-negative metastatic breast cancer (MBC). EJC Suppl.,
2009; 7(2):260-260.
353.Blay, JY; Lluch, A; Gutierrez, M; Martin, M; Kozloff, MF; Prady, C; Tassell, V; Kern, K; Huang, X;
Verma, S. Phase II study of sunitinib in combination with trastuzumab for the treatment of
metastatic breast cancer: activity and safety results. EJC Suppl., 2009; 7(2):260-261.
354.Garcia-Foncillas, J; Honorato, B; Caldes, T; de la Hoya, M; Hernandez, J; Landolfi, S; Mata, M;
Gallach, S; Bautista, MD; Benavides, M. Determina KRAS Project: what have we learned after nine
months?. EJC Suppl., 2009; 7(2):353-353.
355.Castellano, D; Larriba, JG; Aparicio, LMA; Casinello, J; Grande, E; Esteban, E; Sepulveda, J; Rodriguez,
A; Canete, IG. Clinical, biochemical (PSA) and radiographic benefit with sunitinib as a single agent in
metastatic chemoresistant and hormone-refractory prostate cancer (HRPC) patients. EJC Suppl.,
2009; 7(2):417-417.
356.Puente, J; Calderero, V; Garcia-Muro, X; Trigo, JM; Castro, AJ; Martin-Escudero, V; Yebenes, M;
Casado, MA. Costs of adverse events management associated to the treatment of first-line
metastatic renal cell carcinoma with bevacizumab plus interferon alpha -2a compared with sunitinib
in Spain. EJC Suppl., 2009; 7(2):436-436.
357.Martin, S; Bonnin, A; Furio, V; Coronado, PJ; Vidart, JA; Arencibia, JM. Tspan13 expressio n in
epithelial ovarian cancer. EJC Suppl., 2009; 7(2):454-455.
40
358.Gonzalez-Martin, A; Casado, A; Blanco-Sanchez, I; Bover, I; Herrero, A; Santaballa, A; Caballero, C;
Churruca, C; Calvo, E; Ojeda, B. Correlation of Topo II alpha expression and amplification with
efficacy of pegylated liposomal doxorubicin in a GEICO phas e II trial for platinum-resistant (PR)
recurrent ovarian carcinoma (ROC). EJC Suppl., 2009; 7(2):457-457.
359.Massuti, B; Sanchez, JM; Alonso, G; Maestre, JA; Gonzalez-Larriba, JL; Camps, C; RodriguezPaniagua, JM; Felip, E; Sanchez, JJ; Rosell, R. Assessing the value of preoperative chemotherapy in
early-stage non-small cell lung cancer: mature data and prognostic factors analysis of a Phase III
randomized trial of surgery alone vs preoperative Paclitaxel/Carboplatin (PC) vs postoperative PC.
Final NATCH data. A Spanish Lung Cancer Group Trial. EJC Suppl., 2009; 7(3):12 -12.
360.Paiva, BL; Vidirales, MB; Cervero, J; Mateo, G; Perez, J; Montalban, MA; Sureda, A; Montejano, L;
Gutierrez, NC; Coca, AG; Heras, N; Mateos, MV; Lopez-Berges, MC; Boyero, RG; Galende, J;
Hernandez, J; Palomera, L; Carrera, D; Martinez, R; de la Rubia, J; Martin, A; Blade, J; Lahuerta, JJ;
Orfao, A; San Miguel, J. The Presence of Normal PC at Diagnosis by Flow Cytometry is a Favorable
Prognostic Feature in MM. Clin. Lymphoma Myeloma, 2009; 9(Suppl. 1):S15-S15.
361.San Miguel, J; Paiva, BL; Vidriales, MB; Cervero, J; Mateo, G; Perez, JJ; Montalban, MA; Sureda, A;
Montejano, L; Gutierrez, NC; Coca, A; Heras, N; Mateos, MV; Lopez-Berges, MC; Boyero, RG;
Galende, J; Hernandez, J; Palomera, L; Carrera, D; Martinez, R; de la Rubia, J; Martin, A; Blade, J;
Lahuerta, JJ; Orfao, A. Flow Cytometry Remission Is the Most Relevant Prognostic Factor for MM
Patients Who Undergo ASCT. Clin. Lymphoma Myeloma, 2009; 9(Suppl. 1):S16 -S17.
362.Rosinol, L; Cibeira, MT; Marti nez, J; Mateos, MV; Terol, MJ; de la Rubia, J; Palomera, L; de Arriba, F;
Oriol, A; Amor, AA; Besalduch, J; de Paz, R; Garcia -Larana, J; Diaz-Mediavilla, J; Sureda, A; Lahuerta,
JJ; San Miguel, J; Blade, J. Thalidomide/Dexamethasone (TD) Versus Bortezomib
(Velcade)/Thalidomide/Dexamethasone (VTD) Versus VB. Clin. Lymphoma Myeloma, 2009; 9(Suppl.
1):S26-S26.
363.Tabernero, J; Cervantes, A; Delaunoit, T; Hendlisz, A; Youssoufian, H; Zhul, J; Marshall, K; Rowinsky,
E; Valera, JS. A PHASE 2 STUDY OF IMC-11F8, A MONOCLONAL ANTIBODY DIRECTED AGAINST THE
EGFR, IN COMBINATION WITH MFOLFOX6 CHEMOTHERAPY IN THE FIRST-LINE TREATMENT OF
ADVANCED OR METASTATIC COLORECTAL CARCINOMA. Ann. Oncol., 2009; 20(Suppl. 7):18-19.
364.Bachelot, T; Lluch, A; Gutierrez, M; Martin, MM; Kozloff, MF; Prady, C; Tassell, V; Kern, K; Huang, X;
Verma, S; Blay, JY. Activity and safety of sunitinib in combination with trastuzumab for the
treatment of metastatic breast cancer: initial results from a phase II study. Cancer Res., 2009; 69(2.
Suppl. S):285S-285S.
365.Verslype, C; Van Cutsem, E; Dicato, M; Arber, N; Berlin, JD; Cunningham, D; De Gramont, A; DiazRubio, E; Ducreux, M; Gruenberger, T; Haller, D; Haustermans, K; Hoff, P; Kerr, D; Labianca, R;
Moore, M; Nordlinger, B; Ohtsu, A; Rougier, P; Scheitha uer, W; Schmoll, HJ; Sobrero, A; Tabernero,
J; van de Velde, C. The management of hepatocellular carcinoma. Current expert opinion and
recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona,
2008. Ann. Oncol., 2009; 20(Suppl. 7):1-6.
366.Custodio, A; Puente, J; Sastre, J; Diaz-Rubio, E. Second-line therapy for advanced pancreatic cancer:
A review of the literature and future directions. Cancer Treat. Rev., 2009; 35(8):676-684.
367.Garcia-Saenz, JA; Sastre, J; Garcia, EDR. Biomarkers and anti-EGFR therapies for KRAS wild-type
metastatic colorectal cancer. Clin. Transl. Oncol., 2009; 11(11):737-747.
368.Lopez-Tarruella, S; Martin, M. Recent advances in systemic therapy Advances in adjuvant systemic
chemotherapy of early breast cancer. Breast Cancer Res., 2009; 11(2):-.
41
369.Martin, M; Esteva, FJ; Alba, E; Khandheria, B; Perez-Isla, L; Garcia-Saenz, JA; Marquez, A; Sengupta,
P; Zamorano, J. Minimizing Cardiotoxicity While Optimizing Treatment Efficacy with Trastuzumab:
Review and Expert Recommendations. Oncologist, 2009; 14(1):1-11.
370.Gomez, FM; Palussiere, J; Santos, E; Tourdias, T; Cornelis, F; Saiz, V; Montes, H; Eker, O.
Radiofrequency thermocoagulation of lung tumours. Where we are, where we are headed. Clin.
Transl. Oncol., 2009; 11(1):28-34.
371.Papamichael, D; Audisio, R; Horiot, JC; Glimelius, B; Sastre, J; Mitry, E; Van Cutsem, E; Gosney, M;
Kohne, CH; Aapro, M. Treatment of the elderly colorectal cancer patient: SIOG expert
recommendations. Ann. Oncol., 2009; 20(1):5-16.
372.Giraldez, MD; Balaguer, F; Caldes, T; Sanchez-de-Abajo, A; Gomez-Fernandez, N; Ruiz-Ponte, C;
Munoz, J; Garre, P; Gonzalo, V; Moreira, L; Ocana, T; Clofent, J; Carracedo, A; Andreu, M; Jover, R;
Llor, X; Castells, A; Castellvi -Bel, S. Association of MUTYH and MSH6 germline mutations in
colorectal cancer patients. Fam. Cancer, 2009; 8(4):525 -531.
373.Santamaria, CM; Chillon, MC; Garcia -Sanz, R; Perez, C; Caballero, MD; Ramos, F; de Coca, AG;
Alonso, JM; Giraldo, P; Bernal, T; Queizan, JA; Rodriguez, JN; Fernandez-Abellan, P; Barez, A;
Penarrubia, MJ; Vidriales, MB; Balanzategui, A; Sarasquete, ME; Alcoceba, M; Diaz-Mediavilla, J;
Miguel, JFS; Gonzalez, M. High FOXO3a expression is associated with a poorer prognosis in AML
with normal cytogenetics. Leuk. Res., 2009; 33(12):1706-1709.
374.Martinez-Lopez, J; Rivero, A; Rapado, I; Montalban, C; Paz-Carreira, J; Canales, M; Martinez, R;
Sanchez-Godoy, P; De Sevilla, AF; Penalver, FJ; Gonzalez, M; Prieto, E; Salar, A; Burgaleta, C;
Queizan, JA; Penarrubia, MJ; Monteagudo, MD; Cabrera, C; De La Serna, J; Tomas, JF. Influence of
MBL-2 mutations in the infection risk of patients with follicular lymphoma treated with rituximab,
fludarabine, and cyclophosphamide. Leuk. Lymphoma, 2009; 50(8):1283-1289.
375.Sastre, J; Aranda, E; Massuti, B; Tabernero, J; Chaves, M; Abad, A; Carrato, A; Reina, JJ; Queralt, B;
Gomez-Espana, A; Gonzalez-Flores, E; Rivera, F; Losa, F; Garcia, T; Sanchez-Rovira, P; Maestu, I;
Diaz-Rubio, E. Elderly patients with advanced colorectal cancer derive similar benefit without
excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: Comparative
outcomes from the 03-TTD-01 phase III study. Crit. Rev. Oncol./Hematol., 2009; 70(2):134-144.
376.Martin, M; Lluch, A; Ruiz-Simon, A; Ribelles, N; Ruiz-Borrego, M; Rodriguez-Lescure, A; Munoz, M;
Ramos, M; Gonzalez, S; Margeli, M. First safety data from a randomised phase III trial comparing
adjuvant epirubicin-cyclophosphamide -> docetaxel (EC -> T) vs ET capecitabine (X) in N plus
operable breast cancer (BC). Breast, 2009; 18(Suppl. 1):S55-S55.
377.Garcia, JP; Gonzalez, FJC; Munoz, EB; Romo, FG; Picazo, JJ. Cellulitis after a cat bite. Rev. Esp. Quim.,
2009; 22(4):221-223.
378.Alonso, S; Arribi, A; Vergas, J; Martin, MC; Arce, B; Terleira, A; Portoles, A. Pilot Drug Utilization
Study of systemic antifungal agents in the Hospital Clinico San Carlos. Proposal of a study method.
Rev. Esp. Quim., 2009; 22(3):127-134.
379.Rixe, O; Franco, SX; Yardley, DA; Johnston, SR; Martin, M; Arun, BK; Letrent, SP; Rugo, HS. A
randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033
in patients with pretreated metastatic breast cancer. Cancer Chemother. Pharmacol., 2009;
64(6):1139-1148.
380.Eiros, JM; Sanchez-Padilla, E; Luquero, FJ; Nogueira, B; Rojo, S; Atienza -Herrero, J; de Lejarazu, RO.
Viral Load in Spanish HIV patients: trends since the introduction of HAART. Rev. Esp. Quim., 2009;
22(1):34-37.
42
381.Bellmunt, J; Calvo, E; Castellano, D; Climent, MA; Esteban, E; del Muro, XG; Gonzalez-Larriba, JL;
Maroto, P; Trigo, JM. Recommendations from the Spanish Oncology Genitourinary Group for the
treatment of metastatic renal cancer. Cancer Chemother. Pharmacol., 2009; 63(Suppl. 1):S1-S13.
382.Antoniou, AC; Rookus, M; Andrieu, N; Brohet, R; Chang-Claude, J; Peock, S; Cook, M; Evans, DG;
Eeles, R; Nogues, C; Faivre, L; Gesta, P; van Leeuwen, FE; Ausems, MGEM; Sorio, A; Caldes, T;
Simard, J; Lubinski, J; Gerdes, AM; Olah, E; Furhauser, C; Olsson, H; Arver, B; Radice, P; Easton, DF;
Goldgarl, DE. Reproductive and Hormonal Factors, and Ovarian Cancer Risk for BRCA1 and BRCA2
Mutation Carriers: Results from the International BRCA1/2 Carrier Cohort Study. Cancer Epidemiol.
Biomarkers Prev., 2009; 18(2):601-610.
383.Safont, MJ; Artal-Cortes, A; Sirera, R; Gomez-Codina, J; Gonzalez-Larriba, JL; Barneto, I; Carrato, A;
Isla, D; Rosell, R; Camps, C. Retrospective study of efficacy and toxicity on patients older than 70
years within a randomized clinical trial of two cisplatin-based combinations in patients with small cell lung cancer. Lung Cancer, 2009; 63(1):83-87.
384.Felip, E; Massuti, B; Maestre, JA; Alonso, G; Paniagua, JMR; Gonzalez-Larriba, JL; Camps, C; Isla, D;
Overbeck, T; Costas, E; Sanchez, JJ; Rosell, R. A phase III randomized trial of surgery (S) alone, or
preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy followed by S, or S followed by
adjuvant (adj) PC chemotherapy in early stage non-small cell lung cancer (NSCLC): NATCH follow-up
data. J. Thorac. Oncol., 2009; 4(9. Suppl. 1):S283-S283.
385.Massuti, B; Cobo, M; Sanchez, JM; Rodriguez-Paniagua, JM; Jimenez, U; Aguiar, D; Arrabal, R;
Gonzalez-Larriba, JL; Reguart, N; Astudillo, J; Taron, M; Rosell, R. The pharmacogenomic approa ch in
adjuvant setting of NSCLC: postoperative chemotherapy customized according BRCA1 levels;
docetaxel single agent arm compared with platinum doublets; SCAT pilot trial results. J. Thorac.
Oncol., 2009; 4(9. Suppl. 1):S299-S299.
386.Custodio, AB; Gonzalez-Larriba, JL; Bobokova, J; Calles, A; Alvarez, R; Cuadrado, E; Manzano, A; DiazRubio, E. Prognostic and Predictive Markers of Benefit from Adjuvant Chemotherapy in Early -Stage
Non-small Cell Lung Cancer. J. Thorac. Oncol., 2009; 4(7):891-910.
387.Reche-Frutos, J; Calvo-Gonzalez, C; Donate-Lopez, J; Garcia-Feijoo, J. Early neovascular bridging of
choroidal neovascularization after ranibizumab treatment. Graefes Arch. Clin. Exp. Ophthalmol.,
2009; 247(10):1427-1430.
388.Spiegel, D; Wetzel, W; Neuhann, T; Sturmer, J; Hoh, H; Garcia -Feijoo, J; Martinez-De-La-Casa, JM;
Garcia-Sanchez, J. Coexistent primary open-angle glaucoma and cataract: interim analysis of a
trabecular micro-bypass stent and concurrent cataract surgery. Eur. J. Ophthalmol., 2009;
19(3):393-399.
389.Polo, V; Larrosa, JM; Ferreras, A; de la Casa, JMM; Pablo, LE; Honrubia, FM. Comparative Study of
Retinal Nerve Fiber Layer Thickness in Normal Eyes, Ocular Hypertensives, Preperimetric Glaucoma
and Glaucomatous Subjects. Ann. Ophthalmol., 2009; 41(1):24-30.
390.Roldan-Pallares, M; Musa, AS; Hernandez-Montero, J; Bravo-Llatas, C. Preoperative duration of
retinal detachment and preoperative central retinal artery hemodynamics: repercussion on visual
acuity. Graefes Arch. Clin. Exp. Ophthalmol., 2009; 247(5):625-631.
391.Ferreras, A; Pablo, LE; Pajarin, AB; Garcia -Feijoo, J; Honrubia, FM. Scanning laser polarimetry:
logistic regression analysis for perimetric glaucoma diagnosis. Eye, 2009; 23(3):593-600.
392.Arias, L; Armada, F; Donate, J; Garcia-Arumi, J; Giralt, J; Pazos, B; Pinero, A; Martinez, F; Mondejar,
JJ; Ortega, I; Zlateva, G; Buggage, R. Delay in treating age-related macular degeneration in Spain is
associated with progressive vision loss. Eye, 2009; 23(2):326-333.
43
393.Martinez-de-la-Casa, JM; Garcia-Feijoo, J; Saenz-Frances, F; Vizzeri, G; Fernandez-Vidal, A; MendezHernandez, C; Garcia-Sanchez, J. Comparison of Rebound Tonometer and Goldmann Handheld
Applanation Tonometer in Congenital Glaucoma. J. Glaucoma, 2009; 18(1):49 -52.
394.Vizzeri, G; Weinreb, RN; de la Casa, JM; Alencar, LM; Bowd, C; Balasubramanian, M; Medeiros, FA;
Sample, P; Zangwill, LM. Clinicians Agreement in Establishing Glaucomatous Progression Using the
Heidelberg Retina Tomograph. Ophthalmology, 2009; 116(1):14-24.
395.Guilabert, IM; Calvo-Gonzalez, C; Reche-Frutos, J; Donate-Lopez, J; Garcia-Feijoo, J; Leila, M; GarciaSanchez, J. Intravitreal pegabtanib sodium in choroidal neovascularization secondary to angioid
streaks [Letter] Acta Ophthalmol., 2009; 87(5):581-582.
396.Seijas, O; de Liano, PG; Merino, P; Roberts, CJ; de Liano, RG. Topical Anesthesia in Strabismus
Surgery: A Review of 101 Cases. J. Pediatr. Ophthalmol. Strabismus., 2009; 46(4):218-222.
397.Arriola-Villalobos, P; Diaz-Valle, D; Guell, JL; Iradier-Urrutia, MT; Jimenez-Alfaro, I; Cuina-Sardina, R;
Benitez-del-Castillo, JM. Intrastromal corneal ring segment implantation for high astigmatism after
penetrating keratoplasty. J. Cataract. Refract. Surg., 2009; 35(11):1878-1884.
398.Diaz-Valle, D; Arriola-Villalobos, P; Sanchez, JMB; Bueso, ES; de la Casa, JMM; Sardina, RC. Lateonset Severe Diffuse Lamellar Keratitis Associated With Uveitis After LASIK in a Patient With
Ankylosing Spondylitis. J. Refractive Surg., 2009; 25(7):623-625.
399.Llovet, F; Galal, A; Benitez-del-Castillo, JM; Ortega, J; Martin, C; Baviera, J. One-year results of
excimer laser in situ keratomileusis for hyperopia. J. Cataract. Refract. Surg., 2009; 35(7):1156 -1165.
400.Castillo-Gomez, A; Carmona-Gonzalez, D; Martinez-de-la-Casa, JM; Palomino-Bautista, C; GarciaFeijoo, J. Evaluation of image quality after implantation of 2 diffractive multifocal intraocular lens
models. J. Cataract. Refract. Surg., 2009; 35(7):1244-1250.
401.Poch-Broto, J; Carricondo, F; Bhathal, B; Iglesias, MC; Lopez-Moya, J; Rodriguez, F; Sanjuan, J; Gil Loyzaga, P. Cochlear microphonic audiometry: a new hearing test for objective diagnosis of
deafness. Acta Oto-Laryngol., 2009; 129(7):749-754.
402.Sanz, J; Ruiz, J; Martinez, A; Hernandez, S; Asenjo, J; Zimman, H. Chromosome 1p36 loss and Cox-2
overexpression are independent predictors of recurrence in completely removed meningiomas
Grade I and II. Analysis of their association with clinicopathological and immunohistochemical
variables. Virchows Arch., 2009; 455(Suppl. 1):3-3.
403.Vento, M; Moro, M; Escrig, R; Arruza, L; Villar, G; Izquierdo, I; Roberts, LJ; Arduini, A; Escobar, JJ;
Sastre, J; Asensi, MA. Preterm Resuscitation With Low Oxygen Causes Less Oxidative Stress,
Inflammation, and Chronic Lung Disease. Pediatrics, 2009; 124(3):E439-E449.
404.Cabanas, JMG; Quiles, MJP; del Prado, N; Ruiz, MD; del Rio, MG; Zaballo, FB; Fernandez, C; Aloy, JF.
Usefulness of Clinical Risk Index for Babies based on birth weight in predicting hospital death and
severe intraventicular hemorrhage in the SEN 1500 Spanish neonatal network. An. Pediatr., 2009;
71(2):117-127.
405.Arce, VSA; Abancens, BJ. Meropenem and valproic acid. An interaction to remember [Letter] An.
Pediatr., 2009; 70(2):193-194.
406.Moreno, JA; Munoz-Garcia, B; Martin-Ventura, JL; Madrigal -Matute, J; Orbe, J; Paramo, JA; Ortega,
L; Egido, J; Blanco-Colio, LM. The CD163-expressing macrophages recognize and internalize TWEAK
Potential consequences in atherosclerosis. Atherosclerosis, 2009; 207(1):103-110.
407.de las Heras, N; Martin-Fernandez, B; Miana, M; Ballesteros, S; Oubina, MP; Lopez-Farre, AJ;
Cachofeiro, V; Lahera, V. The protective effect of irbesartan in rats fed a high fat diet is associated
with modification of leptin-adiponectin imbalance. J. Hypertens., 2009; 27(Suppl. 6):S37-S41.
44
408.Pozzi, AO; Bernardo, E; Coronado, MT; Punchard, MA; Gonzalez, P; Fantidis, P. Acute arterial
thrombosis in the absence of inflammation: The stress -related anti-inflammatory hormone ACTH
participates in platelet-mediated thrombosis. Atherosclerosis, 2009; 204(1):79-84.
409.Coronado, MT; Pozzi, AO; Punchard, MA; Gonzalez, P; Fantidis, P. Inflammation as a modulator of
the HDL cholesterol-induced inteleukin-10 production by human circulating mononuclear cells
[Letter] Atherosclerosis, 2009; 202(1):183-184.
410.Sobrino, J; Abad, M; Almeseri, R; Alvarez, L; Arnedillo, JM; Bronsoms, J; Fernandez, F; Fernandez,
ME; Fuentes, FJ; Garre, J; Ibanez, P; Lopez, D; Lopez-Vidriero, E; Mangas, A; Domenech, M.
PREVALENCE OF MASKED HYPERTENSION IN NORMOTENSIVE SUBJECTS. J. Hypertens., 2009;
27(Suppl. 4):S45-S46.
411.Tamargo, J; Lopez-Farre, A; Caballero, R; Delpon, E. OMECAMTIV MECARBIL Cardiac Myosin
Activator Treatment of Heart Failure. Drug Future, 2009; 34(12):950-961.
412.de la Sierra, A; Roca-Cusachs, A; Redon, J; Marin, R; Luque, M; de la Figuera, M; Garcia-Garcia, M;
Falkon, L. Effectiveness and Tolerability of Fixed-Dose Combination Enalapril plus Nitrendipine in
Hypertensive Patients Results of the 3-Month Observational, Post-Marketing, Multicentre,
Prospective CENIT Study. Clin. Drug Invest., 2009; 29(7):459-469.
413.Gomez-Garre, D; Munoz-Pacheco, P; Gonzalez-Rubio, ML; Aragoncillo, P; Granados, R; FernandezCruz, A. Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits
monocyte migration in addition to its lipid-lowering effect. Br. J. Pharmacol., 2009; 156(8):12181227.
414.Espinoza, CED; Alonso, S; Terleira, A; Diaz, B; Portoles, A. BIOEQUIVALENCE STUDY OF TWO
QUETIAPINE FORMULATIONS AT A SINGLE ORAL DOSE OF 25 MG IN HEALTHY VOLUNTEERS. Basic
Clin. Pharmacol. Toxicol., 2009; 105(Suppl. 1):108-108.
415.Espinoza, CED; Laredo, L; Portoles, A; Alonso, S. ANTIBIOTIC TREATMENT USED IN HOSPITALISED
PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA. Basic Clin. Pharmacol. Toxicol., 2009;
105(Suppl. 1):136-137.
416.Galderisi, S; Davidson, M; Kahn, RS; Mucci, A; Boter, H; Gheorghe, MD; Rybakowski, JK; Libiger, J;
Dollfus, S; Lopez-Ibor, JJ; Peuskens, J; Hranov, LG; Fleischhacker, WW. Correlates of cognitive
impairment in first episode schizophrenia: The EUFEST study. Schizophr. Res., 2009;
115(40239):104-114.
417.Vazquez-Rivera, S; Gonzalez-Blanch, C; Rodriguez-Moya, L; Moron, D; Gonzalez-Vives, S; Carrasco,
JL. Brief cognitive-behavioral therapy with fibromyalgia patients in routine care. Compr. Psychiat.,
2009; 50(6):517-525.
418.Sanchez-Morla, EM; Barabash, A; Martinez-Vizcaino, V; Tabares-Seisdedos, R; Balanza-Martinez, V;
Cabranes-Diaz, JA; Baca-Baldomero, E; Gomez, JLS. Comparative study of neurocognitive function in
euthymic bipolar patients and stabilized schizophrenic patients. Psychiatry Res., 2009; 169(3):220228.
419.Reneses, B; Munoz, E; Lopez-Ibor, JJ. Factors predicting drop-out in community mental health
centres. World Psychiatry, 2009; 8(3):173-177.
420.Davidson, M; Galderisi, S; Weiser, M; Werbeloff, N; Fleischhacker, WW; Keefe, RS; Boter, H; Keet,
IPM; Prelipceanu, D; Rybakowski, JK; Libiger, J; Hummer, M; Dollfus, S; Lopez-Ibor, JJ; Hranov, LG;
Gaebel, W; Peuskens, J; Lindefors, N; Riecher-Rossler, A; Kahn, RS. Cognitive Effects of Antipsychotic
Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open -Label
Clinical Trial (EUFEST). Am. J. Psychiat., 2009; 166(6):675-682.
45
421.Blasco-Fontecilla, H; Baca-Garcia, E; Dervic, K; Perez-Rodriguez, MM; Saiz-Gonzalez, MD; Saiz-Ruiz, J;
Oquendo, MA; de Leon, J. Severity of personality disorders and suicide attempt. Acta Psychiatr.
Scand., 2009; 119(2):149-155.
422.Diaz-Marsa, M; Sanchez, S; Rico-Villademoros, F. Effectiveness and Tolerability of Oral Ziprasidone
in Psychiatric Inpatients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder: A
Multicenter, Prospective, and Naturalistic Study. J. Clin. Psychiatry, 2009; 70(4):509-517.
423.Pena-Casanova, J; Blesa, R; Aguilar, M; Gramunt-Fombuena, N; Gomez-Anson, B; Oliva, R;
Molinuevo, JL; Robles, A; Barquero, MS; Antunez, C; Martinez-Parra, C; Frank-Garcia, A; Fernandez,
M; Alfonso, V; Sol, JM. Spanish Multicenter Normative Studies (NEURONORMA Project): Methods
and Sample Characteristics. Arch. Clin. Neuropsychol., 2009; 24(4):307-319.
424.Pena-Casanova, J; Quinones -Ubeda, S; Quintana-Aparicio, M; Aguilar, M; Badenes, D; Molinuevo, JL;
Torner, L; Robles, A; Barquero, MS; Villanueva, C; Antunez, C; Martinez-Parra, C; Frank-Garcia, A;
Sanz, A; Fernandez, M; Alfonso, V; Sol, JM; Blesa, R. Spanish Multicenter Normative Studies
(NEURONORMA Project): Norms for Verbal Span, Visuospatial Span, Letter and Number Sequencing,
Trail Making Test, and Symbol Digit Modalities Test. Arch. Clin. Neuropsychol., 2009; 24(4):321 -341.
425.Pena-Casanova, J; Quinones -Ubeda, S; Gramunt-Fombuena, N; Aguilar, M; Casas, L; Molinuevo, JL;
Robles, A; Rodriguez, D; Barquero, MS; Antunez, C; Martinez-Parra, C; Frank-Garcia, A; Fernandez,
M; Molano, A; Alfonso, V; Sol, JM; Blesa, R. Spanish Multicenter Normative Studies (NEURONORMA
Project): Norms for Boston Naming Test and Token Test. Arch. Clin. Neuropsychol., 2009; 24(4):343 354.
426.Pena-Casanova, J; Quintana-Aparicio, M; Quinones-Ubeda, S; Aguilar, M; Molinuevo, JL; Serradell,
M; Robles, A; Barquero, MS; Villanueva, C; Antunez, C; Martinez-Parra, C; Frank-Garcia, A; Aguilar,
MD; Fernandez, M; Alfonso, V; Sol, JM; Blesa, R. Spanish Multicenter Normative Studies
(NEURONORMA Project): Norms for the Visual Object and Space Perception Battery-Abbreviated,
and Judgment of Line Orientation. Arch. Clin. Neuropsychol., 2009; 24(4):355 -370.
427.Pena-Casanova, J; Gramunt-Fombuena, N; Quinones-Ubeda, S; Sanchez-Benavides, G; Aguilar, M;
Badenes, D; Molinuevo, JL; Robles, A; Barquero, MS; Payno, M; Antunez, C; Martinez-Parra, C;
Frank-Garcia, A; Fernandez, M; Alfonso, V; Solk, JM; Blesa, R. Spanish Multicenter Normative
Studies (NEURONORMA Project): Norms for the Rey-Osterrieth Complex Figure (Copy and Memory),
and Free and Cued Selective Reminding Test. Arch. Clin. Neuropsychol., 2009; 24(4):371-393.
428.Pena-Casanova, J; Quinones -Ubeda, S; Gramunt-Fombuena, N; Quintana-Aparicio, M; Aguilar, M;
Badenes, D; Cerulla, N; Molinuevo, JL; Ruiz, E; Robles, A; Barquero, MS; Antunez, C; Martinez-Parra,
C; Frank-Garcia, A; Fernandez, M; Alfonso, V; Sol, JM; Blesa, R. Spanish Multicenter Normative
Studies (NEURONORMA Project): Norms for Verbal Fluency Tests. Arch. Clin. Neuropsychol., 2009;
24(4):395-411.
429.Pena-Casanova, J; Quinones-Ubeda, S; Gramunt-Fombuena, N; Quintana, M; Aguilar, M; Molinuevo,
JL; Serradell, M; Robles, A; Barquero, MS; Payno, M; Antunez, C; Martinez-Parra, C; Frank-Garcia, A;
Fernandez, M; Alfonso, V; Sol, JM; Blesa, R. Spanish Multicenter Normative Studi es (NEURONORMA
Project): Norms for the Stroop Color-Word Interference Test and the Tower of London-Drexel. Arch.
Clin. Neuropsychol., 2009; 24(4):413-429.
430.Torrell, JMR; Cortada, EB; Pinilla, CF; De Burgoa, VS; Vazquez, ER. Reasons for smoking cessation in
Spain by gender and age. Gac. Sanit., 2009; 23(6):539-539.
431.Martinez, C; Regidor, E; Sanchez, E; Pascual, C; de la Fuente, L. Heterogeneity by age in educational
inequalities in cause-specific mortality in women in the Region of Madrid. J. Epidemiol. Community
Health, 2009; 63(10):832-838.
46
432.Luquero, FJ; Garcia, CH; Bouza, JME; Sanz, JC; Sanchez-Padilla, E; Soria, FS; Leonardo, ROD. Profile of
paediatric admissions and emergencies during an epidemic period of rotavirus in Valladolid [Spain].
Utility of a predi ctive model. Gac. Sanit., 2009; 23(1):58-61.
433.Castellsague, X; Cohet, C; Puig-Tintore, LM; Acebes, LO; Salinas, J; Martin, MS; Breitscheidel, L;
Remy, V. Epidemiology and cost of treatment of genital warts in Spain. Eur. J. Public Health, 2009;
19(1):106-110.
434.Rodriguez-Trigo, G. Global Aspects and Health Effects of Oil Tanker Accidents. Epidemiology, 2009;
20(6. Suppl. S):S254-S254.
435.Regidor, E; Sanchez, E; de la Fuente, L; Luquero, FJ; de Mateo, S; Dominguez, V. Major reduction in
AIDS-mortality inequalities after HAART: The importance of absolute differences in evaluating
interventions. Soc. Sci. Med., 2009; 68(3):419-426.
436.Rasilla, JM; Arbonies, JC; Bolton, RD; Pereyra, LI; Andia, GS; Soriano, AP; Fernandez, RA; Martinez,
JM; Gutierrez, LL; Mate, AG; Delgado, JLC. SPECT-CT in sentinel node detection in patients with
melanoma. Rev. Esp. Med. Nucl., 2009; 28(5):229-234.
437.Grana, L; Pedraja, I; Mendez, R; Rodriguez, R. Jejuno-ileal diverticulitis with localized perforation: CT
and US findings. Eur. J. Radiol., 2009; 71(2):318-323.
438.Prieto, C; Vano, E; Ten, JI; Fernandez, JM; Iniguez, AI; Arevalo, N; Litcheva, A; Crespo, E; Floriano, A;
Martinez, D. Image Retake Analysis in Digital Radiography Using DICOM Header Information. J. Digit.
Imaging, 2009; 22(4):393-399.
439.Jacob, RS; Vano-Galvan, E; Vano, E; Ruiz, NG; Soto, JMF; Barrio, DM; Prieto, C. Optimising the Use of
Computed Radiography in Pediatric Chest Imaging. J. Digit. Imaging, 2009; 22(2):104-113.
440.Plaza, V; Bellido-Casado, J; Rodrigo, GJ; Solarte, J; Rodriguez-Trigo, G; Sepulveda, R; Neffen, H;
Perpina, M. Impact of Preventive Treatment With Long-Acting beta(2)-Adrenergic Agonists and
Inhaled Corticosteroids on the Morbidity and Mortality of Severe Asthma Exacerbations in 1543
Patients. Arch. Bronconeumol., 2009; 45(11):545-549.
441.Soler-Cataluna, JJ; Calle, M; Cosio, BG; Marin, JM; Monso, E; Alfageme, I. Health-Care Quality
Standards in Chronic Obstructive Pulmonary Disease. Arch. Bronconeumol., 2009; 45(4):196-203.
442.Tirado-Conde, G; Miravitlles, M; Alvarez-Sala, JL; de Castro, FR; Ancochea, J. Residency Training of
European Respiratory Medicine Specialists: The HERMES Project. Arch. Bronconeumol., 2009;
45(2):92-99.
443.Soler-Cataluna, JJ; Calle, M; Cosio, BG; Marin, JM; Monso, E; Alfageme, I. Welfare quality standards
in the EPOC (vol 45, pg 196, 2009). Arch. Bronconeumol., 2009; 45(7):361-362.
444.Pena-Sagredo, JL; Farinas, MC; Perez-Zafrilla, B; Cruz-Valenciano, A; Crespo, M; Joven-Ibanez, B;
Riera, E; Manero-Ruiz, FJ; Chalmeta, I; Hernandez, MV; Rodriguez-Gomez, M; Maiz, O; Lopez, R;
Cobo, T; Pita, J; Carmona, L; Gonzalez-Gay, MA. Non-typhi Salmonella infection in patients with
rheumatic diseases on TNF-alpha antagonist therapy. Clin. Exp. Rheumatol., 2009; 27(6):920-925.
445.Suarez-Gestal, M; Calaza, M; Dieguez-Gonzalez, R; Perez-Pampin, E; Pablos, JL; Navarro, F; Narvaez,
J; Marenco, JL; Herrero-Beaumont, G; Fernandez-Gutierrez, B; Lamas, JR; de la Serna, AR; Ortiz, AM;
Carreno, L; Canete, JD; Caliz, R; Blanco, FJ; Balsa, A; Gomez-Reino, JJ; Gonzalez, A. Rheumatoid
Arthritis Does Not Share Most of the Newly Identified Systemic Lupus Erythematosus Genetic
Factors. Arthritis Rheum., 2009; 60(9):2558-2564.
446.Leon, L; Jover, JA; Candelas, G; Lajas, C; Vadillo, C; Blanco, M; Loza, E; Perez, MA; Redondo, M;
Abasolo, L. Effectiveness of an Early Cognitive-Behavioral Treatment in Patients With Work
47
Disability Due to Musculoskeletal Disorders. Arthritis Rheum-Arthritis Care Res., 2009; 61(7):9961003.
447.Palomino-Morales, R; Torres, O; Vazquez-Rodriguez, TR; Morado, IC; Castaneda, S; Callejas -Rubio,
JL; Miranda-Filloy, JA; Fernandez-Gutierrez, B; Martin, J; Gonzalez-Gay, MA. Association Between
Toll-like Receptor 4 Gene Polymorphism and Biops y-proven Giant Cell Arteritis. J. Rheumatol., 2009;
36(7):1501-1506.
448.Dieguez-Gonzalez, R; Calaza, M; Perez-Pampin, E; Balsa, A; Blanco, FJ; Canete, JD; Caliz, R; Carreno,
L; de la Serna, AR; Fernandez-Gutierrez, B; Ortiz, AM; Herrero-Beaumont, G; Pablos, JL; Narvaez, J;
Navarro, F; Marenco, JL; Gomez-Reino, JJ; Gonzalez, A. Analysis of TNFAIP3, a feedback inhibitor of
nuclear factor-kappa B and the neighbor intergenic 6q23 region in rheumatoid arthritis
susceptibility. Arthritis Res. Ther., 2009; 11(2):-.
449.Rollin, R; Alvarez-Lafuente, R; Marco, F; Lopez-Duran, L; Hoyas, JA; Jover, JA; Fernandez-Gutierrez,
B. The ubiquitin-proteasome pathway and viral infections in articular cartilage of patients with
osteoarthritis. Rheumatol. Int., 2009; 29(8):969-972.
450.Palomino-Morales, R; Vazquez-Rodriguez, TR; Morado, IC; Castaneda, S; Ortego-Centeno, N;
Miranda-Filloy, JA; Lamas, JR; Martin, J; Gonzalez-Gay, MA. Lack of Association Between STAT4
Gene Polymorphism and Biopsy-proven Giant Cell Arteritis. J. Rheumatol., 2009; 36(5):1021-1025.
451.Perdigones, N; Lamas, JR; Vigo, AG; de la Concha, EG; Jover, JA; Urcelay, E; Gutierrez, BF; Martinez,
A. 6q23 polymorphisms in rheumatoid arthritis Spanish patients. RHEUMATOLOGY, 2009;
48(6):618-621.
452.Dieguez-Gonzalez, R; Akar, S; Calaza, M; Perez-Pampin, E; Costas, J; Torres, M; Vicario, JL; Velloso,
ML; Navarro, F; Narvaez, J; Joven, B; Herrero-Beaumont, G; Gonzalez-Alvaro, I; Fernandez-Gutierrez,
B; de la Serna, AR; Carreno, L; Lopez-Longo, J; Caliz, R; Collado-Escobar, MD; Blanco, FJ; FernandezLopez, C; Balsa, A; Pascual-Salcedo, D; Gomez-Reino, JJ; Gonzalez, A. Genetic variation in the nuclear
factor kappa B pathway in relation to susceptibility to rheumatoid arthritis. Ann. Rheum. Dis., 2009;
68(4):579-583.
453.Lopez-Gonzalez, R; Loza, E; Jover, JA; Del Castillo, JMB; Mendez, R; Hernandez-Garcia, C; Pato, E.
Treatment of refractory posterior uveitis with infliximab: a 7 -year follow-up study. Scand. J.
Rheumatol., 2009; 38(1):58-62.
454.Rozco, G; Abelson, AK; Gonzalez-Gay, MA; Balsa, A; Pascual-Salcedo, D; Garcia, A; FernandezGutierrez, B; Petersson, I; Pons -Estel, B; Eimon, A; Paira, S; Scherbarth, HR; Alarcon-Riquelme, M;
Martin, J. Study of Functional Variants of the BANK1 Gene in Rheumatoid Arthritis. Arthritis Rheum.,
2009; 60(2):372-379.
455.Loza, E; Lopez-Gomez, JM; Abasolo, L; Maese, J; Carmona, L; Batlle-Gualda, E. Economic Burden of
Knee and Hip Osteoarthritis in Spain. Arthritis Rheum-Arthritis Care Res., 2009; 61(2):158-165.
456.Varade, J; Lamas, JR; Rodriguez, L; Fernandez-Arquero, M; Loza-Santamaria, E; Jover, JA; de la
Concha, EG; Fernandez-Gutierrez, B; Urcelay, E; Martinez, A. IL23R and IL12B genes: susceptibility
analysis in rheumatoid arthritis [Editorial] Ann. Rheum. Dis., 2009; 68(7):1230 -1232.
457.Varade, J; Loza-Santamaria, E; Fernandez-Arquero, M; Lamas, JR; Figueredo, MD; Jover, J; de la
Concha, E; Rodriguez, L; Urcelay, E; Fernandez-Gutierrez, B; Martinez-Doncel, A. Shared Epitope and
Anti-Cyclic Citrullinated Peptide Antibodies: Relationship with Age at Onset and Duration of Diseas e
in Rheumatoid Arthritis [Letter] J. Rheumatol., 2009; 36(5):1085 -1086.
458.D'Angelo, S; Ferrante, MC; Atteno, M; Cauli, A; Rotunno, L; Vasile, M; Catanoso, M; Parsons, WJ;
Provenzano, G; Scarpa, R; Mathieu, A; Marchesoni, A; Spadaro, A; Salvarani, C; Lubrano , E; Cutro,
48
MS; Leccese, P; Olivieri, I. The performance of CASPAR criteria in early psoriatic arthritis preliminary results from an Italian prospective multicentric study. Clin. Exp. Rheumatol., 2009;
27(5):719-720.
459.De La Torre, M; Urra, JM; Blanco, J. Raised expression of cytokine receptor gp130 subunit on
peripheral lymphocytes of patients with active lupus. A useful tool for monitoring the disease
activity?. Lupus, 2009; 18(3):216-222.
460.Loza, E; Martinez-Lopez, JA; Carmona, L. A systematic review on the optimum management of the
use of methotrexate in rheumatoid arthritis patients in the perioperative period to minimize
perioperative morbidity and maintain disease control. Clin. Exp. Rheumatol., 2009; 27(5):856-862.
461.Lopez, JAM; Loza, E; Carmona, L. Systematic review on the safety of methotrexate in rheumatoid
arthritis regarding the reproductive system (fertility, pregnancy, and breastfeeding). Clin. Exp.
Rheumatol., 2009; 27(4):678-684.
462.Visser, K; Katchamart, W; Loza, E; Martinez-Lopez, JA; Salliot, C; Trudeau, J; Bombardier, C;
Carmona, L; van der Heijde, D; Bijlsma, JWJ; Boumpas, DT; Canhao, H; Edwards, CJ; Hamuryudan, V;
Kvien, TK; Leeb, BF; Martin-Mola, EM; Mielants, H; Muller-Ladner, U; Murphy, G; Ostergaard, M;
Pereira, IA; Ramos-Remus, C; Valentini, G; Zochling, J; Dougados, M. Multinational evidence-based
recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid
arthritis: integrating systematic literature research and expert opinion of a broad international
panel of rheumatologists in the 3E Initiative. Ann. Rheum. Dis., 2009; 68(7):1086-1093.
463.Loza, E; Jover, JA; Rodriguez, L; Carmona, L. Multimorbidity: Prevalence, Effect on Quality of Life and
Daily Functioning, and Variati on of This Effect When one Condition Is a Rheumatic Disease. Semin.
Arthritis Rheum., 2009; 38(4):312-319.
464.Anselmino, M; Bammer, T; Cebrian, JMF; Daoud, F; Romagnoli, G; Torres, A. Cost-effectiveness and
Budget Impact of Obesity Surgery in Patients with Type 2 Diabetes in Three European Countries(II).
Obes. Surg., 2009; 19(11):1542-1549.
465.Sanchez-Santos, R; Masdevall, C; Baltasar, A; Martinez-Blazquez, C; de Gordejuela, AGR; Ponsi, E;
Sanchez-Pernaute, A; Vesperinas, G; Del Castillo, D; Bombuy, E; Duran-Escribano, C; Ortega, L; de
Adana, JCR; Baltar, J; Maruri, I; Garcia -Blazquez, E; Torres, A. Short- and Mid-term Outcomes of
Sleeve Gastrectomy for Morbid Obesity: The Experience of the Spanish National Registry. Obes.
Surg., 2009; 19(9):1203-1210.
466.Velasco, MV; Casanova, I; Sanchez-Pernaute, A; Perez-Aguirre, E; Torres, A; Puerta, J; Cabrerizo, L;
Rubio, MA. Unusual Late-Onset Wernicke's Encephalopathy Following Vertical Banded Gastroplasty.
Obes. Surg., 2009; 19(7):937-940.
467.Duran, L; Moral, V; Basora, M; Colomina, MJ; Llau, JV; Sanchez, CA; Silva, S; Vila, M. Epidemiological
study of preoperative anaemia in surgical oncology patients in Spain. RECIRON Study. Cir. Espan.,
2009; 85(1):45-52.
468.Sanchez-Pernaute, A; Aguirre, EP; Talavera, P; Valladares, LD; de la Ser na, JP; Mantilla, CS; de Leon,
AR; Torres, A. Laparoscopic approach to esophageal perforation secondary to pneumatic dilation for
achalasia. Surg. Endosc., 2009; 23(5):1106-1109.
469.Zabena, C; Gonzalez-Sanchez, JL; Martinez-Larrad, MT; Torres-Garcia, A; Alvarez-FernandezRepresa, J; Corbaton-Anchuelo, A; Perez-Barba, M; Serrano-Rios, M. The FTO Obesity Gene.
Genotyping and Gene Expression Analysis in Morbidly Obese Patients. Obes. Surg., 2009; 19(1):8795.
49
470.Masdevall, C; Baltasar, A; Martinez-Blazquez, C; de Gordejuela, AGR; Ponsi, E; Sanchez-Pernaute, A;
Vesperinas, G; Del Castillo, D; Bombuy, E; Duran, C; Ortega, L; de Adana, JCR; Baltar, J; Blazquez, EG;
Torres, A. Influence of Technical Variations in Sleeve Gastrectomy: Are We Talking About the Same
Technique?. Obes. Surg., 2009; 19(8):962-963.
471.Perez-Aguirre, E; Talavera, P; Valderrama, OC; Dominguez, I; Cabrerizo, L; Barabash, A; Valladares,
LD; Herrera, MR; Torres, A. Single Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy.
Two-Year Clinical Results. Obes. Surg., 2009; 19(8):965-965.
472.Cardenas-Crespo, S; Garcia-Botella, A; Cabrerizo, L; Vazquez, D; Matia, P; Sanchez-Pernaute, A;
Rubio-Herrera, M; Martin-Antona, E; Torres, A; Torres, A. Medium-Term Clinical and Metabolic
Results After Modified Duodenal Switch, Larrad Biliopancreatic Diversion and Gastric Bypass in the
Treatment of Morbid Obesity. Obes. Surg., 2009; 19(8):1054-1054.
473.Oshiro, EO; Fernandez-Represa, JA. Current state of digestive system robotic surgery in the light of
evidence based medicine. Cir. Espan., 2009; 85(3):132-139.
474.Sierra, AH; Petit, A; Moya, D; Revuelta, I; Mazuecos, MA; Fructuoso, AIS; Errasti, P; Cruzado, JM;
Oppenheimer, F; Campistol, JM. MOLECULAR EXPRESSION OF mTOR PATHWAY IN SKIN KAPOSI'S
SARCOMA AFTER RENAL TRANSPLANTATION. Transpl. Int., 2009; 22(Suppl. 2):263-263.
475.Sanchez-Fructuoso, AI; Romero, NC; Maestro, ML; Vidaurreta, M; Perez-Flores, I; Veganzone, S; De
la Orden, V; Ortega, D; Arroyo, M; Ba rrientos, A. The Prevalence of Uridine DiphosphateGlucuronosyltransferase 1A9 (UGT1A9) Gene Promoter Region: Single-Nucleotide Polymorphisms T275A and C-2152T and Its Influence on Mycophenolic Acid Pharmacokinetics in Stable Renal
Transplant Patients. Am. J. Transplant., 2009; 9(Suppl. 2):498-498.
476.Sanchez-Fructuoso, A; Ruiz, JC; Rengel, M; Andres, A; Morales, JM; Beneyto, I; Guirado, LL;
Cantarell, C. Improvement of Renal Function in Stable Renal Transplant Patients during the First
Year after the Introduction of Mycophenolate Sodium in the Immunosuppressive Regimen.. Am. J.
Transplant., 2009; 9(Suppl. 2):499-499.
477.Fernandez-Gomez, J; Madero, R; Solsona, E; Unda, M; Martinez-Pineiro, L; Gonzalez, M; Portillo, J;
Ojea, A; Pertusa, C; Rodriguez-Molina, J; Camacho, JE; Rabadan, M; Astobieta, A; Montesinos, M;
Isorna, S; Muntanola, P; Gimeno, A; Blas, M; Martinez-Pineiro, JA. Predicting Nonmuscle Invasive
Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The
CUETO Scoring Model. J. Urol., 2009; 182(5):2195-2203.
478.Teruel, JL; Torrente, J; Lucas, MF; Marcen, R; Parra, EG; Zarraga, S; Garcia, G. Evaluating renal
function and indications for starting dialysis. Nefrologia, 2009; 29(Suppl. 1):38-43.
479.Zarraga, S; Garcia, G; Teruel, JL; Torrentia, J; Lucas, MF; Marcen, R; Parra, EG. Choosing the dialysis
method for kidney transplant patients with advanced kidney disease. Nefrologia, 2009; 29(Suppl.
1):44-48.
480.Perez-Flores, I; Sanchez-Fructuoso, A; Marcen, R; Fernandez, A; Lucas, MF; Teruel, JL. Managing a
failed kidney graft. Nephrectomy versus embolisation. Nefrologia, 2009; 29(Suppl. 1):54-61.
481.Marcen, R; Fernandez, A; Lucas, MF; Teruel, JL; Perez-Flores, I; Sanchez-Fructuoso, A. Retransplant.
Nefrologia, 2009; 29(Suppl. 1):62-71.
482.Portoles, J; Corchete, E; Lopez-Sanchez, P; Coronel, F; Ocana, J; Ortiz, A. Patients on peritoneal
dialysis with type 2 diabetes present poorer progress than non-diabetics at the expense of their
cardiovascular comorbidity. Nefrologia, 2009; 29(4):336-342.
50
483.Veiga, FG; Olmol, JMC; Gunthner, S; Pallas, MP; Moyano, AS; Ramos, EB; Rebollo, FJ. Development
and validation of the first spanish questionnaire of quality of life in patients with prostate cancer,
based on the patient's perception. Actas Urol. Esp., 2009; 33(6):623-634.
484.Gardiner, JIM; Amo, FH; Cordero, JMD; Benavente, RC; Moyano, AS; Fernandez, CH. Prognostic
factors for survival in patients with transitional baldder cancer treated with radical cystectomy.
Actas Urol. Esp., 2009; 33(3):249-257.
485.Bolton, RCD; Rasilla, JM; Castejon, MJP; Delgado, JLC. Positron emission tomography (PET) and PETCT in renal, bladder and prostate cancer: Update. Actas Urol. Esp., 2009; 33(1):11-23.
486.Perez, CF; Sierra, JM; Escudero, SC; Ferrer, MEF; Fajardo, GB; Moyano, AS. Prevalence of lower
urinary tract symptoms related with benign prostatic hyperplasia. Study of 1804 men aged 40 or
older in Madrid. Actas Urol. Esp., 2009; 33(1):43-51.
487.Coronel, F; Cigarran, S; Herrero, JA. Early initiation of peritoneal dialysis in diabetic patients. Scand.
J. Urol. Nephrol., 2009; 43(2):148-153.
488.Gomez, CO; Ortega, JS. Detection of Heredity Renal Cancer: Urology Distress [Editorial] Actas Urol.
Esp., 2009; 33(1):3-4.
489.Cordova, MD. Acute ischaemia as a consequence of arteriovenous fistula massage in haemodialysis
[Letter] Nefrologia, 2009; 29(4):367-368.
490.Vazquez, TRM; San Cecilio, RV; Aranda, IU; Guzman, AB. The importance of early diagnosis to the
prognosis of tubulo-interstitial immune-complex nephritis [Letter] Nefrologia, 2009; 29(3):274-274.
491.Gomez, CO; Galante, MI; San Jose, LA; Resel, LE; De La Orden, V; Vidaurreta, M; Veganzones, S;
Rafael, S; Arroyo, M; Diaz-Rubio, E; Maestro, M. CIRCULATING TUMOR CELLS (CTC) IN THE THREE
TUMOR TYPES OF EPITHELIAL ORIGIN: PROSTATE, BREAST AND COLORECTAL, IN PATIENTS WITH
AND WITHOUT METASTASIS. Eur. Urol. Suppl., 2009; 8(4):346-346.
492.Sanz-Ortega, J; Olivier, C; Segura, PP; Romo, IG; Manso, LSJ; Saez, M. Hereditary renal cancer. Actas
Urol. Esp., 2009; 33(2):127-133.
493.Martinez-Laso, J; Roman, A; Head, J; Cervera , I; Rodriguez, M; Rodriguez-Avial, I; Picazo, JJ.
Phylogeny of G9 rotavirus genotype: A possible explanation of its origin and evolution. J. Clin. Virol.,
2009; 44(1):52-57.
51
12. Listado de proyectos competitivos del HCSC activos durante el año 2009
PROYECTOS COFINANCIADOS
DENOMINACIÓN
FINANCIADOR
DOPPLER CIP: DETERMINING OPTIMAL NON-INVASIVE PARAMETERS FOR THE PREDICTION
OF LEFT VENTRICULAR MOPHOLOGIC AND FUNCTIONAL REMODELING IN CHRONIC EU/PRG. MARCO
ISCHEMIC PATIENTS
EUHEART: PERSONALISED & INTEGRATED CARDIAC CARE: PATIENT-SPECIFIC
CARDIOVASCULAR MODELLING AND SIMULATION FOR IN SILICO DISEASE UNDERSTANDING
& MANAGEMENT AND FOR MEDICAL DEVICE EVALUATION & OPTIMIZATION
EUROPREVALL: THE PREVALENCE, COST AND BASIS OF FOOD ALLERGY ACROSS EUROPE
EVINCI: EVALUATION OF INTEGRATED CARDIAC IMAGING FOR THE DETECTION AND
CHARACTERIZATION OF ISCHEMIC HEART DISEASE
FAST: TOWARDS SAFE AND EFFECTIVE IMMUNOTHERAPY OF PERSISTENT LIFETHREATENING FOOD ALLERGIES
HEARTCYCLE: COMPLIANCE AND EFFECTIVENESS IN HF AND CHD CLOSEDLOOP
MANAGEMENT
METABO: CONTROLLING CHRONIC DISEASES RELATED TO METABOLIC DISORDERS
MYHEART: PERSONALISED & INTEGRATED CARDIAC CARE: PATIENT-SPECIFIC
CARDIOVASCULAR MODELLING AND SIMULATION FOR IN SILICO DISEASE UNDERSTANDING
& MANAGEMENT AND FOR MEDICAL DEVICE EVALUATION & OPTIMIZATION
TRAIL TO REDUCE IDDM IN THE GENETICALLY AT RISK-STUDY TRIGR, PROJECT
IP
SERVICIO
ZAMORANO GÓMEZ, JOSÉ LUIS
UNIDAD DE ECOCARDIOGRAFÍA
EU/PRG. MARCO
PÉREZ VILLACASTÍN DOMÍNGUEZ, JULIÁN
UNIDAD DE ECOCARDIOGRAFÍA
EU/PRG. MARCO
FERNÁNDEZ RIVAS, MARÍA MONTSERRAT
ALERGIA
EU/PRG. MARCO
ZAMORANO GÓMEZ, JOSÉ LUIS
UNIDAD DE ECOCARDIOGRAFÍA
EU/PRG. MARCO
FERNÁNDEZ RIVAS, MARÍA MONTSERRAT
ALERGIA
EU/PRG. MARCO
PÉREZ VILLACASTÍN DOMÍNGUEZ, JULIÁN
UNIDAD DE ARRITMIAS
EU/PRG. MARCO
CALLE PASCUAL, ALFONSO LUIS
ENDOCRINOLOGÍA
EU/PRG. MARCO
PÉREZ VILLACASTÍN DOMÍNGUEZ, JULIÁN
UNIDAD DE ECOCARDIOGRAFÍA
EU/PRG. MARCO
NIH
SERRANO RÍOS, MANUEL
MEDICINA INTERNA
52
PROYECTOS CON FINANCIACIÓN PÚBLICA
DENOMINACIÓN
ABORDAJE DE LAS ENFERMEDADES RESPIRATORIAS RARAS. COORDINACIÓN ENTRE NIVELES
ASISTENCIALES
CHILD TRAUMA NETWORK: PSYCHOLOGICAL NETWORK SUPPORT TO VIOLENCE TRAUMATIZED
CHILDREN: DISASTERS, CONFLICTS
ALTERACIONES EN LAS ZONAS ATENUADORAS DE LOS GENES DE RESISTENCIA A MACROLIDOS EN
MOCRORGANISMOS GRAMPOSITIVOS IMPLICADOS EN INFECCIONES RESPIRATORIAS. RELACIÓN
CON LOS PERFILES FENOTIPICOS.
ANÁLISIS PROTEÓMICO DE LA EXPRESIÓN DE PROTEÍNAS DIFERENCIALES EN CÉLULAS MADRE
MESENQUIMALES DE PACIENTES CON ARTROSIS Y EN SUJETOS SANOS.
APLICACIÓN DE TERAPIAS REGENERATIVAS EN HUMANOS:CREACIÓN DE UNA SALA BLANCA
CALIDAD ASISTENCIAL Y SEGURIDAD DE LOS PACIENTES CON ENFERMEDADES REUMÁTICAS:
IMPLANTACIÓN DE UN SISTEMA DE EVENTOS ADVERSOS E REUMATOLOGÍA
CARACTERIZACIÓN FUNCIONAL DE LA CONDUCTANCIA LUMINAL DE POTASIO EN LA MUCOSA
COLINCA DE LOS MAMÍFEROS: NUEVOS ENFOQUES TERAPÉUTICOS PARA LA HIPERSECRECIÓN
INTESTINAL.
CARACTERIZACIÓN MOLECULAR DEL CÁNCER COLORRECTAL EN FAMILIAS AMSTERDAM
NEGATIVAS PARA EL FENOTIPO MUTADOR (HNPCC-MSS)
DESARROLLO DE LA GESTIÓN POR PROCESOS EN EL INSTITUTO DE PSIQUIATRÍA DEL HOSPITAL
CLÍNICO SAN CARLOS
DESARROLLO Y EVALUACIÓN DE NANOSISTEMAS DE AGENTES TERAPEUTICOS
ANTIINFLAMATORIOS PARA EL TRATAMIENTO DEL SINDROME DE OJO SECO
DESCRIPCIÓN DE INMUNOFENOTIPOS EN EL RECONOCIMIENTO INMUNOLÓGICO MEDIANTE UN
ENSAYO MICROARRAY EN LA ALERGIA DE LECHE DE VACA EN POBLACIÓN INFANTIL PEDIÁTRICA.
DETERMINACIÓN DEL MÉTODO MÁS FIABLE PARA LA EVALUACIÓN DE LA LIMPIEZA AUTOMÁTICA
DEL INSTRUMENTAL QUIRÚRGICO Y EQUIPOS DE ANESTESIA.
DISSECTION OF THE ALLERGIC RESPONSE TO FISH ALLERGENS IN THE SPANISH POPULATION:
FROM THE ALLERGENS TO THE CLINICS. **ACCIÓN INTEGRADA 2006
EFECTOS DE UN PROGRAMA ASISTIDO DE EJERCICIO FÍSICO Y ADHERENCIA AL ESTILO DE VIDA
MEDITERRANEA SOBRE EL CONTROL DE LOS FACTORES DE RIESGO CARDIOVASCULAR EN
PACIENTES DIABÉTICOS TIPO 2 RECIEN DIAGNOSTICADOS.
EFECTOS DE UN PROGRAMA DE INTERVENCIÓN NUTICIONAL Y DE ACTIVIDAD FÍSICA BASADO EN
LA ADHERENCIA A UN NIVEL DE EXCELENCIA EN EL ESTILO DE VIDA MEDITERRANEO EN MUJERES
CON ANTECEDENTES DE DIABETES GESTACIONAL.
FINANCIADOR
MSPS
IP
NIETO BARBERO, MARÍA ASUNCIÓN
SERVICIO
NEUMOLOGÍA
ISCIII-MICINN
LÓPEZ-IBOR ALIÑO, JUAN JOSÉ
PSIQUIATRIA
ISCIII-MICINN
PICAZO DE LA GARZA, JUAN JOSÉ
MICROBIOLOGÍA
ISCIII-MICINN
MARCO MARTÍNEZ, FERNANDO
MICINN
ISCIII-MICINN
FERNÁNDEZ GUTIÉRREZ, BENJAMÍN
JOVER JOVER, JUAN ÁNGEL
TRAUMATOLOGÍA
Y C. ORTOPÉDICA
SALA BLANCA
REUMATOLOGÍA
ISCIII-MICINN
MAYOL MARTÍNEZ, JULIO ÁNGEL
CIRUGÍA GENERAL I
ISCIII-MICINN
CALDES LLOPIS, TRINIDAD
MSPS
LÓPEZ-IBOR ALIÑO, JUAN JOSÉ
ONCOLOGÍA
MÉDICA
PSIQUIATRIA
ISCIII-MICINN
BENÍTEZ DEL CASTILLO SÁNCHEZ, JOSÉ MANUEL
OFTALMOLOGÍA
ISCIII-MICINN
FERNÁNDEZ RIVAS, MARÍA MONTSERRAT
ALERGIA
ISCIII-MICINN
FERERES CASTIEL, JOSÉ
MICINN
FERNÁNDEZ RIVAS, MARÍA MONTSERRAT
MEDICINA
PREVENTIVA
ALERGIA
MSPS
CALLE PASCUAL, ALFONSO LUIS
ENDOCRINOLOGÍA
MSPS
CALLE PASCUAL, ALFONSO LUIS
ENDOCRINOLOGÍA
53
DENOMINACIÓN
EFICACIA DE UN PROGRAMA DE GESTIÓN DE ENFERMEDADES EN PACIENTES DE EDAD MUY
AVANZADA CON INSUFICIENCIA CARDIACA E IMPORTANTE COMORBILIDAD: ENSAYO
MULTICÉNTRICO RANDOMIZADO.
ELABORACIÓN DE UNA VÍA CLÍNICA PARA LA HEMORRAGIA SUBARACNOIDEA EN EL HOSPITAL
CLÍNICO SAN CARLOS. MADRID
ENFERMEDADES INFLAMATORIAS INTESTINALES: FARMACOGENÉTICA Y SUSCEPTIBILIDAD
CONFERIDA POR GENES DE LA RUTA DE SEÑALIZACIÓN DEL IL-6.
ENFERMEDADES MUSCULOESQUELÉTICAS
FINANCIADOR
ISCIII-MICINN
IP
RIBERA CASADO, JOSÉ MANUEL
SERVICIO
GERIATRIA
MSPS
MATÍAS GUIU GUIA, JORGE
NEUROLOGÍA
ISCIII-MICINN
GÓMEZ DE LA CONCHA, EMILIO
INMUNOLOGÍA
ISCIII-MICINN
FERNÁNDEZ GUTIÉRREZ, BENJAMÍN
REUMATOLOGÍA
ENSAYO CLÍNICO RANDOMIZADO DOBLE CIEGO DE CARBONATO DE LITIO COMO TERAPIA DE
ASOCIACIÓN EN ESCLEROSIS LATERAL AMIOTRÓFICA
ESTUDIO ALEATORIZADO Y CONTROLADO DE LA EFICACIA DE LA PSICOTERAPIA DINÁMICA BREVE
EN PACIENTES CON TRASTORNOS DE LA PERSONALIDAD BORDELINE
ESTUDIO DE ASOCIACIÓN DE VARIANTES DEL GEN QUE CODIFICA PARA LA SUBUNIDAD ALFA 7 DEL
RECEPTOR NICOTÍNICO NEURONAL (CHRNA7) Y RASGOS FENOTÍPICOS COMUNES A TRASTORNO
BIPOLAR Y ESQUIZOFRENIA
ESTUDIO DE ASOCIACIÓN DE VARIANTES DEL GEN QUE CODIFICA PARA LA SUBUNIDAD ALFA 7 DEL
RECEPTOR NICOTINICO NEURONAL (CHRNA7) Y RASGOS FENOTIPICOS COMUNES A TRANSTORNO
BIPOLAR Y ESQUIZOFRENIA
ESTUDIO DE CÉLULAS TUMORALES EN SANGRE PERIFÉRICA EN CÁNCER DE MAMA Y COLON.
ESTUDIO DE SU VALOR PRONÓSTICO Y DE SU RELACIÓN CON TNM Y LA ENFERMEDAD
METASTÁSICA
ESTUDIO DE LA APOPTOSIS, ESTRÉS OXIDATIVO, Y RECEPTOR DE ENDOTELINA, ETB, EN EL
GLAUCOMA DE ÁNGULO ABIERTO: SU POSIBLE RELACIÓN CON EL GRADO DEL DEFECTO DEL
CAMPO VISUAL.
ESTUDIO DE LA EFECTIVIDAD A LARGO PLAZO DEL TRATAMIENTO DE LA HEPATITIS CRÓNICA C EN
PACIENTES COINFECTADOS POR VIH Y VHC
ESTUDIO DE LA EFICACIA Y SEGURIDAD DE INYECCIONES INTRAVITREAS DE BEVACIZUMAB EN EL
EDEMA MACULAR SECUNDARIO A OCLUSIONES VENOSAS RETINIANA (EBOVER)
ESTUDIO DE LA ENFERMEDAD CORONARIA; EFECTIVIDAD Y OPTIMIZACION DEL TRATAMIENTO
ESTUDIO DE LA RELACIÓN ENTRE EL TRAUMA INFANTIL Y LAS DIFUSIONES BIOLÓGICAS EN EL
TRASTORNO LÍMITE DE LA PERSONALIDAD
ESTUDIO DE UTILIZACIÓN DE ANTIFÚNGICOS SISTÉMICOS EN LOS HOSPITALES ESPAÑOLES
ISCIII-MICINN
GALÁN DÁVILA, LUCÍA
NEUROLOGÍA
ISCIII-MICINN
RENESES PRIETO, BLANCA
PSIQUIATRIA
ISCIII-MICINN
CABRANES DÍAZ, JOSÉ ANTONIO
PSIQUIATRIA
ISCIII-MICINN
CABRANES DÍAZ, JOSÉ ANTONIO
PSIQUIATRIA
ISCIII-MICINN
DÍAZ-RUBIO GARCÍA, EDUARDO
ONCOLOGÍA
MÉDICA
ISCIII-MICINN
FERNÁNDEZ DURANGO, FELISA RAQUEL
OFTALMOLOGÍA
ISCIII-MICINN
TÉLLEZ MOLINA, MARÍA JESÚS
ISCIII-MICINN
DONATE LÓPEZ, JUAN
MEDICINA
INTERNA III
OFTALMOLOGÍA
MICINN
ISCIII-MICINN
PÉREZ VILLACASTÍN DOMÍNGUEZ, JULIÁN
CARRASCO PERERA, JOSÉ LUIS
CARDIOLOGÍA
PSIQUIATRIA
ISCIII-MICINN
PORTOLÉS PÉREZ, ANTONIO
ESTUDIO DEL MAPA PROTEÓMICO DEL PLASMA Y DE LAS PLAQUETAS DE PACIENTES RESISTENTES
A LA ASPIRINA.
ISCIII-MICINN
LÓPEZ FARRÉ, ANTONIO
FARMACOLOGÍA
CLÍNICA
CARDIOLOGÍA
54
DENOMINACIÓN
ESTUDIO TRANSLACIONAL DE LA GENÉTICA DE LA ESCLEROSIS MÚLTIPLE.
FINANCIADOR
ISCIII-MICINN
IP
URCELAY GARCÍA, ELENA
EVALUACIÓN DE LA EFICACIA Y SEGURIDAD DE LA INYECCCIÓN INTRAVÍTREA DE BEVACIZUMAB EN
EL TRATAMIENTO DE LA NEOVASCULARIZACIÓN COROIDEA ASOCIADA A LA MIOPÍA MAGNA
EVALUACIÓN DE LA EFICACIA Y SEGURIDAD DE LA INYECCIÓN INTRAVITREA DE TRIAMCINOLONA
EN EL TRATAMIENTO DEL EDEMA DE MACULA DEL DIABÉTICO.
EVALUACIÓN IN VIVO DEL PAPEL DE LA INTERLEUQUINA 6 Y DEL CORTISOL EN LA VARIACIÓN
CIRCADIANA DE LOS EVENTOS FATALES (INFARTO DE MIOCARDIO, MUERTE SÚBITA, ANGINA
INESTABLE)
FARMACOGENÉTICA DEL INTERFERON BETA EN PACIENTES ESPAÑOLES DE ESCLEROSIS MÚLTIPLE
ISCIII-MICINN
DONATE LÓPEZ, JUAN
SERVICIO
APARATO
DIGESTIVO
OFTALMOLOGÍA
ISCIII-MICINN
DONATE LÓPEZ, JUAN
OFTALMOLOGÍA
ISCIII-MICINN
MACAYA MIGUEL, CARLOS
CARDIOLOGÍA
ISCIII-MICINN
INMUNOLOGÍA
GENÓMICA DEL CÁNCER. PROYECTO COOPERATIVO RED DE CENTROS DE CÁNCER. SUBPRYECTO
NODO DEL HOSPITAL CLÍNICO SAN CARLOS.
IDENTIFICACIÓN DE BIOMARCADORES PROTEICOS ASOCIADOS A RESISTENCIA A LA ASPIRINA Y A
TIENOPIRIDINAS EN PACIENTES CON CARDIOPATIA ISQUÉMICA ESTABLECIDA. (ESTUDIO BIRAT)
ISCIII-MICINN
FERNÁNDEZ ARQUERO, MIGUEL
MARTÍNEZ DONCEL, ALFONSO
DÍAZ-RUBIO GARCÍA, EDUARDO
ISCIII-MICINN
MACAYA MIGUEL, CARLOS
ONCOLOGÍA
MÉDICA
CARDIOLOGÍA
INTERVENCIONIST
A
IDENTIFICACIÓN Y SEGURIDAD INTEGRAL DE PACIENTES EN UN HOSPITAL DE MEDIA -LARGA
ESTANCIA
IMPORTANCIA DE LAS INTERACCIONES ENTRE GENES IMPLICADOS EN RESPUESTA INFLAMATORIA
EN LA SUSCEPTIBILIDAD A ENFERMEDAD CELÍACA.
INCREMENTO DEL NÚMERO DE CORAZONES VÁLIDOS PARA TRASPLANTE TRAS SU RECUPERACIÓN
Y EVALUACIÓN EX_VIVO UTILIZANDO UN NUEVO MÉTODO DE PRESERVACIÓN.
MSPS
ISCIII-MICINN
NÚÑEZ PARDO DE VERA, MARÍA CONCEPCIÓN
INMUNOLOGÍA
ISCIII-MICINN
NÚÑEZ PEÑA, JOSÉ RAMÓN
INFLUENCIA DE LA CIRUGÍA CARDIACA PRECOZ EN EL PRONÓSTICO A CORTO Y LARGO PLAZO DE
LA ENDOCARDITIS I NFECCIOSA. ENDOVAL -1.
INMUNIDAD INNATA, INFECCIÓN POR HHV-6 Y GENÉTICA EN LA PROGRESIÓN DE LA
DISCAPACIDAD EN PACIENTES CON ESCLEROSIS MÚLTIPLE
INMUNOGENÉTICA AVANZADA DE LA ESCLEROSIS MÚLTPLE EN LA POBLACIÓN ESPAÑOLA.
ISCIII-MICINN
VILA COSTA, ISIDRE
CIRUGÍA MAYOR
AMBULATORIA
(CMA)
CARDIOLOGÍA
ISCIII-MICINN
ÁLVAREZ LAFUENTE, ROBERTO
NEUROLOGÍA
ISCIII-MICINN
MARTÍNEZ DONCEL, ALFONSO
INMUNOLOGÍA
INTERVENCIÓN EDUCATIVA EN EL PACIENTE HIPERTENSO CON TRATAMIENTO FARMACOLÓGICO.
MSPS
SAINZ MARTÍN, MARÍA
LINEA DE ESTABILIZACIÓN
ISCIII-MICINN
GÓMEZ GARRE, DULCENOMBRE
LOCALIZACIÓN DE LOS DIFERENTES GENES DE SUSCEPTIBLIDAD PARA LA DEFICIENCIA DE IGA:
REGIONES HLA Y NO HLA.
ISCIII-MICINN
FERNÁNDEZ ARQUERO, MIGUEL
MEDICINA
PREVENTIVA
MEDICINA
INTERNA III
INMUNOLOGÍA
55
DENOMINACIÓN
MARCADORES BIOLÓGICOS DE RESPUESTA A INTERFERÓN BETA EN PACIENTES CON ESCLEROSIS
MÚLTIPLE Y SU RELACIÓN CON LOS NIVELES DE EXPRESIÓN Y DISPONIBILIDAD DEL RECEPTOR DEL
HERPES VIRUS HUMANO-6 (CD46)
MEJORA DE LA CALIDAD DE VIDA MEDIANTE LA MANIPULACIÓN QUIRÚRGICA DE LA ÓPTICA
OCULAR
MODULACIÓN DE LA RESPUESTA INMUNE MEDIANTE LA EXPRESIÓN DE HLA-G Y CD1D EN
CÉLULAS MADRE CD133 POSITIVAS DE CORDÓN UMBILICAL Y SU UTILIDAD EN TERAPIA CELULAR Y
MEDICINA REGENERATIVA.
OTR.RADIOLOGICAL PROTECTION IN INTERVENTIONAL RADIOLOGY
FINANCIADOR
ISCIII-MICINN
IP
ARROYO GONZÁLEZ, RAFAEL VÍCTOR
SERVICIO
NEUROLOGÍA
ISCIII-MICINN
IRADIER URRUTIA, MARÍA TERESA
OFTALMOLOGÍA
ISCIII-MICINN
MARTÍNEZ LASO, JORGE MAURICIO
UCM
MICINN
VAÑÓ CARRUANA, ELISEO
FÍSICA MÉDICA
PAPEL DE LAS CÉLULAS MONONUCLEADAS EN EL SÍNDROME DE RESISTENCIA A ASPIRINA EN
PACIENTES CON CARDIOPATÍA ISQUÉMICA ESTABLECIDA.
ISCIII-MICINN
LÓPEZ FARRÉ, ANTONIO
PARTICIPACIÓN DEL COLESTEROL EN LA FISIOPATOLOGÍA DE LA INSUFICIENCIA CARDICA.
BÚSQUEDA DE NUEVOS ABORDAJES TERAPEÚTICOS
PATOLOGÍAS OCULARES CAUSANTES DE CEGUERA LIGADAS AL ENVEJECIMIENTO
PATRÓN NECROSCÓPICO Y CLÍNICO DE LA MUERTE SÚBITA. PROYECTO ENMARCADO EN LA RED
TEMÁTICA: CARACTERÍSTICAS EPIDEMIOLÓGICAS, CLÍNICAS Y ANATOMAPTOLÓGICAS DE LA
MUERTE SÚBITA EN ESPAÑA (G03/078)
PATRONES DE CARRERA, EVALUACIÓN DEL POTENCIAL DE INSERCIÓN LABORAL E INFLUENCIA EN
LA CONSECUCIÓN DE EMPLEO
PERCEPCIÓN DE CARAS EMOCIONALMENTE NEUTRAS EN PSICOSIS TEMPRANAS: ESTUDIO
MAGNETOENCEFALOGRÁFICO DE PACIENTES MUY DELIRANTES VERSUS POCO DELIRANTES.
PERFIL ESTEROIDEO EN DEPORTISTAS Y SU RELACIÓN CON PARAMETROS FISIOLOGICOS Y
GENETICOS. DESARROLLO DE MODELOS MATEMATICOS PARA LA DETERMINACIÓN DE NIVELES
UMBRALES DE ESTEROIDES EN CONTROL DE DOPAJE
PERSONALIDAD Y MECANISMOS DE RESPUESTA AL ESTRÉS EN LAS MANIFESTACIONES CLÍNICAS DE
LOS TRASTORNOS DE LA CONDUCTA ALIMENTARIA.
PREDICCIÓN DE LA RESPUESTA AL TRATAMIENTO CON DOXORUBICINA O DOCETAXEL EN CÁNCER
DE MAMA MEDIANTE MODELOS PRONÓSTICOS UNIGÉNICOS Y POLIGÉNICOS.
PROGRAMA DE ATENCIÓN PSIQUIATRICA DIRIGIDA A ENFERMOS MENTALES SIN HOGAR DE
MADRID.
PROGRAMA DE DEFINICIÓN DIAGNÓSTICA DEL TRASTORNO POR DEFICIT DE ATENCIÓN E
HIPERACTIVDAD EN LA COMUNIDAD DE MADRID.
PROGRAMA DE MEJORA DE LA COMUNICACIÓN ENTRE EL PERSONAL SANITARIO Y LA PACIENTE
OBSTÉTRICA Y SUS FAMILIARES. ATENCIÓN INTEGRAL EN COMUNICACIÓN DESDE URGENCIAS
HASTA EL ALTA A DOMICILIO
ISCIII-MICINN
GÓMEZ GARRE, DULCENOMBRE
ISCIII-MICINN
ISCIII-MICINN
GARCÍA FEIJOÓ, JULIÁN
MACAYA MIGUEL, CARLOS
CARDIOLOGÍA
INTERVENCIONIST
A
MEDICINA
INTERNA III
OFTALMOLOGÍA
CARDIOLOGÍA
ISCIII-MICINN
ALONSO GARCÍA, MIGUEL
ISCIII-MICINN
LÓPEZ-IBOR ALIÑO, JUAN JOSÉ
MICINN
FERNÁNDEZ PÉREZ, CRI STINA
MEDICINA
PREVENTIVA
ISCIII-MICINN
DÍAZ MARSÁ, MARINA FRANCISCA
PSIQUIATRIA
ISCIII-MICINN
MARTÍN JIMÉNEZ, MIGUEL
MSPS
CRESPO HERVÁS, DOLORES
ONCOLOGÍA
MÉDICA
PSIQUIATRIA
MSPS
ORTIZ ALONSO, TOMÁS
PSIQUIATRIA
MSPS
MAÑAS RUEDA, CRISTINA
ONCOLOGÍA
MÉDICA
PSICOLOGÍA
CLÍNICA
PSIQUIATRIA
56
DENOMINACIÓN
PROGRAMA DE MEJORA DE LA COMUNICACIÓN ENTRE EL PERSONAL SANITARIO Y LA PACIENTE
OBSTÉTRICA Y SUS FAMILIARES. ATENCIÓN INTEGRAL EN COMUNICACIÓN DESDE URGENCIAS
HASTA EL ALTA A DOMICILIO.
PROGRAMA DE PREVENCIÓN DE CAIDAS EN EL ÁMBITO HOSPITALARIO
FINANCIADOR
MSPS
IP
FRANCISCO GARCÍA GARCÍA
SERVICIO
SUBDIRECCIÓN
ENFERMERÍA
MSPS
FERNANDEZ DEL PALACIO, ENCARNACION
PROGRAMA DE PSICOEDUCACIÓN A FAMILIARES DE ENFERMOS ESQUIZOFRÉNICOS Y APOYO A
PACIENTES CON POCA ADHERENCIA AL TRATAMIENTO.
PROTECCIÓN RADIOLÓGICA EN RADIOLOGÍA INTERVENCIONISTA (PRORARI)
MSPS
FRANCISCO GARCÍA GARCÍA
ISCIII-MICINN
VAÑÓ CARRUANA, ELISEO
DIRECCIÓN
ENFERMERÍA
SUBDIRECCIÓN
ENFERMERÍA
FÍSICA MÉDICA
PROTECCIÓN RADIOLÓGICA EN RADIOLOGÍA INTERVENCIONISTA
MICINN
VAÑÓ CARRUANA, ELISEO
FÍSICA MÉDICA
RED DE INVESTIGACIÓN EN INFLAMACIÓN Y ENFERMEDADES REUMÁTICAS
ISCIII-MICINN
FERNÁNDEZ GUTIÉRREZ, BENJAMÍN
RED DE INVESTIGACIÓN EN INSUFICIENCIA CARDIACA EN ESPAÑA. REDINSCOR
RED ESPAÑOLA DE ESCLEROSIS MÚLTIPLE
RED HERACLES: DETERMINANTES GENÉTICOS Y AMBIENTALES DE LA DISFUNCIÓN VASCULAR.
ISCIII-MICINN
ISCIII-MICINN
ISCIII-MICINN
PÉREZ VILLACASTÍN DOMÍNGUEZ, JULIÁN
GÓMEZ DE LA CONCHA, EMILIO
LÓPEZ FARRÉ, ANTONIO
TRAUMATOLOGÍA
Y C. ORTOPÉDICA
CARDIOLOGÍA
INMUNOLOGÍA
CARDIOLOGÍA
RED TEMÁTICA DE INVESTIGACIÓN COOPERATIVA DE CANCER (RTICC): TRANSNACIONAL
PLATAFORMA DE SERVICIO DE DETERMINACIÓN DE CÉLULAS TUMORALES CIRCULANTES EN
CÁNCER COLORRECTAL ESTADIO III"
REDINSCOR RED DE INVESTIGACIÓN DE INSUFICIENCIA CARDIACA EN ESPAÑA
REGULACIÓN DE LA RESPUESTA INMUNE DE DIFERENTES SUBTIPOS DE CÉLULAS DENDRITICAS
MEDIADAS POR CÉLULAS NKT MEDIANTE LA SOBRE EXPRESION DE CE1D EN SANGRE PERIFÉRICA Y
DE CORDON UMBILICAL Y SU APLICACIÓN AL DISEÑO DE VACUNAS.
RELACIÓN DEL ESTRÉS PSICOFÍSICO PREVIO COMO FACTOR DE RIESGO DE ICTUS
ISCIII-MICINN
DÍAZ-RUBIO GARCÍA, EDUARDO
ONCOLOGÍA
MÉDICA
ISCIII-MICINN
ISCIII-MICINN
FERNÁNDEZ-CRUZ PÉREZ, ARTURO
MARTÍNEZ LASO, JORGE MAURICIO
CARDIOLOGÍA
UCM
ISCIII-MICINN
CASTILLO PLA, OLGA
NEUROLOGÍA
RENEVAS
RETICS DE BIOBANCOS
ISCIII-MICINN
ISCIII-MICINN
EGIDO HERRERO, JOSÉ ANTONIO
SANZ ORTEGA, JULIÁN
RETICS DE INNOVACIONES EN TECNOLOGIAS MEDICAS Y SANITARIAS
SISTEMA DE AUDITORÍA CONTROL DE CALIDAD Y DOSIMETRÍA A LOS PACIENTES A TIEMPO REAL
PARA RADIOLOGÍA DIGITAL.
TRATAMIENTO DE LAS LESIONES DEL MANGUITO ROTADOR MEDIANTE EL TRASPLANTE
AUTÓLOGO DE CÉLULAS MADRE MESENQUIMALES DE ASPIRADOS DE MÉDULA ÓSEA
UTILIDAD DE LA TOMOGRAFÍA POR EMISIÓN DE POSITRONES (PET) CON 18F-FDG Y DE LA PET-TAC
EN LA EVALUACIÓN DE LA RESPUESTA AL TRATAMIENTO DE LA ENFERMEDAD DE HODGKIN Y LOS
LINFOMAS DE HODKIN.
VARIABILIDAD DE LA EXPRESIÓN DEL GEN BRCA1 Y RIES GO DE CÁNCER DE MAMA EN LA
POBLACIÓN ESPAÑOLA.
ISCIII-MICINN
CAM
MAYOL MARTÍNEZ, JULIO ÁNGEL
VAÑÓ CARRUANA, ELISEO
NEUROLOGÍA
ANATOMÍA
PATOLÓGICA
CIRUGÍA GENERAL I
FÍSICA MÉDICA
ISCIII-MICINN
FERNÁNDEZ GUTIÉRREZ, BENJAMÍN
REUMATOLOGÍA
ISCIII-MICINN
CARRERAS DELGADO, JOSÉ LUÍS
MEDICINA
NUCLEAR
ISCIII-MICINN
DE LA HOYA MANTECÓN, MIGUEL
ONCOLOGÍA
MÉDICA
57
PROYECTOS CON FINANCIACIÓN PRIVADA
DENOMINACIÓN
FACTORES GENÉTICOS EN LA SUSCEPTIBILIDAD, EVOLUCIÓN Y RESPUESTA A FÁRMACOS EN
PACIENTES ESPAÑOLES DE ARTRITIS REUMATOIDE.
DIAGNÓSTICO EL RECHAZO AGUDO DEL TRASPLANTE RENAL PROCEDENTE DE DONANTE EN
ASISTOLIA MEDIANTE ANÁLISIS PROTEÓMICO DE LA ORINA.
CD46, RECEPTOR CELULAR DEL HERPESVIRUS HUMANO 6, Y RESPUESTA AL TRATAMIENTO CON
INTERFERÓN BETA, EN PACIENTES CON ESCELEROSIS MÚLTIPLE
PATRONES DE EXPRESIÓN DEL GEN BRCA1 QUE PUEDEN CONFERIR MAYOR RIESGO DE CANCER EN
FAMILIAS CON SINDROME MAMA/OVARIO HEREDITARIO.
ESTUDIO DE FACTORES, PRONÓSTICO EN PACIENTES CON CARCINOMA BRONCOGENICO NO
MICROCITICO INTEVENIDOS QUIRURGICAMENTE. CARACTERIZACIÓN MOLECULAR MEDIANTE
TISSUE-ARRAY DE SUBGRUPOS BIOLÓGICOS CON AFECTACIÓN GANGLIONAR FRENTA A PACIENTES
SIN AFECTACIÓN GANGLIONAR.
ESTUDIO ALEATORIZADO PARA COMPRAR 75MG/DÍA VERSUS 150MG/DÍA DE CLOPIDOGREL EN
PACIENTES DIABÉTICOS CON ENFERMEDAD CORONARIA.
EFECTOS FUNCIONALES PRECOCES DEL PRECONDICIONAMIENTO ISQUEMICO EN EL
AUTOTRASPLANTE SEGMENTARIO DE INTESTINO EN EL CERDO.
DESARROLLO DEL PROTEOMA DE LA PARED ARTERIAL DE PACIENTES ARTERIOESCLERÓTICOS CON
DIABETES MELLITUS: INFLUENCIA DE LAS PLAQUETAS.
MODIFICACION FARMACOLÓGICA DE LA FIBRILACIÓN VENTRICULAR MEDIANTE CROMAKALINA Y
CLORURO DE BARIO PARA LOCALIZAR EL ORIGEN DE POSIBLES ROTORES MADRE
ESTUDIO GENÓMICO Y PROTEÓMICO DEL TEJIDO ADIPOSO EN PATOLOGÍAS RELACIONADAS CON
SÍNDROME METABÓLICO: OBESIDAD, DIABETES MELLITUS TIPO 2 Y SÍNDROME DE RESISTENCIA A
LA INSULINA (SÍNDROME METABÓLICO).
IDENTIFICACIÓN DE NUEVOS MARCADORES TUMORALES DE CANCER DE OVARIO.
FINANCIADOR
FMM
IP
GÓMEZ DE LA CONCHA, EMILIO
SERVICIO
INMUNOLOGÍA
FMM
MARQUES VIDAS, MARÍA SAN MIGUEL
NEFROLOGÍA
FMM
ARROYO GONZÁLEZ, RAFAEL VÍCTOR
NEUROLOGÍA
FMM
CALDES LLOPIS, TRINIDAD
ONCOLOGÍA MÉDICA
FMM
GÓMEZ MARTÍNEZ, ANA MARÍA
CIRUGÍA TORÁCICA
FMM
MACAYA MIGUEL, CARLOS
CARDIOLOGÍA
FMM
MAYOL MARTÍNEZ, JULIO ÁNGEL
CIRUGÍA GENERAL I
FMM
MOÑUX DUCAJÚ, GUILLERMO
FMM
PÉREZ VILLACASTÍN DOMÍNGUEZ, JULIÁN
FMM
SERRANO RÍOS, MANUEL
CARDIOLOGÍA
INTERVENCIONISTA
UNIDAD DE
ECOCARDIOGRAFÍA
MEDICINA INTERNA
FMM
VIDART ARAGÓN, JOSÉ ANTONIO
ESTUDIO DE ASOCIACIÓN DE VARIANTES DEL GEN QUE CODIFICA PARA LA SUBUNIDAD ALFA 7 DEL
RECEPTOR NICOTÍNICO NEURONAL (CHRNA7) Y RASGOS FENOTÍPICOS COMUNES A TRASTORNO
BIPOLAR Y ESQUIZOFRENIA
ANÁLISIS DE LOS PERFILES DE MICRORNAS (MIRNAS) Y SU COMBINACIÓN CON LOS RESULTADOS
DE EXPRESIÓN MASIVA DE MRNAS EN CÁNCER DE COLON PARA LA CLASIFICACIÓN DE ENFERMOS.
*POSIBLE COINCIDENCIA CON COD.CEIC: B-07/104 Nº REG. 1079*
CALIBRACIÓN INTRAOPERATIVA DE LA FUNDUPLICATURA LAPAROSCOPICA: RESULTADOS TRAS
UTILIZACIÓN DE BUJIA INTRALUMNINAL Y TRAS MONITORIZACIÓN CON MANOMETRÍA DE ALTA
RESOLUCIÓN
FMM
CABRANES DÍAZ, JOSÉ ANTONIO
OBSTETRICIA Y
GINECOLOGÍA
PSIQUIATRIA
FMM
DÍAZ-RUBIO GARCÍA, EDUARDO
ONCOLOGÍA MÉDICA
FMM
PÉREZ AGUIRRE, MARÍA ELIA
CIRUGÍA GENERAL II
58
DENOMINACIÓN
ANÁLISIS DE LA EXPRESIÓN DEL TGF-B Y SUS RECEPTORES (TBRI, TBRII, TBRIII) EN CÉLULAS MADRE
MESENQUIMALES (MSCS) DE PACIENTES CON ARTROSIS. PERFIL DE LOS GENES Y PROTEÍNAS
EXPRESADOS DIFERENCIALMENTE EN MSCS ESTIMULADAS CON TGF-B UTILIZANDO MICROARRAYS
DE DNA DE GENOMA COMPLETO Y ELECTROFORESIS 2D -DIGE.
IDENTIFICACIÓN Y CARACTERIZACIÓN DE LA SUBPOBLACIÓN DE CÉLULAS TRONCALES TUMORALES
EN LOS GLIOMAS CEREBRALES HUMANOS: RELACIÓN CON LAS CÉLULAS TRONCALES NEURALES
ESTUDIO DE POLIMORFISMOS DE LOS GENES QUE CODIFICAN PARA LA ALFA-1
ANTIQUIMOTRIPSINA, EL PROMOTOR DEL TRANSPORTADOR DE SEROTONINA, EL RECEPTOR
NICOTÍNICO Y ALFA 7 Y APOLIPOPROTEÍNA COMO FACTORES DE RIESGO DE DESARROLLO DE
DETERIORO GOGNITIVO LIGERO Y ENFERMEDAD DEL ALZHEIMER
VALOR PRONÓSTICO Y UTILIDAD COMO MEDIDOR DE RESPUESTA ANTITUMORAL, TRAS
TRATAMIENTO DE QUIMIOTERAPIA DE LAS CÉLULAS TUMORALES CIRCULANTES, DE LA EXPRESIÓN
HER2/NEU Y DE LAS CÉLULAS ENDOTELIALES CIRCULANTES EN CÁNCER DE MAMA METASTÁSICO
RASGOS DE SATURACIÓN DE OXIGENO DE LA HEMOGLOBINA Y SU RELACIÓN CON CÉLULAS
PROGENITORES ENDOTELIALES Y FACTORES ANGIOGÉNICOS REGUALDORES DE LA
VASCULARIZACIÓN RETINIANA EN NIÑOS PREMATUROS DE MENOS DE 28 SEMANAS Y EN UN
MODELO EXPERIMENTAL DE RETINOPATÍA.
INCREMENTO DEL NÚMERO DE CORAZONES VÁLIDOS PARA TRASPLANTE TRAS SU RECUPERACIÓN
Y EVALUACIÓN EX_VIVO UTILIZANDO UN NUEVO MÉTODO DE PRESERVACIÓN.
VALORACIÓN DE LA EFICACIA DEL PET-TAC 18 FDG EN EL DIAGNÓSTICO PRECOZ DE CÁNCER DE
MAMA Y/U OVARICO EN MUJERES PORTADORAS DE MUTACIONES EN LOS GENES BRCA1 Y 2
ACTIVIDAD Y EXPRESIÓN DE 11-BETA-HIDROXI-ESTEROIDE DEHIDROGENASA 1 EN TEJIDO
HEPÁTICO Y ADIPOSO (SUBCUTÁNEO Y VISCERAL) DE PACIENTES CON OBESIDAD MÓRBIDA Y SU
RELACIÓN CON EL SÍNDROME METABÓLICO
VALORACIÓN INTEGRAL DE LA ABLACIÓN DE LA MUCOSA ECTÓPICA DEL ESÓFAGO DE BARETT
MEDIANTE RADIOFRECUENCIA BIPOLAR
CARACTERIZACIÓN MOLECULAR MEDIANTE TISSUE-ARRAYS DE MENGIOMAS: CORRELACIÓN CON
PARÁMETROS HISTOPATOLÓGICOS, RESUPUESTA AL TRATAMIENTO, RECIDIVA Y SUPERVIVENCIA.
ESTUDIO TRANSLACIONAL DE LA GENÉTICA DE LAS ENFERMEDADES INFLAMATORIAS
INTESTINALES
ADAPTACIÓN Y VALIDACIÓN DE UN CUESTIONARIO PARA EVALUAR LA SEVERIDAD DEL SÍNDROME
DE INTESTINO IRRITABLE EN PACIENTES ESPAÑOLES
POLIMORFISMOS DE LA ESFINGOMIELIANASA NEUTRA TIPO 2 COMO FACTOR PREDICTOR DEL
DESARROLLO DE HIPERTENSIÓN ARTERIAL PULMONAR EN LOS PACIENTES CON UNA ENFERMEDAD
PULMONAR OBSTRUCTIVA CRÓNICA.
REACTIVACIÓN RETROVIRAL POR HERPESVIRUS: IMPLICACIÓN EN ESCLEROSIS MÚLTIPLE
FINANCIADOR
FMM
IP
MARCO MARTÍNEZ, FERNANDO
SERVICIO
TRAUMATOLOGÍA Y C.
ORTOPÉDICA
FMM
ZIMMAN MANSFELD, HORACIO MARIO
NEUROCIRUGÍA
FMM
MARCOS DOLADO, ALBERTO
NEUROLOGÍA
FMM
MARTÍN JIMÉNEZ, MIGUEL
ONCOLOGÍA MÉDICA
FMM
MORO SERRANO, MANUEL
NEONATOLOGÍA
FMM
NÚÑEZ PEÑA, JOSÉ RAMÓN
FMM
PÉREZ SEGURA, PEDRO
CIRUGÍA MAYOR
AMBULATORIA (CMA)
ONCOLOGÍA MÉDICA
FMM
RUBIO HERRERA, MIGUEL ÁNGEL
ENDOCRINOLOGÍA
FMM
RUIZ DE LEÓN SAN JUAN, ANTONIO
APARATO DIGESTIVO
FMM
SANZ ORTEGA, JULIÁN
FMM
URCELAY GARCÍA, ELENA
ANATOMÍA
PATOLÓGICA
APARATO DIGESTIVO
FMM
ALMANSA MENCHERO, MARÍA CRISTINA
APARATO DIGESTIVO
FMM
ÁLVAREZ-SALA WALTHER, JOSÉ LUIS
NEUMOLOGÍA
FMM
ARROYO GONZÁLEZ, RAFAEL VÍCTOR
NEUROLOGÍA
59
DENOMINACIÓN
ELECCIÓN DE LA DIANA ÓPTIMA PARA NEUROESTIMULACIÓN EN LOS TRASTORNOS AFECTIVOS.
MAMOGRAFÍA DIGITAL DE CAMPO COMPLETO (MDCC). AVANCES EN LA DETECCIÓN Y
VALORACIÓN DIAGNÓSTICA DE LAS MICROCALCIFICACIONES MAMARIAS. NUEVOS SIGNOS
RADIOLÓGICOS Y CORRELACIÓN ANATOMO-PATOLÓGICA.
ESTUDIO EPIDEMIOLÓGICO NACIONAL DEL DOLOR TORÁCICO NO CARDÍACO
FINANCIADOR
FMM
FMM
IP
BARCIA ALBACAR, JUAN ANTONIO
CEPEDA IZQUIERDO, Mª TERESA
SERVICIO
NEUROCIRUGÍA
RADIODIAGNÓSTICO
FMM
DÍAZ-RUBIO GARCÍA, MANUEL
APARATO DIGESTIVO
ASPECTOS PROTEÓMICOS Y GENÉTICOS DE LA RESISTENCIA A LA ASPIRINA EN PACIENTES CON
CARDIOPATÍA ISQUÉMICA ESTABLECIDA: IMPORTANCIA DE LOS LEUCOCITOS SOBRE ESTE
SÍNDROME.
FACTORES PRONÓSTICOS EN LA COLECISTITIS AGUDA.
FMM
LÓPEZ FARRÉ, ANTONIO
CARDIOLOGÍA
FMM
GONZÁLEZ ARMENGOL, JUAN JORGE
URGENCIAS
VULNERABILIDAD SELECTIVA DE LA MOTONEURONA A LOS EFECTOS NEUROTÓXICOS DEL LÍQUIDO
CEFALORRAQUÍDEO DE PACIENTES DE ESCLEROSIS LATERAL AMIOTRÓFICA (ELA)
HAPLOTIPOS YIN-YANG EN GENES SUPRESORES DE TUMOR Y SUSCEPTIBILIDAD AL CÁNCER; EL GEN
BRCA1 COMO MODELO.
VALORACIÓN DE LA SEGURIDAD Y EFICACIA DE LA INYECCIÓN TRANSENDOCÁRDICA DE CÉLULAS
PROGENITORAS ENDOTELIALES AUTÓLOGAS CD 133 PARA ANGIOGÉNESIS TERAPÉUTICA
PREDICCIÓN EVOLUTIVA EN FASES PRECOCES DE LA HEPATITIS CRÓNICA POR VIRUS DE LA
HEPATITIS C MEDIANTE LA IDENTIFICACIÓN DE MARCADORES MOLECULARES EN EL PROTEOMA
PLASMÁTICO Y LINFOCITARIO Y SU RELACIÓN CON LAS ALTERACIONES HISTOLÓGICAS HEPÁTICAS
DÉFICIT COGNITIVOS E IDEAS SOBREVALORADAS EN EL TRASTORNO OBSESIVO-COMPULSIVO Y EN
LA ESQUIZOFRENIA. ESTUDIO DE NEUROIMAGEN FUNCIONAL CON MAGNETOENCEFALOGRAFÍA.
VALORACIÓN DE LA FUNCIÓN PLAQUETARIA EN PACIENTES CON DISCINESIA VENTRICULAR
IZQUIERDA TRANSITORIA (TAKOTSUBO)
MORBI-MORTALIDAD Y CARACTERIZACIÓN GENOTÍPICA EN EL ÁMBITO RURAL Y URBANO DE LA
PROVINCIA DE SEGOVIA.
BYPASS DUODENO-ILEAL PROXIMAL TÉRMINO-LATERAL-CRUCE DUODENAL E ASA. COMO
TRATAMIENTO DE LA DIABETES MELLITUS TIPO 2
ESTUDIO DEL MAPA PROTEÓMICO TISULAR Y EL PERFIL INMUNOHISTOQUÍMICO DEL CARCINOMA
UROTELIAL VESICAL SUPERFICIAL VS INFILTRANTE.
ESTUDIO DEL ESPECTRO PROTEICO MEDIANTE ESPECTROMETRÍA DE MASAS EN EL CÁNCER DE
OVARIO.
UTILIDAD DEL SEGUIMIENTO ECOCARDIOGRÁFICO TRIDIMENSI ONAL DEL MIOCARDIO Y DE LA
RESONANCIA MAGNÉTICA CARDIACA EN LA CARACTERIZACIÓN Y DETECCIÓN PRECOZ DE
PACIENTES CON MIOCARDIOPATÍA HIPERTRÓFICA.
POLIMORFISMOS GENÉTICOS DE UGT1A9 Y MPR2: PAPEL EN LA FARMACOCINETICA Y EFECTOS
SECUNDARIOS DE ACIDO MICOFENOLICO EN TRASPLANTE RENAL
FMM
MATÍAS GUIU GUIA, JORGE
NEUROLOGÍA
FMM
DE LA HOYA MANTECÓN, MIGUEL
ONCOLOGÍA MÉDICA
FMM
JIMÉNEZ QUEVEDO, PILAR
FMM
LADERO QUESADA, JOSÉ MARÍA
CARDIOLOGÍA
INTERVENCIONISTA
APARATO DIGESTIVO
FMM
LÓPEZ-IBOR ALCOCER, MARÍA INÉS
PSIQUIATRIA
FMM
NÚÑEZ GIL, IVÁN JAVIER
CARDIOLOGÍA
FMM
FERNÁNDEZ PÉREZ, CRISTINA
MEDICINA PREVENTIVA
FMM
SÁNCHEZ PERNAUTE, ANDRÉS
CIRUGÍA GENERAL II
FMM
SANZ ORTEGA, JULIÁN
FMM
VIDART ARAGÓN, JOSÉ ANTONIO
FMM
ZAMORANO GÓMEZ, JOSÉ LUIS
ANATOMÍA
PATOLÓGICA
OBSTETRICIA Y
GINECOLOGÍA
CARDIOLOGÍA
INTERVENCIONISTA
FMM
SÁNCHEZ FRUCTUOSO, ANA ISABEL
NEFROLOGÍA
60
DENOMINACIÓN
RESPUESTA INMUNE INNATA ACTIVADA POR SECUENCIAS OLIGONUCLEOTIDICAS NO METILADAS E
INFECCION POR HERPES/VIRUS HUMANO 6 EN PACIENTES CON ESCLEROSIS MÚLTIPLE
PAPEL DE LAS VARIANTES COMUNES DE GENES DE PÉPTIDOS GASTROINTESTINALES EN LA
RESPUESTA DE LA PERDIDA DE PESO TRAS CIRUGÍA BARIATRICA
IDENTIFICACIÓN DE PROTEINAS ASOCIADAS A LA GÉNESIS DEL ANEURISMA DE AORTA
ABDOMINAL: PAPEL DE LAS PLAQUETAS Y LAS CÉLULAS MONONUCLEADAS
RESONANCIA MAGNÉTICA EN LA ESTADIFICACIÓN DEL CARCINOMA DE PULMÓN: UTILIDAD DE LAS
SECUENCIAS POTENCIADAS EN DIFUSIÓN
ESTUDIO DEL ESTIGMA Y LA DISCRIMINACIÓN ASOCIADAS A LA DEPRESIÓN EN ESPAÑA Y SU
REPERCUSIÓN EN LAS INCAPACIDADES LABORALES TRANSITORIAS POR DEPRESIÓN. (ANTI SITIGMA
PROGRAMME EUROPEAN NETWORK-ASPEN)
DISEÑO Y EVALUACIÓN DE UN MODELO EXPERIMENTAL PARA ESCLEROSIS LATERAL AMIOTRÓFICA
ESPORÁDICA MEDIANTE EL EFECTO CITOTOXICO DEL LCR
ESTUDIO INMUNOHISTOQUÍMICO MEDIANTE TISSUE-ARRAY Y CARACTERIZACIÓN MOLECULAR DE
MUTACIONES DE C-KIT Y PDGFA DE LOS TUMORES DEL ESTROMA GASTROINTESTINAL (GIST).
ESTABLECIMIENTO DE PARÁMETROS PRONÓSTICOS.
ALTERACIONES MOLECULARES DE LOS TUMORES ESÓFAGO-GÁSTRICOS: IMPLICACIONES
PRONÓSTICAS Y TERAPÉUTICAS.
ESTUDIO DE LA REGENRACIÓN EN LA DISCOPATÍA INTERVERTEBRAL DEGENERATIVA CON LA
PROTEINA-1 OSTEOGÉNICA RECOMBINANTE HUMANA Y CON CÉLULAS MADRE MESENQUIMALES
EN UN MODELO EXPERIMENTAL EN COLA DE RATA.
RECUPERACIÓN FUNCIONAL EN LA LUMBALGIA INCAPACITANTE: EFICACIA DE UNA INTERVENCIÓN
COGNITIVO-CONDUCTUAL TEMPRANA
COHORTE DE GESIDA DE PACIENTES COINFECTADOS POR VIH Y VIRUS DE HEPATITIS C QUE
RECIBEN TRATAMIENTO PARA LA HEPATITIS C (2008-2010)
FINANCIADOR
FMM
IP
ARROYO GONZÁLEZ, RAFAEL VÍCTOR
SERVICIO
NEUROLOGÍA
FMM
TORRES GARCÍA, ANTONIO JOSÉ
ENDOCRINOLOGÍA
FMM
MOÑUX DUCAJÚ, GUILLERMO
FMM
FERREIROS DOMÍNGUEZ, JOAQUÍN
ANGIOLOGÍA Y CIRUGÍA
VASCULAR
RADIODIAGNÓSTICO
FMM
LÓPEZ-IBOR ALIÑO, JUAN JOSÉ
PSIQUIATRIA
FMM
MATÍAS GUIU GUIA, JORGE
NEUROLOGÍA
FMM
SANZ ESPONERA, JULIÁN
ANATOMÍA
PATOLÓGICA
FMM
SÁNCHEZ PERNAUTE, ANDRÉS
ONCOLOGÍA MÉDICA
F. MAPFRE
LÓPEZ-DURÁN STERN, LUIS
TRAUMATOLOGÍA Y C.
ORTOPÉDICA
F. MAPFRE
LEÓN MATEOS, LETICIA
REUMATOLOGÍA
FIPSE
TÉLLEZ MOLINA, MARÍA JESÚS
MEDICINA INTERNA III
61